Update April 26 - May 02, 2021, Dr. Peter J. Lansberg MD, PhD

Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics

COVID-19 publications - Week 17 2021 1448 Publications

PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected]

Reliable on-line resources for Covid 19

WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap)

Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance

Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database COVID-19 prevention network Covid-Plex trial - (plasma exchange & convalescent plasma trial)

The Covid-Plex trial is an investigator initiated, multicenter, parallel-group, open-label randomized clinical trial aiming to randomize patients with severe COVID-19 to standard care or standard care plus plasmapheresis and convalescent plasma.

If you are interested to participate Please contact Wladimir Szpirt, Nicholas Carlson Anders, or Perner Bo Feldt-Rasmussen. Depts. Of Intensive Care Therapy and Nephrology, Copenhagen University Hospital Rigshospitalet, Denmark

Covid-Plex trial

Mainstream Media New York Times - Corona update India’s vaccinations decline as its virus outbreak reaches new highs. Europe signals it may not support Biden’s call to waive Covid vaccine patents. Millions of Johnson & Johnson doses sit unused across three continents. Australia confirms it will allow its citizens to return home from India starting May 15, Want a coronavirus vaccine? U.S. pharmacies say walk right in. Pregnant women in Britain will be offered Covid-19 vaccines. Pfizer-BioNTech Vaccine is Highly Effective Against Variants, Studies Find Millions Are Skipping Their Second Doses of Covid Vaccines How Hard Could It Be to Vaccinate the Whole World?

Washington Post - Corona update Drug companies dig in for global patent fight amid flow of billions in vaccine revenue The pandemic has led to innovation. It’s a reason for optimism. 149.5 million vaccinated Germany lets the vaccinated have a bit more fun. Teens shut out from the jabs are not happy. Europe's vaccine campaign is accelerating. It expects to match the U.S. by July. We could see a winter comeback of covid-19 if we don’t get more Americans vaccinated now

Guardian - Corona update Covid-19 unlikely to be ever eradicated, warns Prof Chris Whitty New concerns as Indian Covid variant clusters found across England Tui to offer £20 Covid tests for travellers to green list countries EU wants to mass produce three ‘course-changing’ Covid drugs from October IOC and Pfizer strike vaccine deal for Tokyo Olympics competitors

Key Articles

1. COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials. Pharmaceuticals (Basel) 2021; 14Yan ZP, Yang M, Lai CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923054 In this phase of the COVID, pandemic vaccination efforts have become the focus of attention. To date, 86 vaccines are under development. This review shares the most relevant information of 12 vaccines currently deployed or very close to being released for clinical use. Efficacy and safety data of these vaccines in various populations are presented in a concise and systematic overview to provide health care providers with relevant information.

2. Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database. Vaccines (Basel) 2021; 9Tobaiqy M, Elkout H, MacLure K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923530 From March 11th, several European countries suspended the use of the Astra Zeneca Oxford vaccine. The European Medical Agency (EMA) and World Health Organization came out with reassuring reports, and most, but not all, countries re-started the use of the Astra Zeneca Oxford vaccine. This review shares data collected in the Eudora Vigilance registry from February 17th – March 12th. Of the 17 million individuals that received the vaccine, 54 571 reported adverse events. Thrombotic complications occurred in 28 individuals, of which three died from pulmonary embolisms and one from thrombosis. The observed fatal complications were classified as extremely rare events, and the EMA concluded that the benefits far outweighed the risks.

3. Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia. Stroke 2021; American Heart Association/American Stroke Association Stroke Council L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914590 Cerebral venous sinus thrombosis (CVST) is an extremely thrombotic rare complication that was reported in six cases after use of the Jansen – Johnson & Johnsen (JJJ) vaccine. Thrombotic complications were also reported after the use of the Astra Zeneca Oxford vaccine. Both vaccines share the use of adenoviral vectors. The mRNA based Pfizer and Moderna vaccines did not report any cases of thrombocytopenia associated CVST in 187 million vaccinated individuals. After initial suspension of the JJJ vaccine, the FDA has authorized the continuation of this vaccine, but advised clinicians to be aware of this extremely rare complication and this review provides clinicians with helpful information on CVST diagnosis and management

4. E-Triage Systems for COVID-19 Outbreak: Review and Recommendations. Sensors (Basel) 2021; 21Alhaidari F, Almuhaideb A, Alsunaidi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920744

5. Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19. J Clin Med 2021; 10Wu CC, Lee AJ, Su CH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916281

6. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure. J Clin Med 2021; 10Wolf ME, Luz B, Niehaus L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918932

7. Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates. Antib Ther 2020; 3:115- 125Verma HK, Farran B, Bhaskar L. http://www.ncbi.nlm.nih.gov/pubmed/? term=33912791

8. Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients' lived experience. Clin Infect Dis 2021; Tran VT, Riveros C, Clepier B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912905

9. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int J Environ Res Public Health 2021; 18Sisó- Almirall A, Brito-Zerón P, Conangla Ferrín L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923972

10. Cancer as a prospective sequela of long COVID-19. Bioessays 2021:e2000331Saini G, Aneja R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33914346

11. Neurological update: COVID-19. J. Neurol. 2021:1-9Ren AL, Digby RJ, Needham EJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929617

12. COVID-19: Direct and Indirect Mechanisms of Statins. Int J Mol Sci 2021; 22Pawlos A, Niedzielski M, Gorzelak-Pabiś P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920709

13. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci 2021; 17:1446-1460Park JW, Lagniton PNP, Liu Y, Xu RH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907508

14. Safety of COVID-19 vaccines administered in the EU: Should we be concerned? Toxicol Rep 2021; 8:871-879Hernández AF, Calina D, Poulas K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898273

15. COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment. SN Compr Clin Med 2021:1-7Hapshy V, Aziz D, Kahar P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3389892

Basic Science (93 articles)

1. Analysis of the Genomic Distance Between Bat Coronavirus RaTG13 and SARS-CoV-2 Reveals Multiple Origins of COVID-19. Acta Math Sci 2021; 41:1017-1022Pei S, Yau SS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897081 2. Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule. Acta Pharmacol. Sin. 2021:1-18Lan XF, Olaleye OE, Lu JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931765 3. Quantitative Evaluation of Aerosol Generation from Non-contact Tonometry and its Correlation with Tear Film Characteristics. Adv Ther 2021:1-11Hao W, Wu J, Zhao X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909233 4. Supramolecular cylinders target bulge structures in the 5' UTR of the RNA genome of SARS-CoV-2 and inhibit viral replication. Angew. Chem. Int. Ed. Engl. 2021; Melidis L, Hill H, Coltman N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915014 5. Sinapic Acid Suppresses SARS CoV-2 Replication by Targeting Its Envelope Protein. Antibiotics (Basel) 2021; 10Orfali R, Rateb ME, Hassan HM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920366 6. Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197. Biochem. Biophys. Res. Commun. 2021; 558:79- 85Bellone ML, Puglisi A, Dal Piaz F, Hochkoeppler A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906110 7. PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses. Biomaterials 2021; 273:120827Park HH, Kim H, Lee HS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910079 8. Novel and emerging mutations of SARS-CoV-2: Biomedical implications. Biomed. Pharmacother. 2021; 139:111599Mohammadi E, Shafiee F, Shahzamani K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915502 9. Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro. Biomedicines 2021; 9Gilham D, Smith AL, Fu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919584 10. Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective. Biomedicines 2021; 9Miao M, Clercq E, Li G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920487 11. Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach. Biomolecules 2021; 11Hopp MT, Domingo-Fernández D, Gadiya Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925394 12. The Emerging Role of Epigenetic Mechanisms in the Causation of Aberrant MMP Activity during Human Pathologies and the Use of Medicinal Drugs. Biomolecules 2021; 11Sarker H, Haimour A, Toor R, Fernandez-Patron C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920915 13. Podophyllotoxin: History, Recent Advances and Future Prospects. Biomolecules 2021; 11Shah Z, Gohar UF, Jamshed I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921719 14. Recent Advances of Field-Effect Transistor Technology for Infectious Diseases. Biosensors (Basel) 2021; 11Panahi A, Sadighbayan D, Forouhi S, Ghafar-Zadeh E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918325 15. Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins. Brief. Bioinform. 2021; Qin S, Xu W, Wang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907801 16. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Cell Rep. 2021:109055Mulay A, Konda B, Garcia G, Jr. et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905739 17. Soluble Interleukin-6 Receptor in the COVID-19 Cytokine Storm Syndrome. Cell Rep Med 2021:100269Chen LYC, Biggs CM, Jamal S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899032 18. Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles. Cells 2021; 10Kumar B, Hawkins GM, Kicmal T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918600 19. Dual targeting of cytokine storm and viral replication in COVID-19 by plant- derived steroidal pregnanes: An in silico perspective. Comput. Biol. Med. 2021; 134:104406Gyebi GA, Ogunyemi OM, Ibrahim IM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915479 20. Promising phytochemicals of traditional Himalayan medicinal plants against putative replication and transmission targets of SARS-CoV-2 by computational investigation. Comput. Biol. Med. 2021; 133:104383Natesh J, Mondal P, Kaur B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915361 21. Enzyme kinetic and binding studies identify determinants of specificity for the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease. Comput Struct Biotechnol J 2021; Tecza M, Kagawa TF, Jain M, Cooney JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897974 22. Enzyme kinetic and binding studies identify determinants of specificity for the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease. Comput Struct Biotechnol J 2021; 19:2356-2365Teçza M, Kagawa TF, Jain M, Cooney JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897974 23. Biomolecular interactions with nanoparticles: Applications for COVID-19. Curr Opin Colloid Interface Sci 2021:101461Farouq MAH, Al Qaraghuli MM, Kubiak- Ossowska K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907504 24. Design and manufacturability data on additively manufactured solutions for COVID-19. Data Brief 2021; 36:107012Prabhu R, Masia JS, Berthel JT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898670 25. Drug delivery of amoxicillin molecule as a suggested treatment for covid-19 implementing functionalized mesoporous SBA-15 with aminopropyl groups. Drug Deliv 2021; 28:856-864Alazzawi HF, Salih IK, Albayati TM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928831 26. Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China. Emerg Infect Dis 2021; 27:1492-1495Chu DKW, Hui KPY, Gu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900193 27. Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses. Emerg Infect Dis 2021; 27:1380-1392Wang L, Fan X, Bonenfant G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900165 28. Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications. Emerg Microbes Infect 2021:1-24Shen L, Bard JD, Triche TJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896413 29. In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes. Environ. Sci. Pollut. Res. Int. 2021; Shaldam MA, Yahya G, Mohamed NH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33934306 30. Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID- 19 pandemics. Exp. Biol. Med. (Maywood) 2021:15353702211008106Banerjee A, Mukherjee S, Maji BK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899542 31. Applications of the CRISPR-Cas system for infectious disease diagnostics. Expert Rev Mol Diagn 2021; Li P, Wang L, Yang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899643 32. No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection. Front Cell Infect Microbiol 2021; 11:644574García-Nicolás O, V'Kovski P, Zettl F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912475 33. Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2. Front. Immunol. 2021; 12:640842Becker K, Beythien G, de Buhr N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912167 34. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment. Front. Immunol. 2021; 12:666693Vallée A, Lecarpentier Y, Vallée JN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927728 35. Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS- CoV-2. Front Mol Biosci 2021; 8:645216Kumar DT, Shaikh N, Kumar SU et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898520 36. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection. Front. Pharmacol. 2021; 12:634176Chen RH, Yang LJ, Hamdoun S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897423 37. Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential. Front. Pharmacol. 2021; 12:619373Youssef FS, Altyar AE, Omar AM, Ashour ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912041 38. Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches. Genes (Basel) 2021; 12Jeong HH, Jia J, Dai Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923155 39. Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women. Genes (Basel) 2021; 12Monticelli M, Hay Mele B, Benetti E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921689 40. Identification of PBMC-based Molecular Signature Associational with COVID- 19 Disease Severity. Heliyon 2021:e06866Shaath H, Alajez NM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898797 41. Animal Models of COVID-19 II. Comparative Immunology. Ilar j 2021; Veenhuis RT, Zeiss CJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914873 42. Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections. Immunity 2021; Harb H, Benamar M, Lai PS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915108 43. On the Origin of SARS-CoV-2: Did Cell Culture Experiments Lead to Increased Virulence of the Progenitor Virus for Humans? In Vivo 2021; 35:1313-1326Kaina B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910809 44. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages. Infect Genet Evol 2021; 92:104869González- Candelas F, Shaw MA, Phan T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915216 45. Identification of SARS-CoV-2 origin: Using Ngrams, principal component analysis and Random Forest algorithm. Inform Med Unlocked 2021; 24:100577El Boujnouni H, Rahouti M, El Boujnouni M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898732 46. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19). Int Immunopharmacol 2021; 97:107684Karampoor S, Zahednasab H, Farahmand M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33932696 47. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities. Int Immunopharmacol 2021; 97:107694Moradinasab S, Pourbagheri-Sigaroodi A, Zafari P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932694 48. Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted in a Romanian University Hospital of Infectious Diseases. Int J Infect Dis 2021; Radulescu A, Istrate A, Flonta M, Lupse M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901653 49. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Int J Mol Sci 2021; 22Aleksova A, Gagno G, Sinagra G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926110 50. SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19. Int J Mol Sci 2021; 22Huffman AM, Rezq S, Basnet J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33922918 51. Aptamers for Anti-Viral Therapeutics and Diagnostics. Int J Mol Sci 2021; 22Kim TH, Lee SW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920628 52. Endothelial Extracellular Vesicles: From Keepers of Health to Messengers of Disease. Int J Mol Sci 2021; 22Mathiesen A, Hamilton T, Carter N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924982 53. SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment. Int J Mol Sci 2021; 22Stasiulewicz A, Maksymiuk AW, Nguyen ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921228 54. Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics. Int. J. Pept. Res. Ther. 2021:1-12Jain R, Jain A, Verma SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897313 55. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins. J Biomol Struct Dyn 2021:1-28Elmaaty AA, Darwish KM, Khattab M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928870 56. Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host- pathogen interaction and immunomodulation. J. Funct. Foods 2021; 82:104503Dhar S, Bhattacharjee P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897833 57. Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust. J Infect 2021; Garvey MI, McMurray C, Casey AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932449 58. Activating Killer-cell Immunoglobulin-like Receptors are associated with the severity of COVID-19. J Infect Dis 2021; Bernal E, Gimeno L, Alcaraz MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928374 59. Sex differences in the induction of angiotensin converting enzyme 2 (ACE-2) in mouse lungs after e-cigarette vapor exposure and its relevance to COVID- 19. J. Investig. Med. 2021; Naidu V, Zeki AA, Sharma P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926967 60. SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways. J Med Virol 2021; Han L, Zhuang MW, Deng J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913550 61. Betacoronaviruses genome analysis reveals evolution toward specific codons usage: implications for SARS-CoV-2 mitigation strategies. J Med Virol 2021; Lopes EN, Fonseca V, Frias D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33934387 62. Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2. J. Mol. Graph. Model. 2021; 106:107920Prabhu D, Rajamanikandan S, Sureshan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933885 63. Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part III: A green protocol for facile synthesis of complexes with TCNQ, DDQ, and TFQ acceptors. J. Mol. Liq. 2021; 335:116250Adam AMA, Saad HA, Alsuhaibani AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903781 64. Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part III: A green protocol for facile synthesis of complexes with TCNQ, DDQ, and TFQ acceptors. J. Mol. Liq. 2021; 335:116250Majid AAA, Saad HA, Alsuhaibani AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903781 65. In Search of RdRp and Mpro Inhibitors against SARS CoV-2: Molecular Docking, Molecular Dynamic Simulations and ADMET Analysis. J. Mol. Struct. 2021; 1239:130488Gajjar ND, Dhameliya TM, Shah GB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903778 66. Synthesis, X-ray crystal structure, IR and Raman spectroscopic analysis, quantum chemical computational and molecular docking studies on hydrazone-pyridine compound: as an insight into the inhibitor capacity of Main Protease of SARS-CoV2. J. Mol. Struct. 2021; 1239:130514Topal T, Zorlu Y, Karapınar N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903779 67. Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques. JCI Insight 2021; Sui Y, Li J, Zhang R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908897 68. Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study. Mar. Drugs 2021; 19Aatif M, Muteeb G, Alsultan A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33922914 69. Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications. Mar. Drugs 2021; 19Khalifa SAM, Shedid ES, Saied EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923369 70. Inhibition of SARS-CoV-2 Virus Entry by the Crude Polysaccharides of Seaweeds and Abalone Viscera In Vitro. Mar. Drugs 2021; 19Yim SK, Kim K, Kim IH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921174 71. Nanotechnology-based approaches for emerging and re-emerging viruses: Special emphasis on COVID-19. Microb. Pathog. 2021:104908Saravanan M, Mostafavi E, Vincent S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932543 72. SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs. Microorganisms 2021; 9Inchingolo AD, Inchingolo AM, Bordea IR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920179 73. Targeting SARS-CoV-2 Spike Protein/ACE2 Protein-Protein Interactions: a Computational Study. Mol Inform 2021; Pirolli D, Righino B, De Rosa MC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904240 74. Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2. Molecules 2021; 26Alam MA, Parra-Saldivar R, Bilal M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917694 75. Molecular Dynamic Simulation Search for Possible Amphiphilic Drug Discovery for Covid-19. Molecules 2021; 26Daood U, Gopinath D, Pichika MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921378 76. Native Structure-Based Peptides as Potential Protein-Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor. Molecules 2021; 26Odolczyk N, Marzec E, Winiewska-Szajewska M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918595 77. Inherited and Acquired Corona of Coronavirus in the Host: Inspiration from the Biomolecular Corona of Nanoparticles. Nano Today 2021:101161Gao J, Zeng L, Yao L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897804 78. L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV- 2 Infection. Nutrients 2021; 13Bellamine A, Pham TNQ, Jain J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919991 79. Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19. Pathogens 2021; 10Morotti D, Cadamuro M, Rigoli E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920814 80. Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis. Pharmaceuticals (Basel) 2021; 14Zaki MEA, Al-Hussain SA, Masand VH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924395 81. Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics. Pharmaceutics 2021; 13Puccetti M, Costantini C, Ricci M, Giovagnoli S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916409 82. New perspectives on natural flavonoids on COVID-19-induced lung injuries. Phytother. Res. 2021; Santana FPR, Thevenard F, Gomes KS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928690 83. Reconstitution and functional characterization of SARS-CoV-2 proofreading complex. Protein Expr. Purif. 2021:105894Ma Z, Pourfarjam Y, Kim IK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933612 84. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro. Structure 2021; Cheng MH, Porritt RA, Rivas MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930306 85. Reactivity of human antisera to codon optimized SARS-CoV2 viral proteins expressed in Escherichia coli. Tzu Chi Med J 2021; 33:146-153Toh YH, Huang YW, Chang YC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912411 86. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups. Vaccines (Basel) 2021; 9Rammensee HG, Gouttefangeas C, Heidu S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923363 87. Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters. Viruses 2021; 13Allnoch L, Beythien G, Leitzen E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918079 88. Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2. Viruses 2021; 13Große M, Ruetalo N, Layer M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918670 89. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19. Viruses 2021; 13Ko M, Chang SY, Byun SY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918958 90. The Significance of Phenotyping and Quantification of Plasma Extracellular Vesicles Levels Using High-Sensitivity Flow Cytometry during COVID-19 Treatment. Viruses 2021; 13Kudryavtsev I, Kalinina O, Bezrukikh V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925492 91. Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE. Viruses 2021; 13Lam SD, Ashford P, Díaz-Sánchez S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921873 92. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single- Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro. Viruses 2021; 13Lee G, Budhathoki S, Lee GY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918914 93. Synthesis, antioxidant, antimicrobial and antiviral docking studies of ethyl 2- (2-(arylidene)hydrazinyl)thiazole-4-carboxylates. Z Naturforsch C J Biosci 2021; Haroon M, Akhtar T, Khalid M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901389

Biomarkers - Genetics (149 articles)

1. Early Detection of SARS-CoV-2 Seroconversion in Humans with Aggregation- Induced Near-Infrared Emission Nanoparticle-Labeled Lateral Flow Immunoassay. ACS Nano 2021; Chen R, Ren C, Liu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928784 2. Liver Function Tests Profile in COVID-19 Patients at the Admission Time: A Systematic Review of Literature and Conducted Researches. Adv Biomed Res 2020; 9:74Laali A, Tabibzadeh A, Esghaei M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912490 3. Is there really a correlation between viral load and olfactory and gustatory dysfunction? Am. J. Otolaryngol. 2021:103041Jain A, Pandey AK, Kaur J, Purohit S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931269 4. Supramolecular cylinders target bulge structures in the 5' UTR of the RNA genome of SARS-CoV-2 and inhibit viral replication. Angew. Chem. Int. Ed. Engl. 2021; Melidis L, Hill H, Coltman N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915014 5. Can C-Reactive Protein to Albumin Ratio Predict In-Hospital Death Rate Due to COVID-19 in Patients With Hypertension? Angiology 2021:33197211012145Saylik F, Akbulut T, Kaya S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902353 6. Novel coronavirus seropositivity and related factors among healthcare workers at a university hospital during the prevaccination period: a cross- sectional study. Ann. Clin. Microbiol. Antimicrob. 2021; 20:31Ogutlu A, Karabay O, Erkorkmaz U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902614 7. Positive COVID19-PCR patients as negative controls for COVID19 antibody tests. Ann Med Surg (Lond) 2021; 65:102320Alrabadi N, Haddad R, Al-Faouri I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898040 8. Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients. Ann. Rheum. Dis. 2021; Trahtemberg U, Rottapel R, Dos Santos CC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903092 9. The prognostic role of cardiac troponin in hospitalized COVID-19 patients. Atherosclerosis 2021; 325:83-88Tanboğa IH, Canpolat U, Özcan Çetin EH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910152 10. Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia. Biochem. Med. (Zagreb) 2021; 31:020706Lenicek Krleza J, Zrinski Topic R, Stevanovic V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927556 11. COVID-19 Diagnostic Strategies. Part I: Nucleic Acid-Based Technologies. Bioengineering (Basel) 2021; 8Shaffaf T, Ghafar-Zadeh E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920513 12. Novel and emerging mutations of SARS-CoV-2: Biomedical implications. Biomed. Pharmacother. 2021; 139:111599Mohammadi E, Shafiee F, Shahzamani K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915502 13. Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective. Biomedicines 2021; 9Miao M, Clercq E, Li G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920487 14. Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease. Biosensors (Basel) 2021; 11Antiochia R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917183 15. Recent Advances of Field-Effect Transistor Technology for Infectious Diseases. Biosensors (Basel) 2021; 11Panahi A, Sadighbayan D, Forouhi S, Ghafar-Zadeh E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918325 16. Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections. BMC Med 2021; 19:106Hellewell J, Russell TW, Beale R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902581 17. Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom. BMC Nephrol. 2021; 22:154Wickens O, Chinnadurai R, Mannan F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902482 18. The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies. Cells 2021; 10Kitazawa K, Deinhardt-Emmer S, Inomata T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918318 19. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta- Regression. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211010976Zhan H, Chen H, Liu C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926262 20. Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection. Clin Chem Lab Med 2021; Franco-Martínez L, Tecles F, Torres-Cantero A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908223 21. Comparative analysis of chemical breath-prints through olfactory technology for the discrimination between SARS-CoV-2 infected patients and controls. Clin Chim Acta 2021; Rodríguez-Aguilar M, Díaz de León-Martínez L, Nohemí Zamora-Mendoza B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901429 22. Evaluation of 32 rapid tests for detection of antibodies against SARS-CoV-2. Clin Chim Acta 2021; Tollånes MC, Jenum PA, Kierkegaard H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930425 23. SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection. Clin Infect Dis 2021; Choudhary MC, Crain CR, Qiu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906227 24. SARS-CoV-2 detection on self-collected saliva or anterior nasal specimens compared with healthcare personnel-collected nasopharyngeal specimens. Clin Infect Dis 2021; Marx GE, Biggerstaff BJ, Nawrocki CC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912930 25. Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020. Clin Infect Dis 2021; Shah MM, Salvatore PP, Ford L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33909068 26. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study. Clin. Interv. Aging 2021; 16:675-685Xu W, Huang C, Fei L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911856 27. Clinical characteristics and factors associated with hospital admission or death in 43,103 adult outpatients with COVID-19 managed with the Covidom telesurveillance solution: a prospective cohort study. Clin Microbiol Infect 2021; Yordanov Y, Dinh A, Bleibtreu A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915287 28. Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic SARS- CoV-2 Infection. Cureus 2021; 13:e14101Liput JR, Jordan K, Patadia R, Kander E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927918 29. A Case Report of Severe Hyponatremia Secondary to Coronavirus Disease 2019 Viral Pneumonia. Cureus 2021; 13:e14077Pillutla V, Patel A, Koneru S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903839 30. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico. Cytokine 2021:155543Avila-Nava A, Cortes-Telles A, Torres- Erazo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896708 31. Design and manufacturability data on additively manufactured solutions for COVID-19. Data Brief 2021; 36:107012Prabhu R, Masia JS, Berthel JT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898670 32. Comprehensive evaluation of eight commercial SARS-CoV-2 IgG assays. Diagn. Microbiol. Infect. Dis. 2021; 100:115382Hönemann M, Lück C, Maier M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930691 33. Detection of SARS-COV-2 Proteins Using an ELISA Test. Diagnostics (Basel) 2021; 11Di Domenico M, De Rosa A, Boccellino M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919728 34. A comprehensive antigen production and characterisation study for easy-to- implement, specific and quantitative SARS-CoV-2 serotests. EBioMedicine 2021; 67:103348Klausberger M, Duerkop M, Haslacher H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906067 35. Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China. Emerg Infect Dis 2021; 27:1492-1495Chu DKW, Hui KPY, Gu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900193 36. Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand. Emerg Infect Dis 2021; 27:1317-1322Geoghegan JL, Douglas J, Ren X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900175 37. Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium. Emerg Infect Dis 2021; 27:1405-1415Izquierdo-Lara R, Elsinga G, Heijnen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900177 38. Rhinorrhea following SARS-CoV-2 nasopharyngeal swab: a case for beta-2 transferrin testing. Eur. J. Neurol. 2021; Perneczky J, Neuchrist C, Sellner J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900682 39. Applications of the CRISPR-Cas system for infectious disease diagnostics. Expert Rev Mol Diagn 2021; Li P, Wang L, Yang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899643 40. Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva. Expert Rev Mol Diagn 2021:1-4Tsang HF, Leung WMS, Chan LWC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906571 41. The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19. Expert Rev. Respir. Med. 2021; Kuluöztürk M, Deveci F, Turgut T, Öner Ö. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905286 42. False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives. Expert Rev. Respir. Med. 2021:1-10Mouliou DS, Gourgoulianis KI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896332 43. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection. Front. Immunol. 2021; 12:614676Yuen RR, Steiner D, Pihl RMF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897682 44. Advancing Risk Analysis of COVID-19 Clinical Predictors: The Case of Fasting Blood Glucose. Front Med (Lausanne) 2021; 8:636065Ali H, Al-Shammari AA, Alahmad B, Al-Mulla F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898480 45. Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19. Front Med (Lausanne) 2021; 8:569266Jia X, Zhang P, Tian Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912572 46. Sensitivity of the Molecular Test in Saliva for Detection of COVID-19 in Pediatric Patients With Concurrent Conditions. Front Pediatr 2021; 9:642781Ana Laura GO, Abraham Josué NR, Briceida LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912522 47. Pitfalls in Modeling Asymptomatic COVID-19 Infection. Front Public Health 2021; 9:593176Yang S, Dai S, Huang Y, Jia P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912527 48. A Flexible Transoral Robot Towards COVID-19 Swab Sampling. Front Robot AI 2021; 8:612167Li C, Gu X, Xiao X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33912594 49. Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants. Genes (Basel) 2021; 12Gand M, Vanneste K, Thomas I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924636 50. Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women. Genes (Basel) 2021; 12Monticelli M, Hay Mele B, Benetti E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921689 51. Association between clinical, laboratory findings and chest CT in COVID-19 in a secondary hospital in Jakarta, Indonesia. Germs 2021; 11:32-38Hafiz M, Icksan AG, Harlivasari AD et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898339 52. Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study. Healthcare (Basel) 2021; 9Reinwald M, Deckert PM, Ritter O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922198 53. Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing. Heliyon 2021; 7:e06836Mahalingam S, Peter J, Xu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898857 54. Identification of PBMC-based Molecular Signature Associational with COVID- 19 Disease Severity. Heliyon 2021:e06866Shaath H, Alajez NM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898797 55. Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomes. Hum. Pathol. 2021; Gelarden I, Nguyen J, Gao J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905777 56. HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk. Immunol. Lett. 2021; Bonaccorsi I, Carrega P, Rullo EV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905752 57. Development of a high sensitivity ELISA detecting IgG, A & M antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva. Immunology 2021; Faustini SE, Jossi SE, Perez-Toledo M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33932228 58. Evaluation of the Role of Routine Laboratory Biomarkers in COVID-19 Patients: Perspective from a Tertiary Care Hospital in India. Indian J. Clin. Biochem. 2021:1-12Das B, Bhatia SY, Pal PM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907355 59. Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective. Infect Dis (Auckl) 2021; 14:11786337211010428Hossain ME, Lister D, Bartolo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911876 60. SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia. Infect Dis Health 2021; Lau JS, Buntine P, Price M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903074 61. Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study. Infect Dis Rep 2021; 13:377-387Ciampa ML, O'Hara TA, Joel CL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921604 62. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages. Infect Genet Evol 2021; 92:104869González- Candelas F, Shaw MA, Phan T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915216 63. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation. Infect Genet Evol 2021; 92:104872Mora JAM, Cordero-Laurent E, Godínez A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905892 64. Evaluation of hepatic enzymes activities in COVID-19 patients. Int Immunopharmacol 2021; 97:107701Hwaiz R, Merza M, Hamad B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930704 65. The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic? Int J Biol Sci 2021; 17:1476-1485Guo S, Liu K, Zheng J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907511 66. Students' Views towards Sars-Cov-2 Mass Asymptomatic Testing, Social Distancing and Self-Isolation in a University Setting during the COVID-19 Pandemic: A Qualitative Study. Int J Environ Res Public Health 2021; 18Blake H, Knight H, Jia R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920908 67. SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study. Int J Environ Res Public Health 2021; 18Bułdak RJ, Woźniak-Grygiel E, Wąsik M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924173 68. Relationship of Test Positivity Rates with COVID-19 Epidemic Dynamics. Int J Environ Res Public Health 2021; 18Furuse Y, Ko YK, Ninomiya K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925665 69. Wastewater Surveillance for SARS-CoV-2 on College Campuses: Initial Efforts, Lessons Learned, and Research Needs. Int J Environ Res Public Health 2021; 18Harris-Lovett S, Nelson KL, Beamer P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922263 70. Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2. Int J Environ Res Public Health 2021; 18McConnell D, Hickey C, Bargary N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925518 71. SARS-CoV-2 Seroprevalence among Health Care Workers-A Voluntary Screening Study in a Regional Medical Center in Southern Germany. Int J Environ Res Public Health 2021; 18Müller K, Girl P, Ruhnke M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917840 72. Environmental Detection of SARS-CoV-2 Virus RNA in Health Facilities in Brazil and a Systematic Review on Contamination Sources. Int J Environ Res Public Health 2021; 18Vicente VA, Lustosa BPR, Grisolia ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917465 73. Comparative diagnostic performance of different rapid antigen detection tests for COVID-19 in the real-world hospital setting. Int J Infect Dis 2021; Bruzzone B, De Pace V, Caligiuri P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930540 74. Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy. Int J Infect Dis 2021; Lagi F, Trevisan S, Piccica M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901656 75. Performance Evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel. Int J Infect Dis 2021; Lebourgeois S, Storto A, Gout B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901651 76. Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: multiple factors-based analysis. Int J Infect Dis 2021; Luo C, Liu M, Li Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932603 77. Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted in a Romanian University Hospital of Infectious Diseases. Int J Infect Dis 2021; Radulescu A, Istrate A, Flonta M, Lupse M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901653 78. Early and consecutive RT-PCR tests with both oropharyngeal swabs and sputum could improve testing yield for patients with COVID-19: An Observation Cohort Study in China. Int J Infect Dis 2021; Song Y, Chen C, Wang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930545 79. PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-"Rheumatic Fever" of the 21st Century? Int J Mol Sci 2021; 22Opoka-Winiarska V, Grywalska E, Roliński J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925779 80. The Association of Age, Sex, and RT-PCR Results with the Lymphocyte and Neutrophil Counts in SARS-CoV-2 Infection: A Cross-sectional Analysis of 1450 Iranian Patients with COVID-19. Iran. J. Allergy Asthma Immunol. 2021; 20:129-139Bashash D, Abolghasemi H, Naseri P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904671 81. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy. J Appl Lab Med 2021; Mei ZW, van Wijk XMR, Pham HP, Marin MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930144 82. A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions. J. Biomed. Sci. 2021; 28:34Tseng SH, Lam B, Kung YJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926459 83. Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings. J Clin Med 2021; 10Andrey DO, Yerly S, Meyer B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920076 84. Longitudinal Analysis and Comparison of Six Serological Assays up to Eight Months Post-COVID-19 Diagnosis. J Clin Med 2021; 10Aubry A, Demey B, François C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919328 85. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. J Clin Med 2021; 10Bareille M, Hardy M, Douxfils J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923851 86. Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe. J Clin Med 2021; 10Bartko J, Zehetmayer S, Weseslindtner L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924976 87. Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. J Clin Med 2021; 10Cantini L, Bastianelli L, Lupi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916569 88. Admission High-Sensitive Cardiac Troponin T Level Increase Is Independently Associated with Higher Mortality in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med 2021; 10Larcher R, Besnard N, Akouz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924475 89. Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study. J Clin Med 2021; 10Simon TP, Stoppe C, Breuer T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33924637 90. Evaluation of a Broad Panel of SARS-CoV-2 Serological Tests for Diagnostic Use. J Clin Med 2021; 10Werner M, Pervan P, Glück V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918081 91. COVID-19 Trends in the Phoenix Metropolitan Area from a Mobile Testing Program: Last Quarter of 2020. J. Community Health 2021:1-5Lau CSM, Shu S, Mayer J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914218 92. Emerging materials for the electrochemical detection of COVID-19. J Electroanal Chem (Lausanne) 2021:115289Balkourani G, Brouzgou A, Archonti M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907536 93. Molecular diagnosis of SARS-CoV-2 in seminal fluid. J. Endocrinol. Invest. 2021:1-10Paoli D, Pallotti F, Nigro G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33929709 94. Positive SARS-CoV-2 RNA with Significant Inflammatory State and Thrombophilia after 12 Weeks of Initial Diagnosis of COVID-19 Infection. J. Glob. Infect. Dis. 2021; 13:42-43Betancourt MF, Grant KM, Johnson JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911453 95. SARS-CoV-2 serology testing: Progress and challenges. J. Immunol. Methods 2021; 494:113060Shi AC, Ren P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915155 96. Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust. J Infect 2021; Garvey MI, McMurray C, Casey AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932449 97. False-positive for SARS-CoV-2 antigen test in a man with acute HIV infection. J Infect Chemother 2021; Yamaniha K, Kinjo T, Akamine M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902991 98. A combination of N and S antigens with IgA and IgG measurement strengthens the accuracy of SARS-CoV-2 serodiagnostics. J Infect Dis 2021; Jalkanen P, Pasternack A, Maljanen S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905505 99. Antibody tests: They are more important than we thought. J Math Econ 2021; 93:102485Guimarães L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897088 100. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta- analysis. J Med Virol 2021; Lee J, Song JU. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913533 101. Betacoronaviruses genome analysis reveals evolution toward specific codons usage: implications for SARS-CoV-2 mitigation strategies. J Med Virol 2021; Lopes EN, Fonseca V, Frias D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33934387 102. Optimal Uses of Pooled Testing for COVID-19 incorporating imperfect test performance and pool dilution effect: An Application to Congregate Settings in Los Angeles County. J Med Virol 2021; Nianogo RA, Emeruwa, Gounder P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930195 103. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. J Med Virol 2021; Zervou FN, Louie P, Stachel A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932299 104. Seroprevalence of SARS-CoV-2 Antibody in Echocardiography and Stress Laboratory. J Patient Cent Res Rev 2021; 8:146-150Jain R, Kroboth S, Ignatowski D, Khandheria BK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898648 105. Preprocedure COVID-19 Testing in Early Phase of Pandemic. J Patient Cent Res Rev 2021; 8:151-153Jain R, Kruger B, Citronberg R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898649 106. An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID- 19 vaccination. J Thromb Haemost 2021; Sørvoll IH, Horvei KD, Ernstsen SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909350 107. Vitamin D status of Arab Gulf residents screened for SARS-CoV-2 and its association with COVID-19 infection: a multi-centre case-control study. J Transl Med 2021; 19:166Al-Daghri NM, Amer OE, Alotaibi NH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902635 108. Diagnostic accuracy of three SARS-CoV2 antibody detection assays, neutralizing effect and longevity of serum antibodies. J. Virol. Methods 2021; 293:114173Bubonja-Šonje M, Batičić L, Abram M, Cekinović Grbeša Đ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930473 109. Performance Evaluation of the Siemens SARS-CoV-2 Total Antibody and IgG Antibody Test. Lab Med 2021; Florin L, Maelegheer K, Vandewal W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928377 110. Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19. Lab Med 2021; Lo Sasso B, Gambino CM, Scichilone N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928380 111. Utility of Antigen-Based Rapid Diagnostic Test for Detection of SARS-CoV-2 Virus in Routine Hospital Settings. Lab Med 2021; Thakur P, Saxena S, Manchanda V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928384 112. Cross-Institutional Evaluation of the Abbott ARCHITECT SARS-CoV-2 IgG Immunoassay. Lab Med 2021; Wiencek JR, Bachmann LM, Dinwiddie K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929022 113. Repeat testing for SARS-CoV-2: persistence of viral RNA is common, and clearance is slower in older people. Med. J. Aust. 2021; Stehlik P, Alcorn K, Jones A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899232 114. Severe acute respiratory syndrome coronavirus 2019. Seroepidemiology study in Argentinian slum. Medicina (B. Aires) 2021; 81:135-142Figar S, Pagotto V, Luna L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906129 115. Non-Respiratory Symptoms of Patients Infected with SARS-CoV-2 (Coronavirus Disease 2019): Lessons from Their Initial Presentation at the Hospital. Medicina (Kaunas) 2021; 57Vasiliadis AV, Tsatlidou M, Metaxiotis D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918326 116. Current state of Diagnostic, Screening and Surveillance Testing Methods for COVID-19 from an Analytical Chemistry Point of View. Microchem. J. 2021:106305Martín J, Tena N, Asuero AG. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897053 117. Affinity Sensors for the Diagnosis of COVID-19. Micromachines (Basel) 2021; 12Drobysh M, Ramanaviciene A, Viter R, Ramanavicius A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918184 118. Implementing SARS-CoV-2 Rapid Antigen Testing in the Emergency Ward of a Swiss University Hospital: The INCREASE Study. Microorganisms 2021; 9Caruana G, Croxatto A, Kampouri E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33920307 119. SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs. Microorganisms 2021; 9Inchingolo AD, Inchingolo AM, Bordea IR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920179 120. SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020. Microorganisms 2021; 9Muñoz-Medina JE, Grajales-Muñiz C, Salas-Lais AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921158 121. Inherited and Acquired Corona of Coronavirus in the Host: Inspiration from the Biomolecular Corona of Nanoparticles. Nano Today 2021:101161Gao J, Zeng L, Yao L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897804 122. Relation between Vitamin D and COVID-19 in Aged People: A Systematic Review. Nutrients 2021; 13Dramé M, Cofais C, Hentzien M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920639 123. Impact of COVID-19 Pandemic on Serum Vitamin D Level among Infants and Toddlers: An Interrupted Time Series Analysis and before-and-after Comparison. Nutrients 2021; 13Wong RS, Tung KTS, So HK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924387 124. Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series. Pathogens 2021; 10Heidepriem J, Dahlke C, Kobbe R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917609 125. Recent advances and challenges of RT-PCR tests for the diagnosis of COVID- 19. Pathol. Res. Pract. 2021; 221:153443Teymouri M, Mollazadeh S, Mortazavi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930607 126. Comparison of computed tomography (CT) findings with RT-PCR in the diagnosis of COVID-19 in children. Pediatr Pulmonol 2021; Bağcı Z, Keçeli AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902160 127. Reduced adiponectin levels in patients with COVID-19 acute respiratory failure: A case-control study. Physiol Rep 2021; 9:e14843Kearns SM, Ahern KW, Patrie JT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904656 128. SARS-CoV-2 serological assay and viral testing: a report of professional football setting. Postgrad. Med. J. 2021; Hassanmirzaei B, Haratian Z, Ahmadzadeh Amiri A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931556 129. Plasma LDH: A specific biomarker for lung affectation in COVID-19? Pract Lab Med 2021; 25:e00226Serrano-Lorenzo P, Coya ON, López-Jimenez A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898686 130. Comparison of virus neutralization activity and results of 10 different anti- SARS-CoV-2 serological tests in COVID-19 recovered plasma donors. Pract Lab Med 2021; 25:e00222Szabó Z, Szabó T, Bodó K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898689 131. Diagnostic performance of an automated chemiluminescence immunoassay for SARS-CoV-2 IgG and IgM antibodies detection: A real life experience. Pract Lab Med 2021; 25:e00227Villalta D, Martelli P, Moratto A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898690 132. In pursuit of the right tail for the COVID-19 incubation period. Public Health 2021; 194:149-155Cimolai N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915459 133. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir. Med. 2021; 182:106394E E, R F, Öi E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901787 134. Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19. Rom. J. Intern. Med. 2021; Zendelovska D, Atanasovska E, Petrushevska M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910269 135. CovidArray: A Microarray-Based Assay with High Sensitivity for the Detection of Sars-Cov-2 in Nasopharyngeal Swabs. Sensors (Basel) 2021; 21Damin F, Galbiati S, Gagliardi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916661 136. Towards Detecting Pneumonia Progression in COVID-19 Patients by Monitoring Sleep Disturbance Using Data Streams of Non-Invasive Sensor Networks. Sensors (Basel) 2021; 21Dimitrievski A, Zdravevski E, Lameski P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925869 137. Predictive Capacity of COVID-19 Test Positivity Rate. Sensors (Basel) 2021; 21Fenga L, Gaspari M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916239 138. Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population. Sensors (Basel) 2021; 21Saha A, Bajpai A, Krishna V, Bhattacharya S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918646 139. Strategies for Immunomonitoring after Vaccination and during Infection. Vaccines (Basel) 2021; 9Adam L, Rosenbaum P, Bonduelle O, Combadière B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918841 140. The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes. Viral Immunol 2021; Xie L, Lin Y, Deng Y, Lei B. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902347 141. Evaluation of an Automated High-Throughput Liquid-Based RNA Extraction Platform on Pooled Nasopharyngeal or Saliva Specimens for SARS-CoV-2 RT- PCR. Viruses 2021; 13Chu AW, Yip CC, Chan WM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918447 142. Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2. Viruses 2021; 13Hitzenbichler F, Bauernfeind S, Salzberger B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33920072 143. Five Antigen Tests for SARS-CoV-2: Virus Viability Matters. Viruses 2021; 13Homza M, Zelena H, Janosek J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921164 144. The Significance of Phenotyping and Quantification of Plasma Extracellular Vesicles Levels Using High-Sensitivity Flow Cytometry during COVID-19 Treatment. Viruses 2021; 13Kudryavtsev I, Kalinina O, Bezrukikh V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925492 145. A Novel Immunofluorescence Assay for the Rapid Serological Detection of SARS-CoV-2 Infection. Viruses 2021; 13Nguyen D, Skelly D, Goonawardane N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923271 146. Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences. Viruses 2021; 13Pan B, Ji Z, Sakkiah S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925388 147. Superiority of MALDI-TOF Mass Spectrometry over Real-Time PCR for SARS- CoV-2 RNA Detection. Viruses 2021; 13Rybicka M, Miłosz E, Bielawski KP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922195 148. D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients. Viruses 2021; 13Thoreau B, Galland J, Delrue M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33926038 149. Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2. Viruses 2021; 13Zhao S, Lou J, Chong MKC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918060

Children (49 articles)

1. Adverse and Benevolent Childhood Experiences Predict Mental Health During the COVID-19 Pandemic. Advers Resil Sci 2021:1-12Doom JR, Seok D, Narayan AJ, Fox KR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907733 2. Prevalence of thrombotic complications in children with SARS-CoV-2. Arch. Dis. Child. 2021; Aguilera-Alonso D, Murias S, Martínez-de-Azagra Garde A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931403 3. Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia. Biochem. Med. (Zagreb) 2021; 31:020706Lenicek Krleza J, Zrinski Topic R, Stevanovic V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927556 4. Effect of COVID-19 on childhood Mycoplasma pneumoniae infection in Chengdu, China. BMC Pediatr. 2021; 21:202Zhang Y, Huang Y, Ai T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910509 5. Aberrated supraventricular tachycardia associated with neonatal fever and COVID-19 infection. BMJ Case Rep. 2021; 14Hopkins KA, Webster G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931425 6. Effects of COVID-19 Lockdown on the Emotional and Behavioral Profiles of Preschool Italian Children with and without Familial Risk for Neurodevelopmental Disorders. Brain Sci 2021; 11Cantiani C, Dondena C, Capelli E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918593 7. Child maltreatment reports and Child Protection Service responses during COVID-19: Knowledge exchange among Australia, Brazil, Canada, Colombia, Germany, Israel, and South Africa. Child Abuse Negl. 2021:105078Katz I, Katz C, Andresen S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931238 8. The Impact of the COVID-19 Pandemic on Child Protection System Referrals and Responses in Colorado, USA. Child Maltreat 2021:10775595211012476Brown SM, Orsi R, Chen PCB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896229 9. The incremental burden of invasive pneumococcal disease associated with a decline in childhood vaccination using a dynamic transmission model in Japan: A secondary impact of COVID-19. Comput. Biol. Med. 2021; 133:104429Kitano T, Aoki H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930765 10. Optic Neuritis in a Child With COVID-19: A Rare Association. Cureus 2021; 13:e14094Parvez Y, AlZarooni F, Khan F. http://www.ncbi.nlm.nih.gov/pubmed/? term=33927916 11. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico. Cytokine 2021:155543Avila-Nava A, Cortes-Telles A, Torres- Erazo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896708 12. Lung Ultrasound: Its Findings and New Applications in Neonatology and Pediatric Diseases. Diagnostics (Basel) 2021; 11Iovine E, Nenna R, Bloise S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916882 13. The future is now: pediatric neuropsychological presurgical epilepsy evaluation in the age of COVID-19. Epileptic Disord. 2021; Nussbaum NL, Young SR, DeLeon RC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926855 14. The impact of COVID-19 on the lives and mental health of Australian adolescents. Eur. Child Adolesc. Psychiatry 2021:1-13Li SH, Beames JR, Newby JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913036 15. Sensitivity of the Molecular Test in Saliva for Detection of COVID-19 in Pediatric Patients With Concurrent Conditions. Front Pediatr 2021; 9:642781Ana Laura GO, Abraham Josué NR, Briceida LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912522 16. Case Report: Inflammation and Endothelial Injury Profiling of COVID-19 Pediatric Multisystem Inflammatory Syndrome (MIS-C). Front Pediatr 2021; 9:597926Fraser DD, Patterson EK, Daley M, Cepinskas G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898353 17. Intra-Household and Close-Contact SARS-CoV-2 Transmission Among Children - a Systematic Review. Front Pediatr 2021; 9:613292Spielberger BD, Goerne T, Geweniger A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898355 18. Pediatric Subspecialty Adoption of Telemedicine Amidst the COVID-19 Pandemic: An Early Descriptive Analysis. Front Pediatr 2021; 9:648631Xie J, Prahalad P, Lee TC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928058 19. Low Rate of SARS-CoV-2 Infections in Symptomatic Patients Attending a Pediatric Emergency Department. Front Pediatr 2021; 9:637167Zurl C, Eber E, Siegl A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898359 20. Multisystem inflammatory syndrome in children (MIS-C) temporally associated with SARS-CoV-2: the first clinical case in Ternopil, Ukraine. Germs 2021; 11:120-127Pavlyshyn H, Slyva V, Dyvonyak O, Horishna I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898350 21. Successful Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 (PIMS-TS) with Split Doses of Immunoglobulin G and Estimation of PIMS-TS Incidence in a County District in Southern Germany. Healthcare (Basel) 2021; 9Wehl G, Franke J, Frühwirth M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919536 22. Pediatric cataract surgery practices in the COVID-19 era: Perspectives of a tertiary care institute in Northern India. Indian J Ophthalmol 2021; 69:1284- 1287Gupta PC, Sukhija J, Khurana S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913878 23. COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE- CO-Ped), Italy. Int J Environ Res Public Health 2021; 18Esposito S, Marchetti F, Lanari M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917940 24. Social Inequalities in Health Determinants in Spanish Children during the COVID-19 Lockdown. Int J Environ Res Public Health 2021; 18González-Rábago Y, Cabezas-Rodríguez A, Martín U. http://www.ncbi.nlm.nih.gov/pubmed/? term=33924441 25. Stress and Mental Health among Children/Adolescents, Their Parents, and Young Adults during the First COVID-19 Lockdown in Switzerland. Int J Environ Res Public Health 2021; 18Mohler-Kuo M, Dzemaili S, Foster S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925743 26. Effect of COVID-19 on Health-Related Quality of Life in Adolescents and Children: A Systematic Review. Int J Environ Res Public Health 2021; 18Nobari H, Fashi M, Eskandari A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923120 27. Quality of Life Changes during the COVID-19 Pandemic for Caregivers of Children with ADHD and/or ASD. Int J Environ Res Public Health 2021; 18Pecor KW, Barbyannis G, Yang M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915884 28. Children's Independent Mobility and Physical Activity during the COVID-19 Pandemic: A Qualitative Study with Families. Int J Environ Res Public Health 2021; 18Pelletier CA, Cornish K, Sanders C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33922530 29. Life-Changing Experiences of Mothers with School-Age Children during the COVID-19 Pandemic: Focusing on Their Health Risk Perceptions and Health- Related Behaviors. Int J Environ Res Public Health 2021; 18Yoo HJ, Shim J, Kim N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923205 30. PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-"Rheumatic Fever" of the 21st Century? Int J Mol Sci 2021; 22Opoka-Winiarska V, Grywalska E, Roliński J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925779 31. Elevated Levels of COVID-19-Related Stress and Mental Health Problems Among Parents of Children with Developmental Disorders During the Pandemic. J. Autism Dev. Disord. 2021:1-12Chan RCH, Fung SC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913075 32. The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). J Clin Med 2021; 10Kwiatkowska J, Meyer-Szary J, Mazurek-Kula A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921526 33. Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study. J Clin Med 2021; 10Opoka-Winiarska V, Grywalska E, Korona-Glowniak I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921679 34. [Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital]. Medwave 2021; 21:e8142Luna-Muñoz C, Reyes-Florian G, Seminario-Aliaga M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905406 35. Evaluation of E-Health Applications for Paediatric Patients with Refractory Epilepsy and Maintained on Ketogenic Diet. Nutrients 2021; 13Costa AM, Marchiò M, Bruni G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918854 36. Impact of COVID-19 Pandemic on Serum Vitamin D Level among Infants and Toddlers: An Interrupted Time Series Analysis and before-and-after Comparison. Nutrients 2021; 13Wong RS, Tung KTS, So HK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924387 37. [Effects of the COVID-19 Pandemic on childhood immunization in Morocco: electronic survey of 103 pediatricians]. Pan Afr. Med. J. 2021; 38:134Chekhlabi N, Arrab R, Ettair S, Dini N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912304 38. Acute pulmonary embolism in a child following SARS-CoV-2 infection: a case report. Pan Afr. Med. J. 2021; 38:125Ouarradi AE, Chekhlabi N, Elharras M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912295 39. Could Antigen Presenting Cells Represent a Protective Element during SARS- CoV-2 Infection in Children? Pathogens 2021; 10Lauro R, Irrera N, Eid AH, Bitto A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920011 40. No relationship was observed between Kawasaki disease and COVID-19 in Japan. Pediatr. Int. 2021; Nakamura Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913588 41. Critical analysis of acute kidney injury in pediatric COVID-19 patients in the intensive care unit. Pediatr. Nephrol. 2021:1-12Raina R, Chakraborty R, Mawby I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928439 42. Comparison of computed tomography (CT) findings with RT-PCR in the diagnosis of COVID-19 in children. Pediatr Pulmonol 2021; Bağcı Z, Keçeli AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902160 43. Imaging findings of multisystem inflammatory syndrome in children associated with COVID-19. Pediatr Radiol 2021:1-13Caro-Domínguez P, Navallas M, Riaza-Martin L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904952 44. Neonatal and Pediatric Emergency Room Visits in a Tertiary Center during the COVID-19 Pandemic in Italy. Pediatr. Rep. 2021; 13:168-176Silvagni D, Baggio L, Lo Tartaro Meragliotta P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916938 45. Impact of COVID-19 on child malnutrition, obesity in women and household food insecurity in underserved urban settlements in Sri Lanka: a prospective follow up study. Public Health Nutr. 2021:1-24Jayatissa R, Herath H, Perera AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902778 46. Extrathoracic manifestations of COVID-19 in adults and presentation of the disease in children. Radiologia (Roma) 2021; Plasencia-Martínez JM, Rovira À, Caro Domínguez P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931205 47. Psychological impact during COVID-19 lockdown in children and adolescents with previous mental health disorders. Rev Psiquiatr Salud Ment 2021; Lopez- Serrano J, Díaz-Bóveda R, González-Vallespí L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901700 48. The functional health status of children with cerebral palsy during the COVID- 19 pandemic stay-at-home period: a parental perspective. Turk. J. Pediatr. 2021; 63:223-236Bıyık KS, Özal C, Tunçdemir M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929112 49. Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy. Vaccines (Basel) 2021; 9Montalti M, Rallo F, Guaraldi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3392010

Clinical Features (48 articles)

1. Is there really a correlation between viral load and olfactory and gustatory dysfunction? Am. J. Otolaryngol. 2021:103041Jain A, Pandey AK, Kaur J, Purohit S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931269 2. Temporal patterns of nasal symptoms in patients with mild severity SARS- CoV-2 infection. Am. J. Otolaryngol. 2021; 42:103076Raad RA, Ganti A, Goshtasbi K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915513 3. Development of infectious mononucleosis as an unusual manifestation of COVID-19. Auris Nasus Larynx 2021; Fukuda M, Amano Y, Masumura C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906746 4. Clinical characteristics of SARS-CoV-2 pneumonia diagnosed in a primary care practice in Madrid (Spain). BMC Fam. Pract. 2021; 22:83Guisado-Clavero M, Herrero Gil A, Pérez Álvarez M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33926382 5. Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand's university-based referral hospital. BMC Infect. Dis. 2021; 21:382Sirijatuphat R, Suputtamongkol Y, Angkasekwinai N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902480 6. Clinical, radiological and functional outcomes in patients with SARS-CoV-2 pneumonia: a prospective observational study. BMC Pulm. Med. 2021; 21:136Gianella P, Rigamonti E, Marando M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902513 7. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? BMJ Case Rep. 2021; 14Revannavar SM, P SS, Samaga L, V KV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906877 8. Oral manifestations of COVID-19 patients: An online survey of the Egyptian population. Clin Exp Dent Res 2021; El Kady DM, Gomaa EA, Abdella WS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931952 9. Does COVID-19 cause an increase in spleen dimensions? Possible effects of immune activation, hematopoietic suppression and microthrombosis. Clin Imaging 2021; 79:104-109Tahtabasi M, Hosbul T, Karaman E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932872 10. Clinical characteristics and factors associated with hospital admission or death in 43,103 adult outpatients with COVID-19 managed with the Covidom telesurveillance solution: a prospective cohort study. Clin Microbiol Infect 2021; Yordanov Y, Dinh A, Bleibtreu A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915287 11. Cardiac Troponin I Levels in Hospitalized COVID-19 Patients as a Predictor of Severity and Outcome: A Retrospective Cohort Study. Cureus 2021; 13:e14061Ali J, Khan FR, Ullah R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898144 12. Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic SARS- CoV-2 Infection. Cureus 2021; 13:e14101Liput JR, Jordan K, Patadia R, Kander E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927918 13. Lung Ultrasound: Its Findings and New Applications in Neonatology and Pediatric Diseases. Diagnostics (Basel) 2021; 11Iovine E, Nenna R, Bloise S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916882 14. Characteristics of 1738 Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China. Disaster Med Public Health Prep 2021:1-20Ma X, Gao Y, Di L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926610 15. Symptom Diary-Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020. Emerg Infect Dis 2021; 27:1353- 1361Wiegele PN, Kabar I, Kerschke L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33900166 16. How does allergic rhinitis impact the severity of COVID-19?: a case-control study. Eur Arch Otorhinolaryngol 2021:1-5Guvey A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932179 17. Rhinorrhea following SARS-CoV-2 nasopharyngeal swab: a case for beta-2 transferrin testing. Eur. J. Neurol. 2021; Perneczky J, Neuchrist C, Sellner J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900682 18. A Detailed Characterisation of Appetite, Sensory Perceptional, and Eating- Behavioural Effects of COVID-19: Self-Reports from the Acute and Post-Acute Phase of Disease. Foods 2021; 10Chaaban N, Høier A, Andersen BV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921603 19. The Affinity of Hemoglobin for Oxygen Is Not Altered During COVID-19. Front. Physiol. 2021; 12:578708Gille T, Sesé L, Aubourg E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912067 20. Association between clinical, laboratory findings and chest CT in COVID-19 in a secondary hospital in Jakarta, Indonesia. Germs 2021; 11:32-38Hafiz M, Icksan AG, Harlivasari AD et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898339 21. Autonomic dysfunction detection by an automatic pupillometer as a non- invasive test in patients recovered from COVID-19. Graefes Arch Clin Exp Ophthalmol 2021:1-6Karahan M, Demirtaş AA, Hazar L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907887 22. COVID-19 associated parotitis. IDCases 2021; 24:e01122Lim ZY, Ang AXY, Cross GB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898261 23. Coronavirus Disease 2019 and Nasal Conditions: A Review of Current Evidence. In Vivo 2021; 35:1409-1417Suzaki I, Kobayashi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910818 24. Acute monocular vision loss as presenting symptom of delayed stroke from internal carotid occlusion in COVID-19. Indian J Ophthalmol 2021; 69:1325- 1327Deshpande G, Giri P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913892 25. Retinal manifestations in patients following COVID-19 infection: A consecutive case series. Indian J Ophthalmol 2021; 69:1275-1282Goyal M, Murthy SI, Annum S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913876 26. COVID-19 related multi-inflammatory syndrome presenting with uveitis - A case report. Indian J Ophthalmol 2021; 69:1319-1321Karthika IK, Gulla KM, John J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913889 27. Prospective Analysis of the Chronology of Smell and Taste Dysfunction in COVID-19 Positive ENT Doctors. Indian J Otolaryngol Head Neck Surg 2021:1- 6Sagar P, Kumar R, Fatima R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907681 28. Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective. Infect Dis (Auckl) 2021; 14:11786337211010428Hossain ME, Lister D, Bartolo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911876 29. Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study. Infect Dis Rep 2021; 13:377-387Ciampa ML, O'Hara TA, Joel CL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921604 30. Asymptomatic Cases, the Hidden Challenge in Predicting COVID-19 Caseload Increases. Infect Dis Rep 2021; 13:340-347Snider B, Patel B, McBean E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918578 31. Changes in the respiratory function of COVID-19 survivors during follow-up: a novel respiratory disorder on the rise? Int J Clin Pract 2021:e14301Boutou AK, Georgopoulou A, Pitsiou G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33932073 32. Production of SARS-CoV-2 Antibodies and Emergence of the Clinical Symptoms of COVID-19. Iran. J. Allergy Asthma Immunol. 2021; 20:244- 248Hormati A, Poustchi H, Ghadir MR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33904682 33. Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease. Iran. J. Allergy Asthma Immunol. 2021; 20:140-146Mostafaei A, Ghojazadeh M, Hajebrahimi S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33904672 34. Skin Manifestation of SARS-CoV-2: The Italian Experience. J Clin Med 2021; 10Cazzato G, Foti C, Colagrande A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33917774 35. Development of Sacral/Buttock Retiform Purpura as an Ominous Presenting Sign of COVID-19 and Clinical and Histopathologic Evolution during Severe Disease Course. J. Cutan. Pathol. 2021; McBride JD, Narang J, Simonds R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931901 36. Sudden hearing loss and coronavirus disease 2019: the role of corticosteroid intra-tympanic injection in hearing improvement. J. Laryngol. Otol. 2021:1- 3Rahimi V, Asiyabar MK, Rouhbakhsh N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913413 37. JDDG - Journal of the German Society of Dermatology 2021; 19:639. 38. Im Zusammenhang mit COVID-19-Infektionen beschriebene Hautmanifestationen. JDDG - Journal of the German Society of Dermatology 2021; 19:530-535Tomsitz D, Biedermann T, Brockow K. 39. Assessment of Retinal Neurodegeneration and Choroidal Thickness in COVID- 19 Patients Using Swept-Source OCT Technology. Klin. Monbl. Augenheilkd. 2021; Cetinkaya T, Kurt MM, Akpolat C. 40. Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern Italy. Life (Basel) 2021; 11Pisaturo M, De Angelis G, Maggi P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923857 41. Herpes Simplex Keratitis in Patients with SARS-CoV-2 Infection: A Series of Five Cases. Medicina (Kaunas) 2021; 57Majtanova N, Kriskova P, Keri P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923158 42. Non-Respiratory Symptoms of Patients Infected with SARS-CoV-2 (Coronavirus Disease 2019): Lessons from Their Initial Presentation at the Hospital. Medicina (Kaunas) 2021; 57Vasiliadis AV, Tsatlidou M, Metaxiotis D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918326 43. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (Kaunas) 2021; 57Wong TL, Weitzer DJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925784 44. Rapid clinical evolution for COVID-19 translates into early hospital admission and unfavourable outcome: a preliminary report. Multidiscip Respir Med 2021; 16:744Heim M, Lahmer T, Rasch S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907624 45. Functional Decline in Hospitalized Patients with COVID-19 in the Early Months of the Pandemic. Pm r 2021; Daunter AK, Bowman A, Danko J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929087 46. Extrathoracic manifestations of COVID-19 in adults and presentation of the disease in children. Radiologia (Roma) 2021; Plasencia-Martínez JM, Rovira À, Caro Domínguez P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931205 47. The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes. Viral Immunol 2021; Xie L, Lin Y, Deng Y, Lei B. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902347 48. Attenuation of COVID-19-induced cytokine storm in a young male patient with severe respiratory and neurological symptoms. Wien. Klin. Wochenschr. 2021:1- 6Muschitz C, Trummert A, Berent T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905029

CNS (41 articles)

1. Demyelination as a result of an immune response in patients with COVID-19. Acta Neurol. Belg. 2021; Shabani Z. http://www.ncbi.nlm.nih.gov/pubmed/? term=33934300 2. Myasthenia gravis and COVID-19: A case series and comparison with literature. Acta Neurol. Scand. 2021; Saied Z, Rachdi A, Thamlaoui S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914898 3. The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models. Acta Neuropathol. 2021:1-14Butowt R, Meunier N, Bryche B, von Bartheld CS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903954 4. Inflammatory Neuropsychiatric Disorders and COVID-19 Neuroinflammation. Acta Neuropsychiatr. 2021:1-55Tang SW, Helmeste D, Leonard B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926589 5. Impact of COVID-19 on People Suffering with Epilepsy. Ann. Indian Acad. Neurol. 2021; 24:51-55Sureka RK, Gaur V, Gupta M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911379 6. Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD. BMC Neurol. 2021; 21:183Esmaeili S, Abbasi MH, Abolmaali M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933026 7. Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient. Brain Sci 2021; 11Nuzzo D, Cambula G, Bacile I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918426 8. Does endothelial vulnerability in obstructive sleep apnea syndrome promote COVID-19 encephalopathy? Chest 2021; Breville G, Adler D, Uginet M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930384 9. The influence of the COVID-19 pandemic on patients with chronic inflammatory demyelinating polyradiculoneuropathy. Clin. Neurol. Neurosurg. 2021; 205:106654Stojanov A, Bozovic I, Stojanov J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932773 10. Quality of sleep and fatigue in patients with the relapsing-remitting multiple sclerosis during the coronavirus disease-2019 pandemic. Clin. Neurol. Neurosurg. 2021; 205:106640Stojanov A, Vojinovic S, Stojanov J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901751 11. Digital Ischemia as an Initial Presentation in a COVID-19-Positive Patient Without Any Significant Respiratory Symptoms. Cureus 2021; 13:e14054Acherjee T, Bastien B, Rodriguez-Guerra MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898138 12. Guillain-Barre Syndrome in a Patient With Asymptomatic Coronavirus Disease 2019 Infection and Major Depressive Disorder. Cureus 2021; 13:e14161Mokhashi N, Narla G, Marchionni C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927956 13. Optic Neuritis in a Child With COVID-19: A Rare Association. Cureus 2021; 13:e14094Parvez Y, AlZarooni F, Khan F. http://www.ncbi.nlm.nih.gov/pubmed/? term=33927916 14. Chronic Inflammatory Demyelinating Polyradiculoneuropathy During the COVID-19 Pandemic: Telemedicine Limitations and Strategies for Improvement. Cureus 2021; 13:e14146Zubair AS, Zubair AS, Desai K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927948 15. SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis. Diseases 2021; 9Diaz de la Fe A, Peláez Suárez AA, Fuentes Campos M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921878 16. Post-COVID seizure: A new feature of "long-COVID". eNeurologicalSci 2021; 23:100340Kincaid KJ, Kung JC, Senetar AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898792 17. The Impact of COVID-19 on Palliative Care for People with Parkinson's and Response to Future Pandemics. Expert Rev. Neurother. 2021; Chaudhuri KR, Rukavina K, McConvey V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905283 18. Neurotropic Viruses, Astrocytes, and COVID-19. Front. Cell. Neurosci. 2021; 15:662578Tavčar P, Potokar M, Kolenc M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897376 19. COVID-19 Dysautonomia. Front. Neurol. 2021; 12:624968Goodman BP, Khoury JA, Blair JE, Grill MF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927679 20. Post-infectious focal encephalitis due to COVID-19. Germs 2021; 11:111- 115Fukushima EFA, Nasser A, Bhargava A, Moudgil S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898348 21. Mild to Severe Neurological Manifestations of COVID-19: Cases Reports. Int J Environ Res Public Health 2021; 18Melegari G, Rivi V, Zelent G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915937 22. "If You Can't Control the Wind, Adjust Your Sail": Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study. Int J Environ Res Public Health 2021; 18Poli S, Rimondini M, Gajofatto A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919974 23. Neurological Complications of COVID-19: Underlying Mechanisms and Management. Int J Mol Sci 2021; 22Shehata GA, Lord KC, Grudzinski MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920904 24. Novel Coronavirus (COVID-19)-Associated Guillain-Barre' Syndrome: Case Report. Int Med Case Rep J 2021; 14:251-253Mantefardo B, Gube AA, Awlachew E, Sisay G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907474 25. Sudden hearing loss and coronavirus disease 2019: the role of corticosteroid intra-tympanic injection in hearing improvement. J. Laryngol. Otol. 2021:1- 3Rahimi V, Asiyabar MK, Rouhbakhsh N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913413 26. Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome associated with COVID-19: a case report. J Med Case Rep 2021; 15:219Gagarkin DA, Dombrowski KE, Thakar KB, DePetrillo JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910640 27. Presentation of COVID-19 infection with bizarre behavior and encephalopathy: a case report. J Med Case Rep 2021; 15:220Teimouri-Jervekani Z, Salmasi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910621 28. Neurological Manifestations of COVID-19 Associated Multi-system Inflammatory Syndrome in Children: A Systematic Review and Meta-analysis. J Nepal Health Res Counc 2021; 19:10-18Nepal G, Shrestha GS, Rehrig JH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934126 29. Neurological and cognitive sequelae of Covid-19: a four month follow-up. J. Neurol. 2021:1-7Mattioli F, Stampatori C, Righetti F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932157 30. Neurological update: COVID-19. J. Neurol. 2021:1-9Ren AL, Digby RJ, Needham EJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929617 31. Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong. J. Neurol. Neurosurg. Psychiatry 2021; Fan FSY, Yip TCF, Yiu B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906935 32. A case report of simultaneous autoimmune and COVID-19 encephalitis. J. Neurovirol. 2021:1-3Allahyari F, Hosseinzadeh R, Nejad JH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904138 33. Humility and Acceptance: Working Within Our Limits With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Orthop. Sports Phys. Ther. 2021; 51:197-200Décary S, Gaboury I, Poirier S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930983 34. Neuralgic amyotrophy and Covid 19 infection: 2 cases of spinal accessory nerve palsy. Joint Bone Spine 2021; Coll C, Tessier M, Vandendries C, Seror P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901661 35. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021; 11Palazzuoli A, Giustozzi M, Ruocco G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925334 36. Neurologic Emergencies during the Coronavirus Disease 2019 Pandemic. Neurol. Clin. 2021; 39:671-687Shulman JG, Ford T, Cervantes-Arslanian AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896538 37. Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy. Neurol Sci 2021; Pareyson D, Pantaleoni C, Eleopra R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33929645 38. Evaluation of E-Health Applications for Paediatric Patients with Refractory Epilepsy and Maintained on Ketogenic Diet. Nutrients 2021; 13Costa AM, Marchiò M, Bruni G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918854 39. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta- analysis, and meta-regression. Parkinsonism Relat. Disord. 2021; Putri C, Hariyanto TI, Hananto JE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33931304 40. Case description of a SARS-CoV-2 infected patient with meningitis. Pneumologie 2021; 75:13. 41. Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic. Psychol Health Med 2021:1-9Sbragia E, Colombo E, Pollio C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899615

Coagulation (24 articles)

1. Prevalence of thrombotic complications in children with SARS-CoV-2. Arch. Dis. Child. 2021; Aguilera-Alonso D, Murias S, Martínez-de-Azagra Garde A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931403 2. Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients. Cells 2021; 10Gedefaw L, Ullah S, Leung PHM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923537 3. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta- Regression. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211010976Zhan H, Chen H, Liu C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926262 4. Personalized prophylactic anticoagulation in hospitalized patients with Covid- 19 - The role of anti-Xa monitoring. Clin Microbiol Infect 2021; Kofteridis DP, Ioannou P, Kondili E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933565 5. Cavernous sinus thrombosis with central retinal artey occlusion in COVID-19: A case report and review of literature. Indian J Ophthalmol 2021; 69:1327- 1329Raj A, Kaur N, Kaur N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913893 6. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy. J Appl Lab Med 2021; Mei ZW, van Wijk XMR, Pham HP, Marin MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930144 7. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. J Clin Med 2021; 10Bareille M, Hardy M, Douxfils J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923851 8. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure. J Clin Med 2021; 10Wolf ME, Luz B, Niehaus L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918932 9. Development of Sacral/Buttock Retiform Purpura as an Ominous Presenting Sign of COVID-19 and Clinical and Histopathologic Evolution during Severe Disease Course. J. Cutan. Pathol. 2021; McBride JD, Narang J, Simonds R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931901 10. Positive SARS-CoV-2 RNA with Significant Inflammatory State and Thrombophilia after 12 Weeks of Initial Diagnosis of COVID-19 Infection. J. Glob. Infect. Dis. 2021; 13:42-43Betancourt MF, Grant KM, Johnson JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911453 11. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2- independent mechanism. J. Hematol. Oncol. 2021; 14:72Shen S, Zhang J, Fang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926500 12. Intraluminal carotid thrombosis and acute ischemic stroke associated with COVID-19. J. Neurol. 2021:1-5Hamouda D, Jillella DV, Bhatt N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914141 13. A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration. J Pers Med 2021; 11D'Agostino V, Caranci F, Negro A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917902 14. Failure of Anticoagulation to Prevent Stroke in Context of Lupus-Associated Anti-Phospholipid Syndrome and Mild COVID-19. J. Stroke Cerebrovasc. Dis. 2021:105817Kincaid KJ, Simpkins AN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33933349 15. Post adenoviral-based COVID-19 vaccines thrombosis: A proposed mechanism. J Thromb Haemost 2021; Kadkhoda K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904251 16. An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID- 19 vaccination. J Thromb Haemost 2021; Sørvoll IH, Horvei KD, Ernstsen SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909350 17. COVID 19 infection associated with thrombotic thrombocytopenic purpura. J. Thromb. Thrombolysis 2021:1-4Dhingra G, Maji M, Mandal S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904053 18. Massive intraperitoneal hemorrhage in patients with COVID-19: a case series. J. Thromb. Thrombolysis 2021:1-7Reisi-Vanani V, Lorigooini Z, Dayani MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909261 19. Neurologic Emergencies during the Coronavirus Disease 2019 Pandemic. Neurol. Clin. 2021; 39:671-687Shulman JG, Ford T, Cervantes-Arslanian AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896538 20. Acute pulmonary embolism in a child following SARS-CoV-2 infection: a case report. Pan Afr. Med. J. 2021; 38:125Ouarradi AE, Chekhlabi N, Elharras M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912295 21. Thrombosis in coronavirus disease. We must become active!! Phlebologie 2021; 50:158-159Mendoza E. 22. Challenges in the diagnostic approach of suspected pulmonary embolism in COVID-19 patients. Postgrad. Med. 2021; Stals MAM, Kaptein F, Kroft L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910469 23. Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population. Sensors (Basel) 2021; 21Saha A, Bajpai A, Krishna V, Bhattacharya S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918646 24. Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia. Stroke 2021; American Heart Association/American Stroke Association Stroke Council L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914590 25. D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients. Viruses 2021; 13Thoreau B, Galland J, Delrue M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33926038

Complications (59 articles)

1. Extracorporeal Membrane Oxygenation Instead of Invasive Mechanical Ventilation in a Patient with Severe COVID-19-associated Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2021; Schmidt M, Pineton de Chambrun M, Lebreton G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901416 2. COVID 19 pneumonia in Down syndrome patients: About 2 cases. Ann Med Surg (Lond) 2021; 65:102324El Kaouini A, El Rhalete A, Aabdi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907623 3. Negative SARS-COV-2 pleural effusion in breast carcinoma coincide with COVID-19 infection: Case report. Ann Med Surg (Lond) 2021; 65:102283Setiawan E, Listiarini DA, Ovaditya SZ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898038 4. Correspondence on 'Onset of rheumatoid arthritis after COVID-19: coincidence or connected?'. Ann. Rheum. Dis. 2021; Roongta R, Chattopadhyay A, Ghosh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906857 5. Cancer as a prospective sequela of long COVID-19. Bioessays 2021:e2000331Saini G, Aneja R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33914346 6. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients. BMC Infect. Dis. 2021; 21:398Meng M, Chen L, Zhang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926377 7. Effect of COVID-19 on childhood Mycoplasma pneumoniae infection in Chengdu, China. BMC Pediatr. 2021; 21:202Zhang Y, Huang Y, Ai T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910509 8. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol 2021; Phylactou M, Li JO, Larkin DFP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33910885 9. Dilated esophagus on a preoperative chest radiograph: an easily missed risk factor for aspiration. Braz J Anesthesiol 2021; Wei P, Ye L, Li J, Li J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932396 10. [COVID-19 and patients with cancer: Experiment of a French comprehensive cancer center]. Bull Cancer 2021; Frelaut M, Vaflard P, Vuagnat P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896587 11. A Fatal Extrapulmonary Manifestation of COVID-19. Cureus 2021; 13:e14068Harris CL, Achuthanandan S, Para K, Shetty V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903831 12. A Case Report of Severe Hyponatremia Secondary to Coronavirus Disease 2019 Viral Pneumonia. Cureus 2021; 13:e14077Pillutla V, Patel A, Koneru S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903839 13. Ethical heuristics for pandemic allocation of ventilators across hospitals. Dev World Bioeth 2021; Palacios-González C, Pugh J, Wilkinson D, Savulescu J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934463 14. COVID-19 Co-infection with Legionella pneumophila in 2 Tertiary-Care Hospitals, Germany. Emerg Infect Dis 2021; 27:1535-1537Verhasselt HL, Buer J, Dedy J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900187 15. The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer. ESMO Open 2021; 6:100123Dettorre GM, Patel M, Gennari A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932622 16. Pulmonary artery pseudoaneurysm secondary to COVID-19 treated with endovascular embolisation. Eur J Radiol Open 2021; 8:100346Khurram R, Karia P, Naidu V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898655 17. The Deadly Duo of COVID-19 and Cancer! Front Mol Biosci 2021; 8:643004Bora VR, Patel BM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912588 18. Respiratory supports of COVID-19 patients in intensive care unit: A systematic review. Heliyon 2021; 7:e06813Ouyang L, Yu M, Zhu Y, Gong J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898856 19. Cavernous sinus thrombosis with central retinal artey occlusion in COVID-19: A case report and review of literature. Indian J Ophthalmol 2021; 69:1327- 1329Raj A, Kaur N, Kaur N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913893 20. A case series of presumed fungal endogenous endophthalmitis in post COVID-19 patients. Indian J Ophthalmol 2021; 69:1322-1325Shah KK, Venkatramani D, Majumder PD. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913891 21. Title of the Article: Paranasal Mucormycosis in COVID-19 Patient. Indian J Otolaryngol Head Neck Surg 2021:1-4Saldanha M, Reddy R, Vincent MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903850 22. Public KAP towards COVID-19 and Antibiotics Resistance: A Malaysian Survey of Knowledge and Awareness. Int J Environ Res Public Health 2021; 18Chang CT, Lee M, Lee JCY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918782 23. Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings. Int J Environ Res Public Health 2021; 18Cultrera R, Barozzi A, Libanore M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923992 24. The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). J Clin Med 2021; 10Kwiatkowska J, Meyer-Szary J, Mazurek-Kula A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921526 25. SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population. J Clin Med 2021; 10Marcos S, Albiñana V, Recio-Poveda L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925423 26. Mortality escalates in patients of proximal femoral fractures with COVID-19: A systematic review and meta-analysis of 35 studies on 4255 patients. J Clin Orthop Trauma 2021; 18:80-93Patralekh MK, Jain VK, Iyengar KP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897205 27. Pharmacological Predictors of Morbidity and Mortality in COVID-19. J. Clin. Pharmacol. 2021; Oddy C, McCaul J, Keeling P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908637 28. Development of Sacral/Buttock Retiform Purpura as an Ominous Presenting Sign of COVID-19 and Clinical and Histopathologic Evolution during Severe Disease Course. J. Cutan. Pathol. 2021; McBride JD, Narang J, Simonds R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931901 29. Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs. J Fungi (Basel) 2021; 7Arastehfar A, Shaban T, Zarrinfar H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917967 30. Acute Pulmonary Histoplasmosis Following COVID-19: Novel Laboratorial Methods Aiding Diagnosis. J Fungi (Basel) 2021; 7de Macedo PM, Freitas AD, Bártholo TP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925084 31. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J Fungi (Basel) 2021; 7John TM, Jacob CN, Kontoyiannis DP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920755 32. Acute Gastrointestinal Injury and Feeding Intolerance as Prognostic Factors in Critically Ill COVID-19 Patients. J Gastrointest Surg 2021:1-10Drakos P, Volteas P, Cleri NA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905039 33. Positive SARS-CoV-2 RNA with Significant Inflammatory State and Thrombophilia after 12 Weeks of Initial Diagnosis of COVID-19 Infection. J. Glob. Infect. Dis. 2021; 13:42-43Betancourt MF, Grant KM, Johnson JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911453 34. Clinical Determinants of Severe COVID-19 Disease - A Systematic Review and Meta-Analysis. J. Glob. Infect. Dis. 2021; 13:13-19Sahu AK, Mathew R, Aggarwal P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911447 35. Hemophagocytic lymphohistiocytosis, a new cause of death during 'post- acute COVID-19 syndrome?' A case report. J. Hematop. 2021:1-5Naous E, Nassani BM, Yaghi C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897909 36. Bronchopleural Fistula as a Complication in a COVID-19 Patient Managed With Endobronchial Valves. J Investig Med High Impact Case Rep 2021; 9:23247096211013215Talon A, Arif MZ, Mohamed H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928804 37. Simultaneous development of COVID-19 pneumonia and pulmonary metastasis in a known case of chondrosarcoma: a case report. J Med Case Rep 2021; 15:218Rakhsha A, Mahboubi-Fooladi Z, Jafari A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910620 38. Characterization of T lymphocytes in severe COVID-19 patients. J Med Virol 2021; Fenoglio D, Dentone C, Parodi A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913544 39. COVID 19 infection associated with thrombotic thrombocytopenic purpura. J. Thromb. Thrombolysis 2021:1-4Dhingra G, Maji M, Mandal S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904053 40. Massive intraperitoneal hemorrhage in patients with COVID-19: a case series. J. Thromb. Thrombolysis 2021:1-7Reisi-Vanani V, Lorigooini Z, Dayani MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909261 41. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021; 11Palazzuoli A, Giustozzi M, Ruocco G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925334 42. Early prone positioning therapy for patients with mild COVID-19 disease. Med Clin (Engl Ed) 2021; 156:386-389Liu X, Liu H, Lan Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898754 43. Early-onset symptomatic radiation necrosis after stereotactic radiosurgery in the setting of COVID-19 infection. Med. Dosim. 2021; Weltman E, Kotecha R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910768 44. Skeletal Muscle Damage in COVID-19: A Call for Action. Medicina (Kaunas) 2021; 57Ali AM, Kunugi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921429 45. A Dedicated Veno-Venous Extracorporeal Membrane Oxygenation Unit during a Respiratory Pandemic: Lessons Learned from COVID-19 Part I: System Planning and Care Teams. Membranes (Basel) 2021; 11Dave S, Shah A, Galvagno S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918355 46. A Dedicated Veno-Venous Extracorporeal Membrane Oxygenation Unit during a Respiratory Pandemic: Lessons Learned from COVID-19 Part II: Clinical Management. Membranes (Basel) 2021; 11Shah A, Dave S, Galvagno S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919390 47. COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report. Mol Clin Oncol 2021; 14:117Yerushalmi R, Sagi M, Goldvaser H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903823 48. Causal impact of local inflammation in the nasal cavity on higher brain function and cognition. Neurosci. Res. 2021; Hasegawa Y, Namkung H, Smith A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932551 49. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta- analysis, and meta-regression. Parkinsonism Relat. Disord. 2021; Putri C, Hariyanto TI, Hananto JE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33931304 50. The Monthly Operating Cost of an Institutional COVID-19 Airway Response Team: A Financial Model and Sensitivity Analysis Based on Experience at an Academic Medical Center. Perioper Care Oper Room Manag 2021; 23:100168Stone AB, Grant MC, Dasani SS, Nascimben L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898769 51. Thrombosis in coronavirus disease. We must become active!! Phlebologie 2021; 50:158-159Mendoza E. 52. Functional Decline in Hospitalized Patients with COVID-19 in the Early Months of the Pandemic. Pm r 2021; Daunter AK, Bowman A, Danko J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929087 53. Challenges in the diagnostic approach of suspected pulmonary embolism in COVID-19 patients. Postgrad. Med. 2021; Stals MAM, Kaptein F, Kroft L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910469 54. Effect of serial awake prone positioning on oxygenation in patients admitted to intensive care with COVID-19. Postgrad. Med. J. 2021; Barker J, Pan D, Koeckerling D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931557 55. [CME Rheumatology 23: Rheumatoid Arthritis Following COVID-19/SARS-CoV- 2 Infection]. Praxis (Bern 1994) 2021; 110:293-297Tamborrini G, Micheroli R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906448 56. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir. Med. 2021; 182:106394E E, R F, Öi E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901787 57. E-Triage Systems for COVID-19 Outbreak: Review and Recommendations. Sensors (Basel) 2021; 21Alhaidari F, Almuhaideb A, Alsunaidi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920744 58. Nosocomial Outbreak of SARS-CoV-2 in a "Non-COVID-19" Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission. Viruses 2021; 13Borges V, Isidro J, Macedo F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916205 59. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021; 13Silva Andrade B, Siqueira S, de Assis Soares WR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3391953

Cured – Recovered (21 articles)

1. Predictors of readmission requiring hospitalization after discharge from emergency departments in patients with COVID-19. Am J Emerg Med 2021; 46:146-149Menditto VG, Fulgenzi F, Bonifazi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932638 2. Cancer as a prospective sequela of long COVID-19. Bioessays 2021:e2000331Saini G, Aneja R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33914346 3. Late conditions diagnosed 1-4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data - United States, March 1-June 30, 2020. Clin Infect Dis 2021; Chevinsky JR, Tao G, Lavery AM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33909072 4. SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection. Clin Infect Dis 2021; Choudhary MC, Crain CR, Qiu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906227 5. Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients' lived experience. Clin Infect Dis 2021; Tran VT, Riveros C, Clepier B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912905 6. Pityriasis rubra pilaris post-infection due COVID-19: case report. Colomb Med (Cali) 2021; 52:e7014577Aguilar-Gamboa FR, Cubas-Alarcon D, Villegas-Chiroque M, Failoc-Rojas VE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911322 7. Post-COVID seizure: A new feature of "long-COVID". eNeurologicalSci 2021; 23:100340Kincaid KJ, Kung JC, Senetar AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898792 8. A Follow-Up Investigation of Mental Health Among Discharged COVID-19 Patients in Wuhan, China. Front Public Health 2021; 9:640352Li L, Wu MS, Tao J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912531 9. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int J Environ Res Public Health 2021; 18Sisó-Almirall A, Brito-Zerón P, Conangla Ferrín L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923972 10. Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study. Int J Infect Dis 2021; Sevillano G, Ortega-Paredes D, Loaiza K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930542 11. A COVID-19 Rehabilitation Prospective Surveillance Model for Use by Physiotherapists. J Clin Med 2021; 10Postigo-Martin P, Cantarero-Villanueva I, Lista-Paz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920035 12. Half-year follow-up of patients recovering from severe COVID-19: Analysis of symptoms and their risk factors. J Intern Med 2021; Shang YF, Liu T, Yu JN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904618 13. Intraluminal carotid thrombosis and acute ischemic stroke associated with COVID-19. J. Neurol. 2021:1-5Hamouda D, Jillella DV, Bhatt N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914141 14. COVID-19 and fatigue: Where do we go from here? Response to Ortelli et al. J Neurol Sci 2021; 426:117470Conti I, Cross B, Rooney AG, Nicholson TR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930693 15. Analysis of the Long-Term Impact on Cellular Immunity in COVID-19- Recovered Individuals Reveals a Profound NKT Cell Impairment. mBio 2021; 12Liu J, Yang X, Wang H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906918 16. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (Kaunas) 2021; 57Wong TL, Weitzer DJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925784 17. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir. Med. 2021; 182:106394E E, R F, Öi E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901787 18. Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: Real-life data from a Belgian University Hospital. Respir. Med. 2021; 182:106421Stylemans D, Smet J, Hanon S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901788 19. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax 2021; McGroder CF, Zhang D, Choudhury MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927016 20. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies. Viruses 2021; 13Brehm TT, Pfefferle S, von Possel R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921216 21. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021; 13Silva Andrade B, Siqueira S, de Assis Soares WR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919537

Cardiovascular disease (49 articles)

1. Documentation of Do-Not-Attempt-Cardiopulmonary-Resuscitation Orders amid the COVID-19 Pandemic. Age Ageing 2021; Connellan D, Diffley K, McCabe J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909020 2. Cardiovascular injuries during COVID-19 infection: A PROCESS-compliant case series from the Eastern Morocco. Ann Med Surg (Lond) 2021; 65:102309El Rhalete A, Rhazi I, Bensaid A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898022 3. ST elevation revealing acute myocarditis with SARS cov 2 infection: Case report. Ann Med Surg (Lond) 2021; 65:102313Taouihar S, Bouabdallaoui A, Aabdi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898039 4. Dissecting the management and outcomes of thoracic aortovascular disease during the COVID-19 pandemic. Ann. Vasc. Surg. 2021; McPherson I, Chilvers N, Freystaetter K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905848 5. ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France. Arch Cardiovasc Dis 2021; Bonnet G, Panagides V, Becker M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926830 6. Aberrated supraventricular tachycardia associated with neonatal fever and COVID-19 infection. BMJ Case Rep. 2021; 14Hopkins KA, Webster G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931425 7. Antihypertensive Medications and COVID-19 Diagnosis and Mortality: Population-based Case-Control Analysis in the United Kingdom. Br. J. Clin. Pharmacol. 2021; Rezel-Potts E, Douiri A, Chowienczyk PJ, Gulliford MC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908074 8. The impact of the COVID-19 pandemic on application of European Society of Cardiology (ESC) guidelines for exercise in adults with congenital heart disease: a data-based questionnaire. Cardiol. Young 2021:1-20Thompson SE, Whitehead CA, Notley AS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902783 9. Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients. Cells 2021; 10Gedefaw L, Ullah S, Leung PHM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923537 10. Prevalence and clinical significance of relative bradycardia at hospital admission in patients with Coronavirus Disease 2019 (COVID-19). Clin Microbiol Infect 2021; A O, C F, Mc G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901669 11. Implications of cardiac markers in risk-stratification and management for COVID-19 patients. Crit Care 2021; 25:158Li P, Wu W, Zhang T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902676 12. Digital Ischemia as an Initial Presentation in a COVID-19-Positive Patient Without Any Significant Respiratory Symptoms. Cureus 2021; 13:e14054Acherjee T, Bastien B, Rodriguez-Guerra MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898138 13. Association of Viruses in the Development of Cardiovascular Diseases. Curr. Pharm. Des. 2021; Rauff B, Malik A, Bhatti YA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902408 14. Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-chip model. EMBO Rep 2021:e52744Thacker VV, Sharma K, Dhar N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908688 15. Non-communicable diseases during the COVID-19 pandemic and beyond. Engineering (Beijing) 2021; Pan XF, Yang J, Wen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898076 16. Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis. ESC Heart Fail 2021; Gaudriot B, Mansour A, Thibault V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934560 17. Heart Failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings. Eur J Heart Fail 2021; Hadzibegovic S, Lena A, Churchill TW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932255 18. Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19. Eur J Intern Med 2021; Angeli F, Marazzato J, Verdecchia P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933339 19. Pulmonary artery pseudoaneurysm secondary to COVID-19 treated with endovascular embolisation. Eur J Radiol Open 2021; 8:100346Khurram R, Karia P, Naidu V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898655 20. Comparison of the clinical features and therapeutics of COVID-19 in cardio- cerebrovascular disease (CCVD) and non-CCVD patients. Front Med 2021:1- 9Wang Y, Li L, Pan Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909258 21. Case Report: Cerebrovascular Events Associated With Bacterial and SARS- CoV-2 Infections in an Adolescent. Front. Neurol. 2021; 12:606617de Marcellus C, Dupic L, Roux CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897582 22. Prolonged Intubation in Patients With Prior Cerebrovascular Disease and COVID-19. Front. Neurol. 2021; 12:642912Mukerji SS, Das S, Alabsi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897598 23. Neuro-Imaging Manifestations of COVID-19: Predilection for PICA Infarcts. IDCases 2021:e01131Ahmed M, Gaba WH, Al Mazrouei SS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898251 24. Acute monocular vision loss as presenting symptom of delayed stroke from internal carotid occlusion in COVID-19. Indian J Ophthalmol 2021; 69:1325- 1327Deshpande G, Giri P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913892 25. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Int J Mol Sci 2021; 22Aleksova A, Gagno G, Sinagra G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926110 26. Cardiovascular Outcomes in the Acute Phase of COVID-19. Int J Mol Sci 2021; 22Nakano H, Shiina K, Tomiyama H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33920790 27. COVID-19: Direct and Indirect Mechanisms of Statins. Int J Mol Sci 2021; 22Pawlos A, Niedzielski M, Gorzelak-Pabiś P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920709 28. Systolic dysfunction and complete heart block as complications of fulminant myocarditis in a recovered COVID-19 patient. J Cardiol Cases 2021; Nikoo MH, Mozaffari R, Hatamnejad MR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897917 29. COVID-19 related mortality in post-operative cardiac surgical patients. J. Cardiothorac. Surg. 2021; 16:112Hussain A, Khalil A, Kolvekar P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902671 30. Home Management of Heart Failure and Arrhythmias in Patients with Cardiac Devices during Pandemic. J Clin Med 2021; 10Matteucci A, Bonanni M, Centioni M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920350 31. Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19 Pandemic-A Simulation, Randomised Crossover Trial. J Clin Med 2021; 10Rauch S, van Veelen MJ, Oberhammer R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923620 32. Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19. J Clin Med 2021; 10Wu CC, Lee AJ, Su CH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916281 33. Cardiac arrhythmias in patients with COVID-19: Lessons from 2300 telemetric monitoring days on the intensive care unit. J. Electrocardiol. 2021; 66:102- 107Parwani AS, Haug M, Keller T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906056 34. Fragmented QRS on surface electrocardiography as a predictor of cardiac mortality in patients with SARS-CoV-2 infection. J. Electrocardiol. 2021; 66:108- 112Yildirim A, Karaca IO, Yilmaz FK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906057 35. Impact of the COVID-19 Outbreak on Emergency Care Utilization in Patients with Acute Myocardial Infarction: a Nationwide Population-based Study. J Korean Med Sci 2021; 36:e111Sung HK, Paik JH, Lee YJ, Kang S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904263 36. Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis. J Nepal Health Res Counc 2021; 19:1- 9Budhathoki P, Shrestha DB, Khadka S, Rawal E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934125 37. Failure of Anticoagulation to Prevent Stroke in Context of Lupus-Associated Anti-Phospholipid Syndrome and Mild COVID-19. J. Stroke Cerebrovasc. Dis. 2021:105817Kincaid KJ, Simpkins AN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33933349 38. Impact of the pandemic of COVID-19 on emergency attendance for stroke and acute myocardial infarction in Beijing, China. J. Thromb. Thrombolysis 2021:1- 9Wu Y, Chen F, Sun Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904052 39. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021; 11Palazzuoli A, Giustozzi M, Ruocco G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925334 40. PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic. Orphanet J. Rare Dis. 2021; 16:196Godinas L, Iyer K, Meszaros G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933110 41. Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the COVID-19 lockdown. Pacing Clin. Electrophysiol. 2021; Magnocavallo M, Bernardini A, Mariani MV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908052 42. Acute pulmonary embolism in a child following SARS-CoV-2 infection: a case report. Pan Afr. Med. J. 2021; 38:125Ouarradi AE, Chekhlabi N, Elharras M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912295 43. No relationship was observed between Kawasaki disease and COVID-19 in Japan. Pediatr. Int. 2021; Nakamura Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913588 44. Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore. Physiology (Bethesda) 2021; 36:160-173Saavedra JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904788 45. Challenges in the diagnostic approach of suspected pulmonary embolism in COVID-19 patients. Postgrad. Med. 2021; Stals MAM, Kaptein F, Kroft L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910469 46. Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population. Sensors (Basel) 2021; 21Saha A, Bajpai A, Krishna V, Bhattacharya S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918646 47. Cardiovascular Risk Factors Among Patients Infected with COVID-19 in Saudi Arabia. Vasc Health Risk Manag 2021; 17:161-168Alshaikh MK, Alotair H, Alnajjar F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907410 48. D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients. Viruses 2021; 13Thoreau B, Galland J, Delrue M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33926038 49. [Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19]. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 2021; 121:60-66Kovalchuk VV, Ershova, II, Molodovskaya NV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908234

Diagnosis (11 articles)

1. COVID-19 Diagnostic Strategies Part II: Protein-Based Technologies. Bioengineering (Basel) 2021; 8Shaffaf T, Ghafar-Zadeh E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925032 2. COVID-19 Diagnostic Strategies. Part I: Nucleic Acid-Based Technologies. Bioengineering (Basel) 2021; 8Shaffaf T, Ghafar-Zadeh E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920513 3. Association between clinical, laboratory findings and chest CT in COVID-19 in a secondary hospital in Jakarta, Indonesia. Germs 2021; 11:32-38Hafiz M, Icksan AG, Harlivasari AD et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898339 4. Artificial intelligence in the diagnosis of COVID-19: challenges and perspectives. Int J Biol Sci 2021; 17:1581-1587Huang S, Yang J, Fong S, Zhao Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907522 5. Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy. Int J Infect Dis 2021; Lagi F, Trevisan S, Piccica M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901656 6. Performance Evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel. Int J Infect Dis 2021; Lebourgeois S, Storto A, Gout B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901651 7. Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations. J Immunother Cancer 2021; 9Abid MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931473 8. Current state of Diagnostic, Screening and Surveillance Testing Methods for COVID-19 from an Analytical Chemistry Point of View. Microchem. J. 2021:106305Martín J, Tena N, Asuero AG. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897053 9. Comparison of computed tomography (CT) findings with RT-PCR in the diagnosis of COVID-19 in children. Pediatr Pulmonol 2021; Bağcı Z, Keçeli AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902160 10. Challenges in the diagnostic approach of suspected pulmonary embolism in COVID-19 patients. Postgrad. Med. 2021; Stals MAM, Kaptein F, Kroft L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910469 11. Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic. Virol J 2021; 18:93Marshall NC, Kariyawasam RM, Zelyas N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933115

DM-MS-Obesity (22 articles)

1. Impact of metabolic syndrome in the clinical outcome of disease by SARS- COV-2 in Mexican population. Arch Med Res 2021; León-Pedroza JI, Rodríguez- Cortés O, Flores-Mejía R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33926762 2. Clinical, radiological and functional outcomes in patients with SARS-CoV-2 pneumonia: a prospective observational study. BMC Pulm. Med. 2021; 21:136Gianella P, Rigamonti E, Marando M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902513 3. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review. Cells 2021; 10Demeulemeester F, de Punder K, van Heijningen M, van Doesburg F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920604 4. The Effect of the Covid-19 Shutdown on Glycemic Testing and Control. Clin Chim Acta 2021; Sharma A, Greene DN, Chambliss AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932408 5. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives. Curr Obes Rep 2021:1-30Dalamaga M, Christodoulatos GS, Karampela I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909265 6. Choreo-ballistic movements heralding COVID-19 induced diabetic ketoacidosis. Diabetes Metab Syndr 2021; 15:913-917Ghosh R, Dubey S, Roy D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915346 7. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown. Diabetes Res Clin Pract 2021:108840Tanji Y, Sawada S, Watanabe T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933499 8. The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study. Diabetol Int 2021:1- 6Hosomi Y, Munekawa C, Hashimoto Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898153 9. Study on the effects of changes in lifestyle of patients with diabetes on glycaemic control before and after the declaration of the state of emergency in Japan. Diabetol Int 2021:1-9Masuda M, Tomonaga O. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898154 10. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia 2021:1- 12Schlesinger S, Neuenschwander M, Lang A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907860 11. Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19. Front. Pharmacol. 2021; 12:670468Iovino C, Peiretti E, Giannaccare G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912065 12. Physical Activity in Adolescents with and without Type 1 Diabetes during the New Zealand COVID-19 Pandemic Lockdown of 2020. Int J Environ Res Public Health 2021; 18Telford DM, Signal DM, Hofman PL, Gusso S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922464 13. Pharmacological management of COVID-19 in type 2 diabetes. J. Diabetes Complications 2021:107927Ceriello A, Prattichizzo F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896714 14. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J Fungi (Basel) 2021; 7John TM, Jacob CN, Kontoyiannis DP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920755 15. Diabesity Associated with Poor COVID-19 Outcomes among Hospitalized Patients. J Obes Metab Syndr 2021; Nikniaz Z, Somi MH, Dinevari MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927066 16. Screening for Gestational Diabetes during the COVID-19 Pandemic-Current Recommendations and Their Consequences. Medicina (Kaunas) 2021; 57Panaitescu AM, Ciobanu AM, Popa M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920937 17. Characteristics, Management, and Outcomes of Elderly Patients with Diabetes in a Covid-19 Unit: Lessons Learned from a Pilot Study. Medicina (Kaunas) 2021; 57Ricchio M, Tassone B, Pelle MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916210 18. COVID-19-Related Stress and Anxiety, Body Mass Index, Eating Disorder Symptomatology, and Body Image in Women from Poland: A Cluster Analysis Approach. Nutrients 2021; 13Czepczor-Bernat K, Swami V, Modrzejewska A, Modrzejewska J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924010 19. Adherence to Mediterranean Diet and Selected Lifestyle Elements among Young Women with Type 1 Diabetes Mellitus from Northeast Poland: A Case- Control COVID-19 Survey. Nutrients 2021; 13Grabia M, Puścion-Jakubik A, Markiewicz-Żukowska R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918177 20. Managing Obesity in Lockdown: Survey of Health Behaviors and Telemedicine. Nutrients 2021; 13Minsky NC, Pachter D, Zacay G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921602 21. Vaccinating People with Obesity for COVID-19: EASO Call for Action. Obes Facts 2021:1-2Dicker D, Golan R, Baker JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915546 22. Impact of COVID-19 on child malnutrition, obesity in women and household food insecurity in underserved urban settlements in Sri Lanka: a prospective follow up study. Public Health Nutr. 2021:1-24Jayatissa R, Herath H, Perera AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902778

Education and training and science (61 articles) 1. Exploring the Relationships Between Resilience and News Monitoring with COVID Distress in Health Profession Students. Acad. Psychiatry 2021:1-9Yu A, Wilkes M, Iosif AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928535 2. An evaluation of social media utilization by general surgery programs in the COVID-19 era. Am. J. Surg. 2021; Fang HA, Boudreau HB, Khan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906728 3. Student perception and the effectiveness of Kahoot!: A scoping review in histology, anatomy and medical education. Anat Sci Educ 2021; Donkin R, Rasmussen R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900041 4. An adaptive blended learning model for the implementation of an integrated medical neuroscience course during the Covid-19 pandemic. Anat Sci Educ 2021; T IN, Goodwin RL, Fowler L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915035 5. Staying calm and teaching biochemistry to postgraduates in COVID-19 times: Pros and cons. Biochem Mol Biol Educ 2021; Sepici Dinçel A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904644 6. Life during the pandemic: an international photo-elicitation study with medical students. BMC Med. Educ. 2021; 21:244Dworkin M, Akintayo T, Calem D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906671 7. Challenges and opportunities from the COVID-19 pandemic in medical education: a qualitative study. BMC Med. Educ. 2021; 21:247Hayat AA, Keshavarzi MH, Zare S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926439 8. Clinical research activities during COVID-19: the point of view of a promoter of academic clinical trials. BMC Med. Res. Methodol. 2021; 21:91Valmorri L, Vertogen B, Zingaretti C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931012 9. Pandemic response in pluralistic health systems: a cross-sectional study of COVID-19 knowledge and practices among informal and formal primary care providers in Bihar, India. BMJ Open 2021; 11:e047334Rao KD, Kaur J, Peters MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931411 10. Evaluating the impact of COVID-19 pandemic lockdown on education in Nigeria: Insights from teachers and students on virtual/online learning. Bull Natl Res Cent 2021; 45:76Ebohon O, Obienu AC, Irabor F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897254 11. Knowledge and awareness among physiotherapy students to combat COVID- 19: A questionnaire based study. Clin Epidemiol Glob Health 2021; 11:100748Jangra MK, Saxena A, Anurag P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898864 12. The PhenX Toolkit: Establishing Standard Measures for COVID-19 Research. Curr Protoc 2021; 1:e111Krzyzanowski MC, Terry I, Williams D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905618 13. Correction in Active Cases Data of COVID-19 for the US States by Analytical study. Disaster Med Public Health Prep 2021:1-8Solanki R, Varshney A, Gourishetty R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926607 14. Distance Education During the COVID-19 Pandemic in Turkey: Identifying the Needs of Early Childhood Educators. Early Child Educ J 2021:1-8Alan Ü. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897251 15. A comprehensive antigen production and characterisation study for easy-to- implement, specific and quantitative SARS-CoV-2 serotests. EBioMedicine 2021; 67:103348Klausberger M, Duerkop M, Haslacher H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906067 16. Lessons learned through listening to biology students during a transition to online learning in the wake of the COVID-19 pandemic. Ecol. Evol. 2021; 11:3450-3458Humphrey EA, Wiles JR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898001 17. A comparative study between outcomes of an in-person versus online introductory field course. Ecol. Evol. 2021; 11:3625-3635Race AI, De Jesus M, Beltran RS, Zavaleta ES. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898015 18. Impact of online classes on the satisfaction and performance of students during the pandemic period of COVID 19. Educ Inf Technol (Dordr) 2021:1- 25Gopal R, Singh V, Aggarwal A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33903795 19. COVID 19 response: An analysis of teachers' perception on pedagogical successes and challenges of digital teaching practice during new normal. Educ Inf Technol (Dordr) 2021:1-24Kundu A, Bej T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897267 20. Distance education in COVID-19 pandemic: An evaluation of parent's, child's and teacher's competences. Educ Inf Technol (Dordr) 2021:1-21Öçal T, Halmatov M, Ata S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897269 21. Medical Students' Voluntary Service During the COVID-19 Pandemic in Poland. Front Public Health 2021; 9:618608Domaradzki J, Walkowiak D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928061 22. The Role of Clinical Researchers During COVID-19: Balancing Individual, Scientific, and Social Benefits of Research. Front Public Health 2021; 9:638964Oviedo DC, Perez-Lao AR, Villarreal AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898376 23. COVID-19 Research: Challenges to Interpret Numbers and Propose Solutions. Front Public Health 2021; 9:651089Struelens MJ, Vineis P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912532 24. Application of Artificial Intelligence in COVID-19 Pandemic: Bibliometric Analysis. Healthcare (Basel) 2021; 9Islam MM, Poly TN, Alsinglawi B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918686 25. The Psychological Symptoms of College Student in China during the Lockdown of COVID-19 Epidemic. Healthcare (Basel) 2021; 9Li Y, Qin L, Shi Y, Han J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920411 26. Student Health Implications of School Closures during the COVID-19 Pandemic: New Evidence on the Association of e-Learning, Outdoor Exercise, and Myopia. Healthcare (Basel) 2021; 9Liu J, Li B, Chen Q, Dang J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922486 27. An Experimental Education Project for Consultations of Older Adults during the Pandemic and Healthcare Lockdown. Healthcare (Basel) 2021; 9Neumann- Podczaska A, Seostianin M, Madejczyk K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917509 28. Dental Education Challenges during the COVID-19 Pandemic Period in Italy: Undergraduate Student Feedback, Future Perspectives, and the Needs of Teaching Strategies for Professional Development. Healthcare (Basel) 2021; 9Varvara G, Bernardi S, Bianchi S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921516 29. Publication trend of COVID-19 and non-COVID-19 articles in the Indian Journal of Ophthalmology during the pandemic. Indian J Ophthalmol 2021; 69:1241- 1248Gurnani B, Kaur K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913868 30. COVID-19 and ophthalmology: A scientometric analysis. Indian J Ophthalmol 2021; 69:1234-1240Kalra G, Kaur R, Ichhpujani P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913867 31. Adoption of newer teaching methods to overcome challenges of training in ophthalmology residency during the COVID-19 pandemic. Indian J Ophthalmol 2021; 69:1292-1297Pradeep TG, Sundaresh DD, Ramani S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913881 32. Global landscape of patents related to human coronaviruses. Int J Biol Sci 2021; 17:1588-1599Liu K, Gu Z, Islam MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907523 33. The perceived global impact of the COVID-19 pandemic on doctors' medical and surgical training: an international survey. Int J Clin Pract 2021:e14314Laloo R, Karri RS, Wanigasooriya K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33932265 34. Knowledge, Attitudes, and Practices Related to COVID-19 Among Malawi Adults: A Community-Based Survey. Int J Environ Res Public Health 2021; 18Li Y, Liu G, Egolet RO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924451 35. Knowledge, Attitude, and Practice of Indonesian Residents toward COVID-19: A Cross-Sectional Survey. Int J Environ Res Public Health 2021; 18Muslih M, Susanti HD, Rias YA, Chung MH. http://www.ncbi.nlm.nih.gov/pubmed/? term=33922420 36. Knowledge and Practices during the COVID-19 Outbreak in the Middle East: A Cross-Sectional Study. Int J Environ Res Public Health 2021; 18Naser AY, Dahmash EZ, Alsairafi ZK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925024 37. The Effectiveness of the Blended Learning in Conservative Dentistry with Endodontics on the Basis of the Survey among 4th-Year Students during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Nijakowski K, Lehmann A, Zdrojewski J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923047 38. Knowledge and Perception of COVID-19 Pandemic during the First Wave (Feb- May 2020): A Cross-Sectional Study among Italian Healthcare Workers. Int J Environ Res Public Health 2021; 18Rizzo C, Campagna I, Pandolfi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916577 39. Gender Differences in the COVID-19 Pandemic Risk Perception, Psychology, and Behaviors of Spanish University Students. Int J Environ Res Public Health 2021; 18Rodriguez-Besteiro S, Tornero-Aguilera JF, Fernández-Lucas J, Clemente- Suárez VJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917827 40. Fall 2020 COVID-19 Needs Assessment among New Jersey Secondary School Educational Professionals. Int J Environ Res Public Health 2021; 18Shendell DG, Aggarwal J, Campbell MLF et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33924392 41. Searching for a new normal-Hospital-employed researchers' experiences during the COVID-19 pandemic. Int. J. Nurs. Pract. 2021:e12931Berthelsen C, Beck M, Hølge-Hazelton B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908138 42. Impact of COVID-19 on Surgical Residency Programs A Glass Half-Full Reflection. Int J Surg 2021; 89:105958Angeramo CA, Schlottmann F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930571 43. Global digital social learning as a strategy to promote engagement in the era of COVID-19. J. Clin. Nurs. 2021; Davidson PM, Lin CJ, Beaman A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904196 44. An academic-practice partnership during COVID-19 pandemic: Transitioning from a clinical to virtual fellowship. J. Clin. Nurs. 2021; Gillett C, Mason S, Fleming L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913557 45. Malaysian pharmacy students' perspectives on the virtual objective structured clinical examination during the coronavirus disease 2019 pandemic. J Educ Eval Health Prof 2021; 18:6Elnaem MH, Akkawi ME, Nazar NIM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910270 46. Simulation Centers and Simulation-Based Education during the Time of COVID 19: A Multi-Center Best Practice Position Paper by the World Academic Council of Emergency Medicine. J. Emerg. Trauma Shock 2021; 14:3-13Lateef F, Suppiah M, Chandra S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911429 47. Ethical Characteristics of Research Proposals Related to COVID-19 Pandemic in Nepal: A Retrospective Review. J Nepal Health Res Counc 2021; 19:148- 153Ghimire N, Hamal PK, Panthee A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33934150 48. Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape. J Pers Med 2021; 11Chatterjee A, Nardi C, Oberije C, Lambin P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919882 49. Going virtual for EAPM 2021. J. Psychosom. Res. 2021:110499Fiedorowicz JG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896645 50. Changing the Status Quo: Developing a Virtual Sub-Internship in the Era of COVID-19. J Surg Educ 2021; Mikhail D, Margolin EJ, Sfakianos J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896734 51. Evaluating the effectiveness of an online faculty development programme for nurse educators about remote teaching during COVID-19. J Taibah Univ Med Sci 2021; 16:268-273Swaminathan N, Govindharaj P, Jagadeesh NS, Ravichandran L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897333 52. Highlights from the American society of hematology conference 2020. J. Thromb. Thrombolysis 2021:1-9Grover P, Gulati S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900522 53. Complex scenarios with competing factors: A conception paper applied to the COVID-19 case. Nonlinear Dyn 2021:1-15Brandão MP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897104 54. "Interventional Pain Training using Phantom Model during COVID-19 Pandemic". Pain Pract 2021; Silva V, Martínez L, Santiago M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934501 55. COVID-19 has changed the way we think about training future pediatric hematologists/oncologists. Pediatr Blood Cancer 2021:e29088Moerdler S, Gampel B, Levine JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913620 56. Developing a blended learning postgraduate teaching programme in anaesthesia: pandemic and beyond. Postgrad. Med. J. 2021; Cooke PC, Hajamohideen N, Gooneratne H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33931560 57. Towards Covid-19 Literacy: Investigating the Literacy Levels of University Students in Colombia. Sci Educ (Dordr) 2021:1-24Archila PA, Danies G, Molina J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897108 58. Day-to-day discovery of preprint-publication links. Scientometrics 2021:1- 20Cabanac G, Oikonomidi T, Boutron I. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897069 59. Training the Next Industrial Engineers and Managers about Industry 4.0: A Case Study about Challenges and Opportunities in the COVID-19 Era. Sensors (Basel) 2021; 21Benis A, Amador Nelke S, Winokur M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919164 60. COVID-19 Pandemic and its Impact on Pharmacy Education. Turk J Pharm Sci 2021; 18:122-123Ashiq K, Bajwa MA, Ashiq S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900392 61. Knowledge, Attitudes, and Practices towards COVID-19 Transmission and Preventive Measures among Residents of Nigeria: A Population-Based Survey through Social Media. West Afr. J. Med. 2021; 38:347-358Akafa AT, Amos Y, Okeke A, Oreh AC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901392

Elderly (22 articles)

1. The COVID-19 Pandemic Appears to Have Increased Longevity in Japanese Centenarians. Age Ageing 2021; Aoki Y, Mehmet SC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909007 2. The Role of Vitamin K in Humans: Implication in Aging and Age-Associated Diseases. Antioxidants (Basel) 2021; 10Popa DS, Bigman G, Rusu ME. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917442 3. Changes in physical activity and rest-activity circadian rhythm among Hong Kong community aged population before and during COVID-19. BMC Public Health 2021; 21:836Lee PMY, Huang B, Liao G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933046 4. The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system. Cent Eur J Immunol 2021; 46:1- 9Marcinkiewicz J, Witkowski JM, Olszanecki R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897278 5. The Impact of Pets on Everyday Life for Older Adults During the COVID-19 Pandemic. Front Public Health 2021; 9:652610Applebaum JW, Ellison C, Struckmeyer L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898382 6. COVID-19 and Quarantine, a Catalyst for Ageism. Front Public Health 2021; 9:589244Barth N, Guyot J, Fraser SA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33912526 7. Physical Activity Among Predominantly White Middle-Aged and Older US Adults During the SARS-CoV-2 Pandemic: Results From a National Longitudinal Survey. Front Public Health 2021; 9:652197Joseph RP, Pituch KA, Guest MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928065 8. COVID-19 Disparities in Nursing Homes. Healthcare (Basel) 2021; 9Loubert L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915764 9. COVID-19 and Mental Health: A Study of Stress, Resilience, and Depression among the Older Population in Pakistan. Healthcare (Basel) 2021; 9Mumtaz A, Manzoor F, Jiang S, Anisur Rahaman M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33917346 10. Older Adults' Avoidance of Public Transportation after the Outbreak of COVID- 19: Korean Subway Evidence. Healthcare (Basel) 2021; 9Park B, Cho J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920432 11. COVID-19-related deaths in residential care homes for elderly: The situation in Italy. J. Forensic Leg. Med. 2021; 80:102179Ventura F, Molinelli A, Barranco R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934045 12. Evaluation of the Prescribed Drugs to Elderly in a Tertiary Healthcare Center for Possible Drug Interactions with Investigational Drugs for COVID-19 Treatment. J Res Pharm Pract 2020; 9:212-217Keche Y, Gaikwad N, Dhaneria S, Joshi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912505 13. Repeat testing for SARS-CoV-2: persistence of viral RNA is common, and clearance is slower in older people. Med. J. Aust. 2021; Stehlik P, Alcorn K, Jones A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899232 14. Characteristics, Management, and Outcomes of Elderly Patients with Diabetes in a Covid-19 Unit: Lessons Learned from a Pilot Study. Medicina (Kaunas) 2021; 57Ricchio M, Tassone B, Pelle MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916210 15. Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy. Neurol Sci 2021; Pareyson D, Pantaleoni C, Eleopra R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33929645 16. COVID-19 Pandemic Healthcare Resource Allocation, Age and Frailty. New Bioeth 2021:1-6Smithard DG, Haslam J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913400 17. Relation between Vitamin D and COVID-19 in Aged People: A Systematic Review. Nutrients 2021; 13Dramé M, Cofais C, Hentzien M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920639 18. Coronavirus Disease 19 from the Perspective of Ageing with Focus on Nutritional Status and Nutrition Management-A Narrative Review. Nutrients 2021; 13Rothenberg E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919840 19. Psychosocial Impact of COVID-19 Pandemic in Elderly Psychiatric Patients: a Longitudinal Study. Psychiatr. Q. 2021:1-19Seethaler M, Just S, Stötzner P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904123 20. Nursing Home and Vaccination Consent: The Italian Perspective. Vaccines (Basel) 2021; 9Cannovo N, Scendoni R, Fede MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923367 21. Household Cases Suggest That Cats Belonging to Owners with COVID-19 Have a Limited Role in Virus Transmission. Viruses 2021; 13Bessière P, Fusade- Boyer M, Walch M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919936 22. "You have to take it that way." A study of the subjective experience of the corona pandemic by older people in need of help and care living at home. Zeitschrift fur Gerontologie und Geriatrie 2021; Nikelski A, Trompetter E, Feldmann S et al.

Epidemiology (113 articles)

1. Impact of COVID-19 on Care-Home Mortality and Life Expectancy in Scotland. Age Ageing 2021; Burton JK, Reid M, Gribben C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914870 2. Assessment of the impacts and transmission of coronavirus observed in the Republic of Korea in 2020-2021. Air Qual Atmos Health 2021:1-9Chung YS, Kim HS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897911 3. More stringent measures against COVID-19 are associated with lower cases and deaths in Florida and Miami-Dade. Am J Emerg Med 2021; Piquero AR, Kurland J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931277 4. COVID-19 in Women's health: Epidemiology. Best Pract. Res. Clin. Obstet. Gynaecol. 2021; Jardine J, Morris E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906791 5. A Retrospective Analysis of the COVID-19 Pandemic Evolution in Italy. Biology (Basel) 2021; 10Fochesato A, Simoni G, Reali F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917920 6. Timeliness of contact tracing among flight passengers during the COVID-19 epidemic in Vietnam. BMC Infect. Dis. 2021; 21:393Pham TQ, Hoang NA, Quach HL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910507 7. Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand's university-based referral hospital. BMC Infect. Dis. 2021; 21:382Sirijatuphat R, Suputtamongkol Y, Angkasekwinai N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902480 8. The heterogeneity of the COVID-19 pandemic and national responses: an explanatory mixed-methods study. BMC Public Health 2021; 21:835Chen YY, Assefa Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933062 9. Excess of all-cause mortality is only partially explained by COVID-19 in Veneto (Italy) during spring outbreak. BMC Public Health 2021; 21:797Gallo E, Prosepe I, Lorenzoni G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902527 10. Does lock-down of Wuhan effectively restrict early geographic spread of novel coronavirus epidemic during chunyun in China? A spatial model study. BMC Public Health 2021; 21:825Hu Y, Kong L, Yao T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926395 11. Estimation of the serial interval and proportion of pre-symptomatic transmission events of COVID- 19 in Ireland using contact tracing data. BMC Public Health 2021; 21:805McAloon CG, Wall P, Griffin J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906635 12. Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study. Clin Epidemiol Glob Health 2021; 11:100747Doi A, Iwata K, Kuroda H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898863 13. COVID-19 Outbreaks at Two Construction Sites - New York City, October- November 2020. Clin Infect Dis 2021; Bushman D, Sekaran J, Jeffery N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912901 14. Widespread SARS-CoV-2 Transmission Among Attendees at a Large Motorcycle Rally and their Contacts, 30 US Jurisdictions, August-September, 2020. Clin Infect Dis 2021; Carter RJ, Rose D, Sabo R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912907 15. COVID-19 Mitigation Efforts and Testing During an In-Person Training Event - Uganda, October 12-29, 2020. Clin Infect Dis 2021; Laws RL, Biraro S, Kirungi W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912911 16. Elementary effects analysis of factors controlling COVID-19 infections in computational simulation reveals the importance of social distancing and mask usage. Comput. Biol. Med. 2021; 134:104369Li KKF, Jarvis SA, Minhas F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915478 17. Mortality Rates of Coronavirus Disease 2019 (COVID-19) Caused by the Novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Cureus 2021; 13:e14081Kandi V, Thungaturthi S, Vadakedath S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903841 18. The COVID-19 Pandemic-an Epidemiological Perspective. Curr. Allergy Asthma Rep. 2021; 21:29Vilella A, Trilla A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907920 19. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives. Curr Obes Rep 2021:1-30Dalamaga M, Christodoulatos GS, Karampela I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909265 20. Bretton Woods' Pandemic Policies: A Gender Equality Analysis-Perspectives from Latin America. Development (Rome) 2021:1-10Bohoslavsky JP, Rulli M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903788 21. Regional Coronavirus Hotspots During the COVID-19 Outbreak in the Netherlands. Economist (Leiden) 2021:1-14Hassink WHJ, Kalb G, Meekes J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896962 22. Epidemiology of Confirmed COVID-19 Deaths in Adults, England, March- December 2020. Emerg Infect Dis 2021; 27:1468-1471Brown AE, Heinsbroek E, Kall MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900176 23. Successful Control of an Onboard COVID-19 Outbreak Using the Cruise Ship as a Quarantine Facility, Western Australia, Australia. Emerg Infect Dis 2021; 27:1279-1287Codreanu TA, Ngeh S, Trewin A, Armstrong PK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900170 24. SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA. Emerg Infect Dis 2021; 27:1288- 1295Ehrlich HY, Harizaj A, Campbell L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33900171 25. Novel SARS-CoV-2 Variant Derived from Clade 19B, France. Emerg Infect Dis 2021; 27:1540-1543Fourati S, Decousser JW, Khouider S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900195 26. Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand. Emerg Infect Dis 2021; 27:1317-1322Geoghegan JL, Douglas J, Ren X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900175 27. Detecting COVID-19 Clusters at High Spatiotemporal Resolution, New York City, New York, USA, June-July 2020. Emerg Infect Dis 2021; 27Greene SK, Peterson ER, Balan D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900181 28. Racial and Ethnic Disparities in Incidence of SARS-CoV-2 Infection, 22 US States and DC, January 1-October 1, 2020. Emerg Infect Dis 2021; 27:1477- 1481Hollis ND, Li W, Van Dyke ME et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33900192 29. Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium. Emerg Infect Dis 2021; 27:1405-1415Izquierdo-Lara R, Elsinga G, Heijnen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900177 30. Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar. Emerg Infect Dis 2021; 27:1343- 1352Jeremijenko A, Chemaitelly H, Ayoub HH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900174 31. Coordinated Strategy for a Model-Based Decision Support Tool for Coronavirus Disease, Utah, USA. Emerg Infect Dis 2021; 27:1259-1265Meredith HR, Arehart E, Grantz KH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33900179 32. Epidemiologic Findings from Case Investigations and Contact Tracing for First 200 Cases of Coronavirus Disease, Santa Clara County, California, USA. Emerg Infect Dis 2021; 27:1301-1308Ortiz N, Villarino E, Lee JT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900168 33. SARS-CoV-2 Serial Interval Variation, Montana, USA, March 1-July 31, 2020. Emerg Infect Dis 2021; 27:1486-1491Reed IG, Walker ES, Landguth EL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900189 34. Undocumented Migrants Reintroducing COVID-19, Yunnan Province, China. Emerg Infect Dis 2021; 27:1543-1545Zhang M, Zhou J, Jia S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900185 35. Planning for the Next Pandemic: Reflections on the Early Phase of the Australian COVID-19 Public Health Response from the Emergency Department. Emerg. Med. Australas. 2021; Govindasamy LS, Hsiao KH, Foong LH, Judkins S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928756 36. Spatio-temporal characteristics and control strategies in the early period of COVID-19 spread: a case study of the mainland China. Environ. Sci. Pollut. Res. Int. 2021:1-14Ning J, Chu Y, Liu X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33904137 37. Environmental implications of reduced electricity consumption in Wuhan during COVID-19 outbreak: A brief study. Environ Technol Innov 2021; 23:101578Xu X, Zhang W, Yin Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898658 38. Clinical and Socio-demographic Profile of the First 33 COVID-19 Cases Treated at Dedicated Treatment Center in Ethiopia. Ethiop J Health Sci 2020; 30:645- 652Teklu S, Sultan M, Azazh A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33911824 39. Intra-Household and Close-Contact SARS-CoV-2 Transmission Among Children - a Systematic Review. Front Pediatr 2021; 9:613292Spielberger BD, Goerne T, Geweniger A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898355 40. Under-Reporting of COVID-19 Cases Among Indigenous Peoples in Brazil: A New Expression of Old Inequalities. Front Psychiatry 2021; 12:638359Fellows M, Paye V, Alencar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912084 41. Covid-19 Dynamic Monitoring and Real-Time Spatio-Temporal Forecasting. Front Public Health 2021; 9:641253da Silva CC, de Lima CL, da Silva ACG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898377 42. Estimating the COVID-19 Prevalence in Spain With Indirect Reporting via Open Surveys. Front Public Health 2021; 9:658544Garcia-Agundez A, Ojo O, Hernández- Roig HA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898383 43. Assessment of COVID-19 Pandemic in Nepal: A Lockdown Scenario Analysis. Front Public Health 2021; 9:599280Sharma K, Banstola A, Parajuli RR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898371 44. Pitfalls in Modeling Asymptomatic COVID-19 Infection. Front Public Health 2021; 9:593176Yang S, Dai S, Huang Y, Jia P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912527 45. [Epidemiologic evidence on the role of hospitality venues in the transmission of COVID-19: A rapid review of the literature]. Gac. Sanit. 2021; Bilal U, Gullón P, Padilla-Bernáldez J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933322 46. SARS-CoV-2 testing in North Carolina: Racial, ethnic, and geographic disparities. Health Place 2021; 69:102576Brandt K, Goel V, Keeler C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915376 47. An interrupted time series analysis of the lockdown policies in India: a national-level analysis of COVID-19 incidence. Health Policy Plan. 2021; Thayer WM, Hasan MZ, Sankhla P, Gupta S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33899097 48. The past and present of pandemic management: health diplomacy, international epidemiological surveillance, and COVID-19. Hist Philos Life Sci 2021; 43:64D'Abramo F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929621 49. SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia. Infect Dis Health 2021; Lau JS, Buntine P, Price M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903074 50. Containment effort reduction and regrowth patterns of the Covid-19 spreading. Infect Dis Model 2021; 6:632-642Lanteri D, Carco D, Castorina P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898882 51. Analysis of intervention effectiveness using early outbreak transmission dynamics to guide future pandemic management and decision-making in Kuwait. Infect Dis Model 2021; 6:693-705Tyshenko MG, Oraby T, Longenecker J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898885 52. Study on the SEIQR model and applying the epidemiological rates of COVID- 19 epidemic spread in Saudi Arabia. Infect Dis Model 2021; 6:678-692Youssef H, Alghamdi N, Ezzat MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898884 53. Demand for longer quarantine period among common and uncommon COVID- 19 infections: a scoping review. Infect Dis Poverty 2021; 10:56Li ZY, Zhang Y, Peng LQ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902695 54. Exploring COVID-19 Daily Records of Diagnosed Cases and Fatalities Based on Simple Nonparametric Methods. Infect Dis Rep 2021; 13:302-328Diebner HH, Timmesfeld N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915940 55. Assessment of basic reproduction number (R(0)), spatial and temporal epidemiological determinants, and genetic characterization of SARS-CoV-2 in Bangladesh. Infect Genet Evol 2021:104884Islam A, Sayeed MA, Rahman MK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930563 56. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation. Infect Genet Evol 2021; 92:104872Molina-Mora JA, Cordero-Laurent E, Godínez A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905892 57. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation. Infect Genet Evol 2021; 92:104872Mora JAM, Cordero-Laurent E, Godínez A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905892 58. Modeling the Dynamics of COVID-19 in Nigeria. Int J Appl Comput Math 2021; 7:67Adewole MO, Onifade AA, Abdullah FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898652 59. Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy. Int. J. Biol. Macromol. 2021; 183:203- 212Gupta Y, Maciorowski D, Zak SE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915212 60. A Non-Linear Biostatistical Graphical Modeling of Preventive Actions and Healthcare Factors in Controlling COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Abdulla F, Nain Z, Karimuzzaman M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922634 61. Seroprevalence of SARS-CoV-2 Infection and Adherence to Preventive Measures in Cuenca, Ecuador, October 2020, a Cross-Sectional Study. Int J Environ Res Public Health 2021; 18Acurio-Páez D, Vega B, Orellana D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925680 62. Early Interventions and Impact of COVID-19 in Spain. Int J Environ Res Public Health 2021; 18Alfonso Viguria U, Casamitjana N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921238 63. Impact of COVID-19 Pandemic on Total Mortality in Poland. Int J Environ Res Public Health 2021; 18Barański K, Brożek G, Kowalska M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924261 64. Identification of Vulnerable Populations and Areas at Higher Risk of COVID-19- Related Mortality during the Early Stage of the Epidemic in the United States. Int J Environ Res Public Health 2021; 18Correa-Agudelo E, Mersha TB, Branscum AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921217 65. Predicting the Dynamics of the COVID-19 Pandemic in the United States Using Graph Theory-Based Neural Networks. Int J Environ Res Public Health 2021; 18Davahli MR, Fiok K, Karwowski W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33917544 66. Relationship of Test Positivity Rates with COVID-19 Epidemic Dynamics. Int J Environ Res Public Health 2021; 18Furuse Y, Ko YK, Ninomiya K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925665 67. Perceived Effectiveness, Restrictiveness, and Compliance with Containment Measures against the Covid-19 Pandemic: An International Comparative Study in 11 Countries. Int J Environ Res Public Health 2021; 18Georgieva I, Lantta T, Lickiewicz J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917334 68. Wastewater Surveillance for SARS-CoV-2 on College Campuses: Initial Efforts, Lessons Learned, and Research Needs. Int J Environ Res Public Health 2021; 18Harris-Lovett S, Nelson KL, Beamer P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922263 69. The Effect of Containment Measures during the Covid-19 Pandemic to Sedentary Behavior of Thai Adults: Evidence from Thailand's Surveillance on Physical Activity 2019-2020. Int J Environ Res Public Health 2021; 18Katewongsa P, Potharin D, Rasri N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922340 70. SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study. Int J Environ Res Public Health 2021; 18Korth J, Wilde B, Dolff S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922895 71. Spread of Epidemic Disease on Edge-Weighted Graphs from a Database: A Case Study of COVID-19. Int J Environ Res Public Health 2021; 18Manríquez R, Guerrero-Nancuante C, Martínez F, Taramasco C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921934 72. Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2. Int J Environ Res Public Health 2021; 18McConnell D, Hickey C, Bargary N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925518 73. SARS-CoV-2 Seroprevalence among Health Care Workers-A Voluntary Screening Study in a Regional Medical Center in Southern Germany. Int J Environ Res Public Health 2021; 18Müller K, Girl P, Ruhnke M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917840 74. Risk of Exposure to COVID-19: Visit Duration Data Can Inform Our Daily Activities Choices: An Epidemiological Investigation Using Community Mobility Data from the Metropolitan Area of Genoa, Italy. Int J Environ Res Public Health 2021; 18Oliva C, Favato G. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925428 75. The Tipping Effect of Delayed Interventions on the Evolution of COVID-19 Incidence. Int J Environ Res Public Health 2021; 18Rypdal K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922564 76. Estimation of Excess Mortality and Years of Life Lost to COVID-19 in Norway and Sweden between March and November 2020. Int J Environ Res Public Health 2021; 18Rypdal M, Rypdal K, Løvsletten O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917872 77. Social Distancing Associations with COVID-19 Infection and Mortality Are Modified by Crowding and Socioeconomic Status. Int J Environ Res Public Health 2021; 18VoPham T, Weaver MD, Adamkiewicz G, Hart JE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924821 78. SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan. Int J Environ Res Public Health 2021; 18Yoshihara T, Ito K, Zaitsu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916399 79. Trend Analysis and Forecasting the Spread of COVID-19 Pandemic in Ethiopia Using Box-Jenkins Modeling Procedure. Int. J. Gen. Med. 2021; 14:1485- 1498Gebretensae YA, Asmelash D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907451 80. Examining the diffusion of coronavirus disease 2019 cases in a metropolis: a space syntax approach. Int J Health Geogr 2021; 20:17Yao Y, Shi W, Zhang A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926460 81. Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study. J Allergy Clin Immunol Pract 2021; Lee SW, Kim SY, Moon SY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33931377 82. A compartment modelling approach to reconstruct and analyze gender and age-grouped CoViD-19 Italian data for decision-making strategies. J. Biomed. Inform. 2021:103793Cartocci A, Cevenini G, Barbini P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901696 83. Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe. J Clin Med 2021; 10Bartko J, Zehetmayer S, Weseslindtner L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924976 84. Physical Activity and the Risk of COVID-19 Infection and Mortality: A Nationwide Population-Based Case-Control Study. J Clin Med 2021; 10Cho DH, Lee SJ, Jae SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917558 85. Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study. J Clin Med 2021; 10Opoka-Winiarska V, Grywalska E, Korona-Glowniak I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921679 86. Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust. J Infect 2021; Garvey MI, McMurray C, Casey AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932449 87. Seroprevalence of SARS-CoV-2 Antibodies in University Students: cross- sectional study, December 2020, England. J Infect 2021; Vusirikala A, Whitaker H, Jones S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933527 88. Road to recovery: Managing an epidemic. J Math Econ 2021; 93:102482Loertscher S, Muir EV. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897087 89. Possible Effects of Air Temperature on COVID-19 Disease Severity and Transmission Rates. J Med Virol 2021; Kang D, Ellgen C, Kulstad E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913555 90. Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea. J. Microbiol. 2021; 59:530-533Jeong HW, Chang HH, Kim EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907974 91. Modelling the impact of household size distribution on the transmission dynamics of COVID-19. J R Soc Interface 2021; 18:20210036Liu P, McQuarrie L, Song Y, Colijn C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906389 92. Actual Racial/Ethnic Disparities in COVID-19 Mortality for the Non-Hispanic Black Compared to Non-Hispanic White Population in 35 US States and Their Association with Structural Racism. J Racial Ethn Health Disparities 2021:1- 13Siegel M, Critchfield-Jain I, Boykin M, Owens A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905110 93. [Controversies during the COVID-19 pandemic]. Medicina (B. Aires) 2021; 81:241-251Cornistein W, Desse J, Nuccetelli Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906143 94. Population-Based COVID-19 Screening in Mexico: Assessment of Symptoms and Their Weighting in Predicting SARS-CoV-2 Infection. Medicina (Kaunas) 2021; 57Martinez-Fierro ML, Diaz-Lozano M, Alvarez-Zuñiga C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917858 95. Current Status of Putative Animal Sources of SARS-CoV-2 Infection in Humans: Wildlife, Domestic Animals and Pets. Microorganisms 2021; 9Maurin M, Fenollar F, Mediannikov O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33920724 96. [The characteristics of population mortality of the Russian Federation, the Central Federal Okrug and City of Moscow in 2020]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 2021; 29:189-193Shchepin VO, Khabriev RU. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901352 97. In pursuit of the right tail for the COVID-19 incubation period. Public Health 2021; 194:149-155Cimolai N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915459 98. [SARS-CoV‑2 incidental findings among Hamburg deaths: an epidemiological monitoring during the dynamic infection event in spring 2020]. Rechtsmedizin (Berl) 2021:1-7Klein A, Langenwalder F, Heinrich F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897111 99. A new fractional mathematical modelling of COVID-19 with the availability of vaccine. Results Phys 2021; 24:104213Kumar P, Erturk VS, Murillo-Arcila M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898210 100. [Comparative study of the COVID-19 admissions between first and second wave in a cohort of 1,235 patients]. Rev. Esp. Quimioter. 2021; López-Juárez P, Serrano-Oviedo L, Pérez-Ortiz JM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913313 101. Are countries' precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide. Saudi Pharm J 2021; Alshammari TM, Alenzi KA, Alnofal FA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897262 102. Prediction of COVID-19 Trend in India and Its Four Worst-Affected States Using Modified SEIRD and LSTM Models. SN Comput Sci 2021; 2:224Bedi P, Dhiman S, Gole P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899004 103. COVID-19 mortality analysis from soft-data multivariate curve regression and machine learning. Stoch. Environ. Res. Risk Assess. 2021:1-20Torres-Signes A, Frías MP, Ruiz-Medina MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897300 104. A general model for Covid-19 epidemic kinetics: application to italian and german data. Theor. Biol. Forum. 2020; 113:19-30Amadei A, Aschi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929001 105. First known COVID-19 case and contact tracing efforts in Istanbul, Turkey. Turk J Med Sci 2021; Güner AE, Sürmeli A, Kural K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929142 106. Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States. Value Health 2021; 24:632-640Basu A, Gandhay VJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933231 107. Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs. Value Health 2021; 24:641-647Manski CF, Tetenov A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933232 108. Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands. Value Health 2021; 24:658-667Mouter N, Collewet M, de Wit GA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933234 109. Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies. Value Health 2021; 24:615-624Zhao J, Jin H, Li X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933229 110. The basic reproductive number and particle-to-plaque ratio: comparison of these two parameters of viral infectivity. Virol J 2021; 18:92McCormick W, Mermel LA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931090 111. Genomic Surveillance of Circulating SARS-CoV-2 in South East Italy: A One- Year Retrospective Genetic Study. Viruses 2021; 13Capozzi L, Bianco A, Del Sambro L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922257 112. Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences. Viruses 2021; 13Pan B, Ji Z, Sakkiah S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925388 113. A pre- and during Pandemic Survey of Sars-Cov-2 Infection in Stray Colony and Shelter Cats from a High Endemic Area of Northern Italy. Viruses 2021; 13Spada E, Vitale F, Bruno F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33916759

Gastro-enterology (13 articles)

1. COVID-19 Outbreaks at Two Construction Sites - New York City, October- November 2020. Clin Infect Dis 2021; Bushman D, Sekaran J, Jeffery N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912901 2. Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019. Clin Infect Dis 2020; Xiang F, Sun J, Chen PH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33909004 3. Impact of COVID-19 on the outcomes of gastrointestinal surgery. Clin. J. Gastroenterol. 2021:1-15Gupta R, Gupta J, Ammar H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928515 4. Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19. Front Mol Biosci 2021; 8:647508Yang Y, Huang W, Fan Y, Chen GQ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912590 5. Nutritional and Gastroenterological Monitoring of Patients With Celiac Disease During COVID-19 Pandemic: The Emerging Role of Telemedicine and Point-of- Care Gluten Detection Tests. Front Nutr 2021; 8:622514Costantino A, Roncoroni L, Noviello D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928109 6. Gastroenterology 2021: from the heart of the COVID-19 pandemic. Frontline Gastroenterol. 2021; 12:249-251Tavabie OD, Clough J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907619 7. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut 2021; Kennedy NA, Lin S, Goodhand JR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33903149 8. COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020. Inflamm. Bowel Dis. 2021; Xu F, Carlson SA, Wheaton AG, Greenlund KJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904584 9. Perceived Effectiveness, Restrictiveness, and Compliance with Containment Measures against the Covid-19 Pandemic: An International Comparative Study in 11 Countries. Int J Environ Res Public Health 2021; 18Georgieva I, Lantta T, Lickiewicz J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917334 10. Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19. Intest Res 2021; Koroku M, Omori T, Kambayashi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902268 11. COVID-19 related pancreatic cancer surveillance disruptions amongst high- risk individuals. Pancreatology 2021; Katona BW, Mahmud N, Dbouk M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926820 12. Population Disequilibrium as Promoter of Adaptive Explorations in Hepatitis C Virus. Viruses 2021; 13García-Crespo C, Gallego I, Soria ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916702 13. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection? World J. Gastroenterol. 2021; 27:1406-1418Troisi J, Venutolo G, Pujolassos Tanyà M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911464

Guidelines (8 articles)

1. The impact of the COVID-19 pandemic on application of European Society of Cardiology (ESC) guidelines for exercise in adults with congenital heart disease: a data-based questionnaire. Cardiol. Young 2021:1-20Thompson SE, Whitehead CA, Notley AS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902783 2. Position paper dated January 27, 2021 - COVID-19 vaccination for patients with active cancer. Geburtshilfe Frauenheilkd. 2021; 81:373-377. 3. COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic? Infect Dis Rep 2021; 13:259-284Jirjees F, Saad AK, Al Hano Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915690 4. COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE- CO-Ped), Italy. Int J Environ Res Public Health 2021; 18Esposito S, Marchetti F, Lanari M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917940 5. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int J Environ Res Public Health 2021; 18Sisó-Almirall A, Brito-Zerón P, Conangla Ferrín L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923972 6. A report on the development of COVID-19 guidelines for rehabilitation professionals in African settings. Pan Afr. Med. J. 2021; 38:129Ngeh EN, Chigbo NN, Whitehouse Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912299 7. Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: Real-life data from a Belgian University Hospital. Respir. Med. 2021; 182:106421Stylemans D, Smet J, Hanon S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901788

Imaging (22 articles)

1. Ensemble-based bag of features for automated classification of normal and COVID-19 CXR images. Biomed. Signal Process. Control 2021; 68:102656Ashour AS, Eissa MM, Wahba MA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897803 2. Clinical, radiological and functional outcomes in patients with SARS-CoV-2 pneumonia: a prospective observational study. BMC Pulm. Med. 2021; 21:136Gianella P, Rigamonti E, Marando M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902513 3. Radiation-Induced Pneumonitis in the Era of the COVID-19 Pandemic: Artificial Intelligence for Differential Diagnosis. Cancers (Basel) 2021; 13Giordano FM, Ippolito E, Quattrocchi CC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921652 4. Automated quantitative thin slice volumetric low dose CT analysis predicts disease severity in COVID-19 patients. Clin Imaging 2021; 79:96-101Stoleriu MG, Gerckens M, Obereisenbuchner F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33910141 5. Lung Ultrasound: Its Findings and New Applications in Neonatology and Pediatric Diseases. Diagnostics (Basel) 2021; 11Iovine E, Nenna R, Bloise S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916882 6. Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine. Diagnostics (Basel) 2021; 11Seban RD, Champion L, Deleval N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918702 7. Can Alveolar-Arterial Difference and Lung Ultrasound Help the Clinical Decision Making in Patients with COVID-19? Diagnostics (Basel) 2021; 11Secco G, Salinaro F, Bellazzi C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922829 8. Impact of the COVID-19 pandemic on radiology department emergency ultrasound utilization. Emerg Radiol 2021:1-7Messina MD, Stein MW, Armstrong IJ, Wolf EL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914184 9. A comprehensive review of imaging findings in COVID-19 - status in early 2021. Eur J Nucl Med Mol Imaging 2021:1-25Afshar-Oromieh A, Prosch H, Schaefer-Prokop C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932183 10. Visual lung damage CT score at hospital admission of COVID-19 patients and 30-day mortality. Eur Radiol 2021:1-10Charpentier E, Soulat G, Fayol A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914118 11. Machine learning automatically detects COVID-19 using chest CTs in a large multicenter cohort. Eur Radiol 2021; Mortani Barbosa EJ, Jr., Georgescu B, Chaganti S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934177 12. Sufmacs: a machine learning-based robust image segmentation framework for covid-19 radiological image interpretation. Expert Syst Appl 2021:115069Chakraborty S, Mali K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897121 13. Association between clinical, laboratory findings and chest CT in COVID-19 in a secondary hospital in Jakarta, Indonesia. Germs 2021; 11:32-38Hafiz M, Icksan AG, Harlivasari AD et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898339 14. Neuro-Imaging Manifestations of COVID-19: Predilection for PICA Infarcts. IDCases 2021:e01131Ahmed M, Gaba WH, Al Mazrouei SS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898251 15. Comparison of the CO-RADS and the RSNA chest CT classification system concerning sensitivity and reliability for the diagnosis of COVID-19 pneumonia. Insights Imaging 2021; 12:55Abdel-Tawab M, Basha MAA, Mohamed IAI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913066 16. Optimal hyperparameter selection of deep learning models for COVID-19 chest X-ray classification. Intell Based Med 2021; 5:100034Adedigba AP, Adeshina SA, Aina OE, Aibinu AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899036 17. Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn J Radiol 2021:1-12Cozzi D, Cavigli E, Moroni C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900542 18. Assessment of Retinal Neurodegeneration and Choroidal Thickness in COVID- 19 Patients Using Swept-Source OCT Technology. Klin. Monbl. Augenheilkd. 2021; Cetinkaya T, Kurt MM, Akpolat C. 19. CT-Based COVID-19 triage: Deep multitask learning improves joint identification and severity quantification. Med. Image Anal. 2021; 71:102054Goncharov M, Pisov M, Shevtsov A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932751 20. Comparison of computed tomography (CT) findings with RT-PCR in the diagnosis of COVID-19 in children. Pediatr Pulmonol 2021; Bağcı Z, Keçeli AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902160 21. Imaging findings of multisystem inflammatory syndrome in children associated with COVID-19. Pediatr Radiol 2021:1-13Caro-Domínguez P, Navallas M, Riaza-Martin L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904952 22. Initial findings in chest X-rays as predictors of worsening lung infection in patients with COVID-19: correlation in 265 patients. Radiologia (Roma) 2021; Petite Felipe DJ, Rivera Campos MI, San Miguel Espinosa J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902938

Immune response (62 articles)

1. Early Detection of SARS-CoV-2 Seroconversion in Humans with Aggregation- Induced Near-Infrared Emission Nanoparticle-Labeled Lateral Flow Immunoassay. ACS Nano 2021; Chen R, Ren C, Liu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928784 2. Innate immune-mediated antiviral response to SARS-CoV-2 and convalescent sera a potential prophylactic and therapeutic agent to tackle COVID-19. Antib Ther 2020; 3:212-220Abdullah, Faisal S, Aman K, Rahman AU. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912794 3. Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients. Cells 2021; 10Gedefaw L, Ullah S, Leung PHM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923537 4. The dual role of the immune system in the course of COVID-19. The fatal impact of the aging immune system. Cent Eur J Immunol 2021; 46:1- 9Marcinkiewicz J, Witkowski JM, Olszanecki R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897278 5. Does COVID-19 cause an increase in spleen dimensions? Possible effects of immune activation, hematopoietic suppression and microthrombosis. Clin Imaging 2021; 79:104-109Tahtabasi M, Hosbul T, Karaman E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932872 6. Serosurveillance of Health Care Workers in a COVID Hospital: Immune Response, and Its Longevity. Cureus 2021; 13:e14020Mishra M, Chaudhry R, Rana F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898113 7. Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine. Diagnostics (Basel) 2021; 11Seban RD, Champion L, Deleval N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918702 8. A comprehensive antigen production and characterisation study for easy-to- implement, specific and quantitative SARS-CoV-2 serotests. EBioMedicine 2021; 67:103348Klausberger M, Duerkop M, Haslacher H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906067 9. Immunogenicity of the BNT162b2 mRNA Vaccine in Heart Transplanted Patients-A Prospective Cohort Study. Eur J Heart Fail 2021; Itzhaki Ben Zadok O, Shaul AA, Ben-Avraham B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915002 10. No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection. Front Cell Infect Microbiol 2021; 11:644574García-Nicolás O, V'Kovski P, Zettl F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912475 11. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID- 19. Front. Immunol. 2021; 12:633769Zhang J, Zhao C, Zhao W. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912161 12. Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19. Front Med (Lausanne) 2021; 8:569266Jia X, Zhang P, Tian Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912572 13. Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19. Front Mol Biosci 2021; 8:647508Yang Y, Huang W, Fan Y, Chen GQ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912590 14. Case Report: Inflammation and Endothelial Injury Profiling of COVID-19 Pediatric Multisystem Inflammatory Syndrome (MIS-C). Front Pediatr 2021; 9:597926Fraser DD, Patterson EK, Daley M, Cepinskas G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898353 15. Multisystem inflammatory syndrome in children (MIS-C) temporally associated with SARS-CoV-2: the first clinical case in Ternopil, Ukraine. Germs 2021; 11:120-127Pavlyshyn H, Slyva V, Dyvonyak O, Horishna I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898350 16. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut 2021; Kennedy NA, Lin S, Goodhand JR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33903149 17. Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study. Healthcare (Basel) 2021; 9Reinwald M, Deckert PM, Ritter O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922198 18. Successful Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 (PIMS-TS) with Split Doses of Immunoglobulin G and Estimation of PIMS-TS Incidence in a County District in Southern Germany. Healthcare (Basel) 2021; 9Wehl G, Franke J, Frühwirth M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919536 19. Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing. Heliyon 2021; 7:e06836Mahalingam S, Peter J, Xu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898857 20. Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections. Immunity 2021; Harb H, Benamar M, Lai PS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915108 21. The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment. Int J Biol Sci 2021; 17:1507-1520Wang Y, Zheng J, Islam MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907514 22. Seroprevalence of SARS-CoV-2 Infection and Adherence to Preventive Measures in Cuenca, Ecuador, October 2020, a Cross-Sectional Study. Int J Environ Res Public Health 2021; 18Acurio-Páez D, Vega B, Orellana D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925680 23. Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: multiple factors-based analysis. Int J Infect Dis 2021; Luo C, Liu M, Li Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932603 24. Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted in a Romanian University Hospital of Infectious Diseases. Int J Infect Dis 2021; Radulescu A, Istrate A, Flonta M, Lupse M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901653 25. PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-"Rheumatic Fever" of the 21st Century? Int J Mol Sci 2021; 22Opoka-Winiarska V, Grywalska E, Roliński J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925779 26. IgM anti-SARS-CoV-2-specific determination: useful or confusing? Big Data analysis of a real-life scenario. Intern Emerg Med 2021; Trenti T, Pecoraro V, Pirotti T, Plebani M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934298 27. Production of SARS-CoV-2 Antibodies and Emergence of the Clinical Symptoms of COVID-19. Iran. J. Allergy Asthma Immunol. 2021; 20:244- 248Hormati A, Poustchi H, Ghadir MR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33904682 28. Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe. J Clin Med 2021; 10Bartko J, Zehetmayer S, Weseslindtner L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924976 29. Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. J Clin Med 2021; 10Cantini L, Bastianelli L, Lupi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916569 30. Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study. J Clin Med 2021; 10Opoka-Winiarska V, Grywalska E, Korona-Glowniak I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921679 31. Activating Killer-cell Immunoglobulin-like Receptors are associated with the severity of COVID-19. J Infect Dis 2021; Bernal E, Gimeno L, Alcaraz MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928374 32. A combination of N and S antigens with IgA and IgG measurement strengthens the accuracy of SARS-CoV-2 serodiagnostics. J Infect Dis 2021; Jalkanen P, Pasternack A, Maljanen S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905505 33. Antibody tests: They are more important than we thought. J Math Econ 2021; 93:102485Guimarães L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897088 34. Characterization of T lymphocytes in severe COVID-19 patients. J Med Virol 2021; Fenoglio D, Dentone C, Parodi A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913544 35. Comparable endemic coronavirus nucleoprotein-specific antibodies in mild and severe Covid-19 patients. J Med Virol 2021; Leach S, Harandi AM, Bergström T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913546 36. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. J Med Virol 2021; Zervou FN, Louie P, Stachel A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932299 37. Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities. J. Neuroimmunol. 2021; 356:577578Pourriyahi H, Saghazadeh A, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933818 38. Performance Evaluation of the Siemens SARS-CoV-2 Total Antibody and IgG Antibody Test. Lab Med 2021; Florin L, Maelegheer K, Vandewal W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928377 39. Utility of Antigen-Based Rapid Diagnostic Test for Detection of SARS-CoV-2 Virus in Routine Hospital Settings. Lab Med 2021; Thakur P, Saxena S, Manchanda V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928384 40. Cross-Institutional Evaluation of the Abbott ARCHITECT SARS-CoV-2 IgG Immunoassay. Lab Med 2021; Wiencek JR, Bachmann LM, Dinwiddie K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929022 41. Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin. Life (Basel) 2021; 11Focosi D, Genoni A, Lucenteforte E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915711 42. Analysis of the Long-Term Impact on Cellular Immunity in COVID-19- Recovered Individuals Reveals a Profound NKT Cell Impairment. mBio 2021; 12Liu J, Yang X, Wang H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906918 43. Severe acute respiratory syndrome coronavirus 2019. Seroepidemiology study in Argentinian slum. Medicina (B. Aires) 2021; 81:135-142Figar S, Pagotto V, Luna L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906129 44. [Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital]. Medwave 2021; 21:e8142Luna-Muñoz C, Reyes-Florian G, Seminario-Aliaga M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905406 45. Implementing SARS-CoV-2 Rapid Antigen Testing in the Emergency Ward of a Swiss University Hospital: The INCREASE Study. Microorganisms 2021; 9Caruana G, Croxatto A, Kampouri E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33920307 46. SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs. Microorganisms 2021; 9Inchingolo AD, Inchingolo AM, Bordea IR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920179 47. SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020. Microorganisms 2021; 9Muñoz-Medina JE, Grajales-Muñiz C, Salas-Lais AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921158 48. Causal impact of local inflammation in the nasal cavity on higher brain function and cognition. Neurosci. Res. 2021; Hasegawa Y, Namkung H, Smith A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932551 49. Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc. Nutrients 2021; 13Corrao S, Mallaci Bocchio R, Lo Monaco M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921297 50. Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series. Pathogens 2021; 10Heidepriem J, Dahlke C, Kobbe R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917609 51. Could Antigen Presenting Cells Represent a Protective Element during SARS- CoV-2 Infection in Children? Pathogens 2021; 10Lauro R, Irrera N, Eid AH, Bitto A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920011 52. Imaging findings of multisystem inflammatory syndrome in children associated with COVID-19. Pediatr Radiol 2021:1-13Caro-Domínguez P, Navallas M, Riaza-Martin L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904952 53. Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics. Pharmaceutics 2021; 13Puccetti M, Costantini C, Ricci M, Giovagnoli S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916409 54. Comparison of virus neutralization activity and results of 10 different anti- SARS-CoV-2 serological tests in COVID-19 recovered plasma donors. Pract Lab Med 2021; 25:e00222Szabó Z, Szabó T, Bodó K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898689 55. Diagnostic performance of an automated chemiluminescence immunoassay for SARS-CoV-2 IgG and IgM antibodies detection: A real life experience. Pract Lab Med 2021; 25:e00227Villalta D, Martelli P, Moratto A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898690 56. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses. Trends Microbiol. 2021; Siggins MK, Thwaites RS, Openshaw PJM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896688 57. Strategies for Immunomonitoring after Vaccination and during Infection. Vaccines (Basel) 2021; 9Adam L, Rosenbaum P, Bonduelle O, Combadière B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918841 58. Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland. Vaccines (Basel) 2021; 9Kowalska M, Niewiadomska E, Barański K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919206 59. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups. Vaccines (Basel) 2021; 9Rammensee HG, Gouttefangeas C, Heidu S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923363 60. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Viruses 2021; 13Huynh A, Arnold DM, Smith JW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923828 61. Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies. Viruses 2021; 13James J, Rhodes S, Ross CS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924168 62. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech). Viruses 2021; 13Korth J, Jahn M, Dorsch O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923063

Management miscellaneous diseases (102 articles)

1. The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease- Focused Panel survey analysis. Abdom Radiol (NY) 2021:1-8Surasi DSS, Wang X, Bathala TK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904992 2. Medium-term effects of COVID-19 pandemic on epilepsy: A follow-up study. Acta Neurol. Scand. 2021; Lallana S, Fonseca E, Restrepo JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905117 3. Navigating the new normal: accessing community and institutionalised care for dementia during COVID-19. Aging Ment. Health 2021:1-6Giebel C, Hanna K, Callaghan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908284 4. Addressing the needs of older adults receiving alcohol treatment during the COVID-19 pandemic: a qualitative study. Aging Ment. Health 2021:1-6Seddon J, Trevena P, Wadd S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928805 5. Common themes in early state policy responses to substance use disorder treatment during COVID-19. Am. J. Drug Alcohol Abuse 2021:1-11Andraka- Christou B, Bouskill K, Haffajee RL et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33909518 6. Trends in visits related to drug use adverse effects in an urban ED during COVID-19. Am J Emerg Med 2021; Ramdin C, Muckey E, Rosania A, Nelson L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933308 7. The yearly impact of COVID-19 pandemic on emergency ophthalmic care at a secondary center. Am J Emerg Med 2021; Tsaousis KT, Chaloulis S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902961 8. Managing Non-COVID Acute Neurology Amidst the Pandemic: Challenges and Work in Progress. Ann. Indian Acad. Neurol. 2021; 24:11-14Gupta A, Vishnu VY, Singh MB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911373 9. Interruption of outpatient follow-up in physical and rehabilitation medicine: observational cross-sectional study of deleterious consequences of the first COVID-19 lockdown in France. Ann. Phys. Rehabil. Med. 2021:101531Laffont I, Gelis A, Balva C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933693 10. Response to: 'Correspondence on 'Onset of rheumatoid arthritis after COVID- 19: coincidence or connected?'' by Roongta et al. Ann. Rheum. Dis. 2021; Derksen V, van der Woude D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906855 11. Should the Increased Awareness of the One Health Approach Brought by the COVID-19 Pandemic Be Used to Further Tackle the Challenge of Antimicrobial Resistance? Antibiotics (Basel) 2021; 10Rhouma M, Tessier M, Aenishaenslin C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923886 12. Beware of the Bicycle! An increase in paediatric bicycle related injuries during the COVID-19 period in Western Australia. ANZ J Surg 2021; van Oudtshoorn S, Chiu KYC, Khosa J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905619 13. Delayed emergency healthcare seeking behaviour by Dutch emergency department visitors during the first COVID-19 wave: a mixed methods retrospective observational study. BMC Emerg. Med. 2021; 21:56Nab M, van Vehmendahl R, Somers I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33932988 14. Consequences of the emergency response to COVID-19: a whole health care system review in a single city in the United Kingdom. BMC Emerg. Med. 2021; 21:55Tankel JW, Ratcliffe D, Smith M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33932980 15. Social determinants of seeking emergency and routine dental care in Saudi Arabia during the COVID-19 pandemic. BMC Oral Health 2021; 21:212Meisha DE, Alsolami AM, Alharbi GM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902535 16. Functional health and symptoms in Spain before and during the COVID-19 pandemic. BMC Public Health 2021; 21:837Lehmann J, Holzner B, Giesinger JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933042 17. Delivering cervical cancer screening during the COVID-19 emergency. BMJ Sex Reprod Health 2021; Acuti Martellucci C, Morettini M, Flacco ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926910 18. Advanced cancer and COVID-19 comorbidity: medical oncology-palliative medicine ethics meetings in a comprehensive cancer centre. BMJ Support Palliat Care 2021; Thery L, Vaflard P, Vuagnat P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927013 19. Implications of COVID-19 infection on patients with uveitis under biologic treatment. Br J Ophthalmol 2021; AlBloushi AF, Alfawaz AM, Abu El Asrar AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931386 20. Effect of COVID-19 pandemic on glaucoma surgical practices in the UK. Br J Ophthalmol 2021; Holland LJ, Mercieca KJ, Kirwan JF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931388 21. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol 2021; Phylactou M, Li JO, Larkin DFP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33910885 22. Migraine during COVID-19: Data from Second Wave Pandemic in an Italian Cohort. Brain Sci 2021; 11Gentile E, Delussi M, Abagnale C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920175 23. [Low dose radiotherapy for COVID-19 pneumopathy: Biological rationale and literature review]. Cancer Radiother. 2021; Miran C, Bonnet É, Allignet B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903009 24. The "COVID-19 Pandemic Gap" and Its Influence on Oncologic Outcomes of Bladder Cancer. Cancers (Basel) 2021; 13Tulchiner G, Staudacher N, Fritz J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916962 25. Transient reductions in HIV clinic attendance and food security during the COVID-19 pandemic for people living with HIV in four African countries. Clin Infect Dis 2021; Dear N, Duff E, Esber A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906235 26. Substantial decline in invasive pneumococcal disease (IPD) during COVID-19 pandemic in Hong Kong. Clin Infect Dis 2021; Teng JLL, Fok KMN, Lin KPK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907808 27. Impact of COVID-19 on the outcomes of gastrointestinal surgery. Clin. J. Gastroenterol. 2021:1-15Gupta R, Gupta J, Ammar H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928515 28. Impact of COVID-19 Outbreak on Emergency Visits and Emergency Consultations: A Cross-Sectional Study. Cureus 2021; 13:e14052İlhan B, Bozdereli Berikol G, Dogan H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33903830 29. Surgical Versus Conservative Management of Acute Appendicitis During the COVID-19 Pandemic: A Single-Centre Retrospective Study. Cureus 2021; 13:e14095Lotfallah A, Aamery A, Moussa G, Manu M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927917 30. Outcome of a HIV Positive Patient Infected with COVID-19 after an Autologous Bone Marrow Transplantation: A Case Report. Curr HIV Res 2021; Mardani M, Sharifi-Razavi A, Sheibani S, Baziboroun M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902413 31. Satisfaction among Cancer Patients Undergoing Radiotherapy during the COVID-19 Pandemic: An Institutional Experience. Curr. Oncol. 2021; 28:1507- 1517Di Lalla V, Patrick H, Siriani-Ayoub N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920247 32. The future is now: pediatric neuropsychological presurgical epilepsy evaluation in the age of COVID-19. Epileptic Disord. 2021; Nussbaum NL, Young SR, DeLeon RC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926855 33. Periodontal health related-inflammatory and metabolic profiles of patients with end-stage renal disease: potential strategy for predictive, preventive, and personalized medicine. Epma j 2021:1-12Ma X, Wang Y, Wu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903806 34. Making a complex dental care tailored to the person: population health in focus of predictive, preventive and personalised (3P) medical approach. Epma j 2021:1-12Tachalov VV, Orekhova LY, Kudryavtseva TV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897916 35. Diagnosis and treatment delay of head and neck cancers during COVID-19 era in a tertiary care academic hospital: what should we expect? Eur Arch Otorhinolaryngol 2021:1-5De Luca P, Bisogno A, Colacurcio V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929609 36. Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature. Front. Oncol. 2021; 11:662211Woźniak K, Sachs W, Boguradzki P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912468 37. The Sum of Fears in Cancer Patients Inside the Context of the COVID-19. Front Psychiatry 2021; 12:557834Bandinelli L, Ornell F, von Diemen L, Kessler FHP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897477 38. Dynamic Management of Lung Cancer Care During Surging COVID-19. Front Surg 2021; 8:663364Wang A, Chang SH, Kim EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898509 39. Gene expression analysis of MCF7 cell lines of breast cancer treated with herbal extract of Cissampelos pareira revealed association with viral diseases. Gene Rep 2021; 23:101169Güven E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907720 40. OPTIMIZATION OF RED BLOOD CELL UNIT STORAGE DURING SARS-COV-2 PANDEMIC: ADOPTING NEW STRATEGIES TO ENSURE SUPPLY IN A DECENTRALIZED BLOOD BANK IN BRAZIL. Hematol Transfus Cell Ther 2021; Costa CB, Cortez AJP, Adão DD et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907728 41. Impact of the Covid-19 Pandemic on Orthopaedic and Trauma Surgery - A Systematic Review of the Current Literature. In Vivo 2021; 35:1337-1343Blum P, Putzer D, Liebensteiner MC, Dammerer D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33910811 42. Lung Cancer, Covid-19 Infections and Chemotherapy. In Vivo 2021; 35:1877- 1880Haineala B, Zgura A, Badiu DC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33910875 43. Fundus evaluation in COVID-19 positives with non-severe disease. Indian J Ophthalmol 2021; 69:1271-1274Bypareddy R, Rathod BLS, Shilpa YD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913875 44. Pediatric cataract surgery practices in the COVID-19 era: Perspectives of a tertiary care institute in Northern India. Indian J Ophthalmol 2021; 69:1284- 1287Gupta PC, Sukhija J, Khurana S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913878 45. Overcoming challenges in implementing measures across multiple centers of a chain of hospitals to combat COVID-19 pandemic. Indian J Ophthalmol 2021; 69:1289-1291Singh MJ, Verma D, Banerjee TB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913880 46. Impact of COVID-19 on follow-up and medication adherence in patients with glaucoma in a tertiary eye care centre in south India. Indian J Ophthalmol 2021; 69:1264-1270Subathra GN, Rajendrababu SR, Senthilkumar VA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913874 47. Stigmatic Impact of COVID-19 Pandemic on Head & Neck Cancers Survivors. Indian J Otolaryngol Head Neck Surg 2021:1-5Goyal AK, Bakshi J, Panda NK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907679 48. A Nationwide Survey on the Impact of COVID-19 Pandemic on Minimal Invasive Surgery in Urology Practice. Int J Clin Pract 2021:e14309Danacioglu YO, Soytas M, Polat S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932070 49. Alcohol Use and Mental Health among Older American Adults during the Early Months of the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Eastman MR, Finlay JM, Kobayashi LC. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923483 50. Nonattendance at Scheduled Appointments in Outpatient Clinics Due to COVID-19 and Related Factors in Taiwan: A Health Belief Model Approach. Int J Environ Res Public Health 2021; 18Hsieh YP, Yen CF, Wu CF, Wang PW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922171 51. Health Risks and Consequences of a COVID-19 Infection for People with Disabilities: Scoping Review and Descriptive Thematic Analysis. Int J Environ Res Public Health 2021; 18Kamalakannan S, Bhattacharjya S, Bogdanova Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923986 52. Patient Satisfaction with Oncological Care during the SARS-CoV-2 Virus Pandemic. Int J Environ Res Public Health 2021; 18Konieczny M, Cipora E, Sawicka J, Fal A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924702 53. Avoidance of Healthcare Utilization in South Korea during the Coronavirus Disease 2019 (COVID-19) Pandemic. Int J Environ Res Public Health 2021; 18Lee M, You M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924096 54. Perspectives from Dentists, Dental Assistants, Students, and Patients on Dental Care Adapted to the COVID-19 Pandemic: A Cross-Sectional Survey. Int J Environ Res Public Health 2021; 18Schlenz MA, Schmidt A, Wöstmann B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918575 55. Follow-Up Survey of the Impact of COVID-19 on People Living with HIV during the Second Semester of the Pandemic. Int J Environ Res Public Health 2021; 18Siewe Fodjo JN, Faria de Moura Villela E, Van Hees S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925506 56. Examining Dementia Family Caregivers' Forgone Care for General Practitioners and Medical Specialists during a COVID-19 Lockdown. Int J Environ Res Public Health 2021; 18Werner P, Tur-Sinai A, AboJabel H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916152 57. Impact of COVID-19 Confinement on Adolescent Patients with Anorexia Nervosa: A Qualitative Interview Study Involving Adolescents and Parents. Int J Environ Res Public Health 2021; 18Zeiler M, Wittek T, Kahlenberg L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923791 58. Seeking Healthcare During Lockdown: Challenges, Opportunities and Lessons for the Future. Int J Health Policy Manag 2021; Imlach F, McKinlay E, Kennedy J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906337 59. Impact of the COVID-19 pandemic on tuberculosis management in Spain. Int J Infect Dis 2021; Aznar ML, Espinosa-Pereiro J, Saborit N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930543 60. The Impact of COVID-19 Pandemic on Vascular Leg Ulcers. Int. J. Low. Extrem. Wounds 2021:15347346211010958Sallustro M, Florio A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909491 61. Endocrine-Disrupting Chemicals and Infectious Diseases: From Endocrine Disruption to Immunosuppression. Int J Mol Sci 2021; 22Adegoke EO, Rahman MS, Park YJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920428 62. Effect of COVID-19 on Hospital Visits in Ningbo, China: An Interrupted Time Series Analysis. Int. J. Qual. Health Care 2021; Yang ZM, Wu MY, Lu JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909042 63. Rehabilitation guidance for hip fracture patients during the COVID-19 pandemic using chat software: A new model. J. Back Musculoskelet. Rehabil. 2021; Gao SS, Wang YJ, Zhang GX, Zhang WT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896813 64. Effect of the coronavirus disease pandemic on bronchoscopic diagnosis of lung cancer in a provincial city in Japan. J. Cardiothorac. Surg. 2021; 16:115Goto T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910601 65. Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. J Clin Med 2021; 10Cantini L, Bastianelli L, Lupi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916569 66. Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study. J Clin Med 2021; 10Opoka-Winiarska V, Grywalska E, Korona-Glowniak I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921679 67. Safety evaluation of providing trauma service during COVID-19 phase one lockdown. J Clin Orthop Trauma 2021; 18:44-50Choudhry B, Sleiman S, Dutta A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897206 68. Review of orthopaedic trauma surgery during the peak of COVID-19 pandemic - An observational cohort study in the UK. J Clin Orthop Trauma 2021; De C, Kainth N, Harbham PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903787 69. Mortality escalates in patients of proximal femoral fractures with COVID-19: A systematic review and meta-analysis of 35 studies on 4255 patients. J Clin Orthop Trauma 2021; 18:80-93Patralekh MK, Jain VK, Iyengar KP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897205 70. Approach to a Patient with Cutaneous Malignancy in the Time of COVID-19 Pandemic. J. Cutan. Aesthet. Surg. 2020; 13:349-352Dash S, Saha S, Gupta S, Singhal M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911420 71. 40 Weeks In: A Look at How One NIH Institute Handled the Unimaginable. J Dent Res 2021:220345211013305D'Souza R, Lee JS, Shum L, Hoffman M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906484 72. The Impact of the COVID 19 Pandemic on Emergency Department Attendance: What Seems To Be Keeping the Patients Away? J. Emerg. Trauma Shock 2020; 13:246-251Lateef F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897139 73. Adamantiades-Behçet's disease (Behçet's disease) and COVID-19. J Eur Acad Dermatol Venereol 2021; Zouboulis CC, van Laar JAM, Schirmer M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914986 74. Primary Care Access During the COVID-19 Pandemic: a Simulated Patient Study. J Gen Intern Med 2021:1-6Kyle MA, Tipirneni R, Thakore N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904036 75. Effects of Emergency Care-related Health Policies during the COVID-19 Pandemic in Korea: a Quasi-Experimental Study. J Korean Med Sci 2021; 36:e121Pak YS, Ro YS, Kim SH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33904264 76. Victoria (Australia) radiotherapy response to working through the first and second wave of COVID-19: Strategies and staffing. J. Med. Imaging Radiat. Oncol. 2021; Rykers K, Tacey M, Bowes J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908186 77. How COVID-19 Lockdown in Italy Has Affected Type of Calls and Management of Toxic Exposures: a Retrospective Analysis of a Poison Control Center Database From March 2020 to May 2020. J. Med. Toxicol. 2021:1-7Milella MS, Boldrini P, Vivino G, Grassi MC. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905077 78. Preparedness and impact of COVID 19 infection at tertiary care neurology centers in Pakistan. J Neurol Sci 2021; 425:117462Kanwar D, Awan S, Sajjad A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901995 79. Online medication purchasing during the Covid-19 pandemic: potential risks to patient safety and the urgent need to develop more rigorous controls for purchasing online medications, a pilot study from the United Arab Emirates. J Pharm Policy Pract 2021; 14:38Jairoun AA, Al-Hemyari SS, Abdulla NM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931118 80. The Importance of Practice Facilitation in Primary Care When Pandemic Takes Hold: Relationships of Resilience. J. Prim. Care Community Health 2021; 12:21501327211014093Hatch BA, Ferrara L, Dickinson C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928813 81. Evaluation of the Prescribed Drugs to Elderly in a Tertiary Healthcare Center for Possible Drug Interactions with Investigational Drugs for COVID-19 Treatment. J Res Pharm Pract 2020; 9:212-217Keche Y, Gaikwad N, Dhaneria S, Joshi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912505 82. Non-melanoma skin cancer activity during the COVID-19 pandemic- A single UK tertiary centre experience. JPRAS Open 2021; Abbassi O, Waseem S, Murphy S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907705 83. [The Febrile Emergency Unit at Muñiz Hospital facing COVID-19, HIV and tuberculosis]. Medicina (B. Aires) 2021; 81:143-148Lagrutta L, Sotelo CA, Estecho BR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906130 84. Saliva: What Dental Practitioners Should Know about the Role of This Biofluid in the Transmission and Diagnostic of SARS-CoV-2. Medicina (Kaunas) 2021; 57Casillas Santana MA, Dipp Velázquez FA, Sámano Valencia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917276 85. PKU and COVID19: How the pandemic changed metabolic control. Mol Genet Metab Rep 2021; 27:100759Rovelli V, Zuvadelli J, Ercoli V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907667 86. Temporal trends in inpatient oncology census before and during the COVID-19 pandemic and rates of nosocomial COVID-19 among patients with cancer at a large academic center. Oncologist 2021; Zubiri L, Rosovsky RP, Mooradian MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932247 87. Reduced cervical cancer screening in Zimbabwe as an indirect impact of the COVID-19 pandemic: implications for prevention. Pan Afr. Med. J. 2021; 38:131Murewanhema G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912301 88. COVID-19: Measles and Antibiotic Resistance Are a Matter of Concern. Pathogens 2021; 10Di Guardo G. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918683 89. Ethical considerations and patient safety concerns for cancelling non-urgent surgeries during the COVID-19 pandemic: a review. Patient Saf Surg 2021; 15:19Brown NJ, Wilson B, Szabadi S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33926498 90. Neonatal and Pediatric Emergency Room Visits in a Tertiary Center during the COVID-19 Pandemic in Italy. Pediatr. Rep. 2021; 13:168-176Silvagni D, Baggio L, Lo Tartaro Meragliotta P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916938 91. Mitigating Isolation of People Aging With HIV During the COVID-19 Pandemic. Public Health Rep. 2021:333549211015661Brown B, Taylor J, Fisher CB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930276 92. The "Quarantine Dry Eye": The Lockdown for Coronavirus Disease 2019 and Its Implications for Ocular Surface Health. Risk Manag. Healthc. Policy 2021; 14:1629-1636Napoli PE, Nioi M, Fossarello M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907480 93. Changing trends in the outpatient dental visits during the COVID - 19 pandemic in a tertiary care hospital. Saudi J. Biol. Sci. 2021; Madi M, Kumar M, Varchas P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903794 94. Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic. Scand J Urol 2021:1-8Fallara G, Sandin F, Styrke J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913376 95. Otolaryngology activity in two hospitals in northern and central Italy differently affected by COVID-19 pandemic. Sci. Prog. 2021; 104:36850421998487Minni A, Pilolli F, Ralli M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913788 96. Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users. Subst. Abuse Treat. Prev. Policy 2021; 16:36Manthey J, Kilian C, Carr S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902668 97. Experiences of breast cancer survivors during the COVID-19 pandemic: a qualitative study. Support. Care Cancer 2021:1-13Seven M, Bagcivan G, Pasalak SI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905013 98. The functional health status of children with cerebral palsy during the COVID- 19 pandemic stay-at-home period: a parental perspective. Turk. J. Pediatr. 2021; 63:223-236Bıyık KS, Özal C, Tunçdemir M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929112 99. Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study. Value Health 2021; 24:648-657Gravesteijn B, Krijkamp E, Busschbach J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933233 100. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech). Viruses 2021; 13Korth J, Jahn M, Dorsch O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923063 101. Demand for essential non-ambulatory neurosurgical care decreased while acuity of care increased during the COVID surge. World Neurosurg 2021; Shao B, Tang OY, Leary OP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905912 102. [Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19]. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 2021; 121:60-66Kovalchuk VV, Ershova, II, Molodovskaya NV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908234

Management (70 articles)

1. Is home-based therapy in Fabry disease the answer to compelling patients' needs during the COVID-19 pandemic? Survey results from the Polish FD Collaborative Group. Adv Clin Exp Med 2021; 30:449-454Kusztal M, Kłopotowski M, Bazan-Socha S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908195 2. Extracorporeal Membrane Oxygenation Instead of Invasive Mechanical Ventilation in a Patient with Severe COVID-19-associated Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2021; Schmidt M, Pineton de Chambrun M, Lebreton G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901416 3. ICU bed capacity during COVID-19 pandemic In France: from ephemeral beds to continuous and permanent adaptation. Anaesth Crit Care Pain Med 2021; 40:100873Lefrant JY, Pirracchio R, Benhamou D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910085 4. Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use. Antibiotics (Basel) 2021; 10Kullar R, Johnson S, McFarland LV, Goldstein EJC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918619 5. Can Prophylactic High Flow of Humidified and Warmed Filtered Air Improve Survival from Bacterial Pneumonia and SARS-CoV-2 in Elderly Individuals? The Role of Surfactant Protein A. Antioxidants (Basel) 2021; 10Abbasi A, Phelps DS, Ravi R, Floros J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922049 6. The Role of Vitamin K in Humans: Implication in Aging and Age-Associated Diseases. Antioxidants (Basel) 2021; 10Popa DS, Bigman G, Rusu ME. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917442 7. Construction of a demand and capacity model for intensive care and hospital ward beds, and mortality from COVID-19. BMC Med. Inform. Decis. Mak. 2021; 21:138Martin C, McDonald S, Bale S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906636 8. Assessment of depression, anxiety and stress levels in the Ecuadorian general population during social isolation due to the COVID-19 outbreak: a cross-sectional study. BMC Psychiatry 2021; 21:212Mautong H, Gallardo-Rumbea JA, Alvarado-Villa GE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910550 9. Probabilities of ICU admission and hospital discharge according to patient characteristics in the designated COVID-19 hospital of Kuwait. BMC Public Health 2021; 21:799Kipourou DK, Leyrat C, Alsheridah N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902520 10. Individually optimal choices can be collectively disastrous in COVID-19 disease control. BMC Public Health 2021; 21:832Stoddard M, Van Egeren D, Johnson KE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931055 11. Advance care planning for patients with COVID-19: a communication guide. Br. J. Hosp. Med. (Lond.) 2021; 82:1-6Palipane N, Ponnampalampillai A, Gupta S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914627 12. Sphenopalatine ganglion block for refractory COVID-19 headache: a descriptive case series. Braz J Anesthesiol 2021; Machado FC, Neto GC, Carone RSD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932392 13. Dilated esophagus on a preoperative chest radiograph: an easily missed risk factor for aspiration. Braz J Anesthesiol 2021; Wei P, Ye L, Li J, Li J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932396 14. Personalized prophylactic anticoagulation in hospitalized patients with Covid- 19 - The role of anti-Xa monitoring. Clin Microbiol Infect 2021; Kofteridis DP, Ioannou P, Kondili E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933565 15. Ethical heuristics for pandemic allocation of ventilators across hospitals. Dev World Bioeth 2021; Palacios-González C, Pugh J, Wilkinson D, Savulescu J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934463 16. Switching to a Coronavirus disease 2019 (COVID-19) center : Lessons from Ariana Hospital experience. Disaster Med Public Health Prep 2021:1-14Belloumi N, Bachouch I, Chermiti Ben Abdallah F, Fenniche S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926612 17. Planning for the Next Pandemic: Reflections on the Early Phase of the Australian COVID-19 Public Health Response from the Emergency Department. Emerg. Med. Australas. 2021; Govindasamy LS, Hsiao KH, Foong LH, Judkins S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928756 18. Comparison of the clinical features and therapeutics of COVID-19 in cardio- cerebrovascular disease (CCVD) and non-CCVD patients. Front Med 2021:1- 9Wang Y, Li L, Pan Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909258 19. Selective Vagus Nerve Stimulation as a Therapeutic Approach for the Treatment of ARDS: A Rationale for Neuro-Immunomodulation in COVID-19 Disease. Front. Neurosci. 2021; 15:667036Mastitskaya S, Thompson N, Holder D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927594 20. A Breathing Sonification System to Reduce Stress During the COVID-19 Pandemic. Front. Psychol. 2021; 12:623110Van Kerrebroeck B, Maes PJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912105 21. A Vulnerability Analysis for the Management of and Response to the COVID-19 Epidemic in the Second Most Populous State in Brazil. Front Public Health 2021; 9:586670Campos IS, Aratani VF, Cabral KB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928060 22. Can transdisciplinary approaches contribute to the COVID-19 fight? Glob Health Promot 2021:17579759211002376Aslan D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908313 23. The ICF Classification as a Simple Tool to Aid in the Assessment of Healthcare Services in a Non-COVID-19 Hospital during the COVID-19 Pandemic. Healthcare (Basel) 2021; 9Lucki M, Wareńczak A, Chlebuś E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916092 24. Respiratory supports of COVID-19 patients in intensive care unit: A systematic review. Heliyon 2021; 7:e06813Ouyang L, Yu M, Zhu Y, Gong J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898856 25. Role of Statins in Coronavirus-Related Disease (COVID-19): A Retrospective Cohort Study in Northern Italy. High Blood Press Cardiovasc Prev 2021:1- 10Greco S, D'Amuri A, Giorgini E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905094 26. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy 2021; Pinheiro MM, Fabbri A, Infante M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906375 27. A Non-Linear Biostatistical Graphical Modeling of Preventive Actions and Healthcare Factors in Controlling COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Abdulla F, Nain Z, Karimuzzaman M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922634 28. The Commonly Utilized Natural Products during the COVID-19 Pandemic in Saudi Arabia: A Cross-Sectional Online Survey. Int J Environ Res Public Health 2021; 18AlNajrany SM, Asiri Y, Sales I, AlRuthia Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924884 29. COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE- CO-Ped), Italy. Int J Environ Res Public Health 2021; 18Esposito S, Marchetti F, Lanari M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917940 30. Prediction Models for Public Health Containment Measures on COVID-19 Using Artificial Intelligence and Machine Learning: A Systematic Review. Int J Environ Res Public Health 2021; 18Payedimarri AB, Concina D, Portinale L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922693 31. Factors Associated with the Implementation of Non-Pharmaceutical Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A Systematic Review. Int J Environ Res Public Health 2021; 18Regmi K, Lwin CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920613 32. A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 Incidence. Int J Environ Res Public Health 2021; 18Schubert L, Strassl R, Burgmann H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921037 33. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int J Environ Res Public Health 2021; 18Sisó-Almirall A, Brito-Zerón P, Conangla Ferrín L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923972 34. COVID-19: Direct and Indirect Mechanisms of Statins. Int J Mol Sci 2021; 22Pawlos A, Niedzielski M, Gorzelak-Pabiś P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920709 35. Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19. Intest Res 2021; Koroku M, Omori T, Kambayashi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902268 36. A Randomized open label parallel group pilot study to evaluate efficacy of Ayurveda interventions in the management of Asymptomatic and Mild COVID- 19 patients-Experiences of a Lucknow based Level 2 hospital of Uttar Pradesh, India. J. Ayurveda Integr. Med. 2021; Rais A, Negi DS, Yadav A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897204 37. A predictive model of clinical deterioration among hospitalized COVID-19 patients by harnessing hospital course trajectories. J. Biomed. Inform. 2021:103794Mauer E, Lee J, Choi J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33933654 38. Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19. J Clin Med 2021; 10Bodro M, Cofan F, Ríos J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917093 39. A Perspective on COVID-19 Management. J Clin Med 2021; 10Pavelić K, Kraljević Pavelić S, Brix B, Goswami N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918624 40. Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19. J Clin Med 2021; 10Wu CC, Lee AJ, Su CH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916281 41. Pharmacological Predictors of Morbidity and Mortality in COVID-19. J. Clin. Pharmacol. 2021; Oddy C, McCaul J, Keeling P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908637 42. Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host- pathogen interaction and immunomodulation. J. Funct. Foods 2021; 82:104503Dhar S, Bhattacharjee P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897833 43. Sudden hearing loss and coronavirus disease 2019: the role of corticosteroid intra-tympanic injection in hearing improvement. J. Laryngol. Otol. 2021:1- 3Rahimi V, Asiyabar MK, Rouhbakhsh N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913413 44. COVID-19 and Cleft and Craniofacial Surgery in Indian Scenario. J. Maxillofac. Oral Surg. 2021:1-6Ramanathan M, Ravichandran SK, Parameswaran A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897127 45. Decreased In-Hospital Mortality Associated with Aspirin Administration in Hospitalized Patients Due to Severe COVID-19. J Med Virol 2021; Aghajani MH, Moradi O, Amini H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913549 46. Intensive Care Unit Nurses Living Through COVID-19: A Qualitative Study. J. Nurs. Manag. 2021; Cadge W, Lewis M, Bandini J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930237 47. Failure of Anticoagulation to Prevent Stroke in Context of Lupus-Associated Anti-Phospholipid Syndrome and Mild COVID-19. J. Stroke Cerebrovasc. Dis. 2021:105817Kincaid KJ, Simpkins AN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33933349 48. Is Rural Kansas Prepared? An Assessment of Resources Related to the COVID-19 Pandemic. Kans J Med 2021; 14:95-102Berland H, Hughes D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903809 49. Early prone positioning therapy for patients with mild COVID-19 disease. Med Clin (Engl Ed) 2021; 156:386-389Liu X, Liu H, Lan Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898754 50. Mathematical model optimized for prediction and health care planning for COVID-19. Med. Intensiva 2021; Garrido JM, Martínez-Rodríguez D, Rodríguez- Serrano F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926752 51. Emergency department presentations by residents of Sydney quarantine hotels during the COVID-19 outbreak. Med. J. Aust. 2021; Dinh M, Hutchings O, Bein K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908054 52. Clinical course and care requirements during the 2020 COVID-19 epidemic in South Australia. Med. J. Aust. 2021; Haustead D, Toh DJ, Reddi B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928650 53. A Dedicated Veno-Venous Extracorporeal Membrane Oxygenation Unit during a Respiratory Pandemic: Lessons Learned from COVID-19 Part I: System Planning and Care Teams. Membranes (Basel) 2021; 11Dave S, Shah A, Galvagno S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918355 54. A Dedicated Veno-Venous Extracorporeal Membrane Oxygenation Unit during a Respiratory Pandemic: Lessons Learned from COVID-19 Part II: Clinical Management. Membranes (Basel) 2021; 11Shah A, Dave S, Galvagno S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919390 55. The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia. Microorganisms 2021; 9Marras L, Caputo M, Bisicchia S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919907 56. Authors' response to the Letter to the Editor regarding: Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations. Multidiscip Respir Med 2021; 16:768D'Amato G, Acanfora L, Paoli LD, D'Amato M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907626 57. eNeuroIntensive Care in India: The Need of the Hour. Neurol. India 2021; 69:245- 251Haranath SP, Ganapathy K, Kesavarapu SR, Kuragayala SD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904432 58. COVID-19: In- or Outpatient Care? - Risk Score to Differentiate Expected Mild and Severe Cases. Notarzt 2021; Peters L, Burkert S, Dinse-Lambracht A et al. 59. Understanding the principles of infection prevention and control. Nurs. Stand. 2021; Wynn M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899381 60. Relation between Vitamin D and COVID-19 in Aged People: A Systematic Review. Nutrients 2021; 13Dramé M, Cofais C, Hentzien M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920639 61. Clinical and therapeutic outcomes of COVID-19 intensive care units (ICU) patients: a retrospective study in Ghana. Pan Afr. Med. J. 2021; 38:107Afriyie- Mensah J, Aboagye ET, Ganu VJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33912277 62. Home Management of Patients with Moderate or Severe Respiratory Failure Secondary to COVID-19, Using Remote Monitoring and Oxygen with or without HFNC. Pathogens 2021; 10Annunziata A, Coppola A, Carannante N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915796 63. The Monthly Operating Cost of an Institutional COVID-19 Airway Response Team: A Financial Model and Sensitivity Analysis Based on Experience at an Academic Medical Center. Perioper Care Oper Room Manag 2021; 23:100168Stone AB, Grant MC, Dasani SS, Nascimben L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898769 64. Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore. Physiology (Bethesda) 2021; 36:160-173Saavedra JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904788 65. Effect of serial awake prone positioning on oxygenation in patients admitted to intensive care with COVID-19. Postgrad. Med. J. 2021; Barker J, Pan D, Koeckerling D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931557 66. Modelling the effectiveness of intervention strategies to control COVID-19 outbreaks and estimating healthcare demand in Germany. Public Health Pract (Oxf) 2021; 2:100121Chadsuthi S, Modchang C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899039 67. Multiplex Ventilation: Solutions for Four Main Safety Problems. Respir. Care 2021; Sorg ME, Branson RD, Hatipoğlu U, Chatburn RL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906955 68. E-Triage Systems for COVID-19 Outbreak: Review and Recommendations. Sensors (Basel) 2021; 21Alhaidari F, Almuhaideb A, Alsunaidi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920744 69. Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:310Molino S, Pisarevsky A, Mingorance FL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910614 70. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021; 13Silva Andrade B, Siqueira S, de Assis Soares WR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919537

Mental – public health (173 articles)

1. Adverse and Benevolent Childhood Experiences Predict Mental Health During the COVID-19 Pandemic. Advers Resil Sci 2021:1-12Doom JR, Seok D, Narayan AJ, Fox KR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907733 2. Mixed Emotions, but Not Positive or Negative Emotions, Facilitate Legitimate Virus-Prevention Behaviors and Eudaimonic Outcomes in the Emergence of the COVID-19 Crisis. Affect Sci 2021:1-13Oh VYS, Tong EMW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899002 3. Functional Connectome Prediction of Anxiety Related to the COVID-19 Pandemic. Am. J. Psychiatry 2021:appiajp202020070979He L, Wei D, Yang F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900813 4. Changes in the Psychological State of Medical Personnel in the Department of Radiotherapy at a Tertiary Care Teaching Hospital in China during the Epidemic. Ann Work Expo Health 2021; Chen F, Zhan W, Xu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907794 5. The impact of COVID-19 on stress, anxiety, and coping in youth with and without autism and their parents. Autism Res. 2021; Corbett BA, Muscatello RA, Klemencic ME, Schwartzman JM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913261 6. Psychopathological Impact and Resilient Scenarios in Inpatient with Schizophrenia Spectrum Disorders Related to Covid Physical Distancing Policies: A Systematic Review. Behav Sci (Basel) 2021; 11Caponnetto P, Benenati A, Maglia MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924365 7. Meaning Matters: Self-Perceived Meaning in Life, Its Predictors and Psychological Stressors Associated with the COVID-19 Pandemic. Behav Sci (Basel) 2021; 11Humphrey A, Vari O. http://www.ncbi.nlm.nih.gov/pubmed/? term=33924422 8. Death Anxiety in Social Workers as a Consequence of the COVID-19 Pandemic. Behav Sci (Basel) 2021; 11Martínez-López J, Lázaro-Pérez C, Gómez- Galán J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926098 9. Fatigue, anxiety, depression and sleep quality in patients undergoing haemodialysis. BMC Nephrol. 2021; 22:157Al Naamani Z, Gormley K, Noble H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910523 10. The relationship between sexual function and mental health in Iranian pregnant women during the COVID-19 pandemic. BMC Pregnancy Childbirth 2021; 21:327Effati-Daryani F, Jahanfar S, Mohammadi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902479 11. Immediate psychological outcomes associated with COVID-19 pandemic in frontline physicians: a cross-sectional study in Egypt. BMC Psychiatry 2021; 21:215Abu-Elenin MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910544 12. Prevalence and associated factors of psychosocial distress among seafarers during COVID-19 pandemic. BMC Psychiatry 2021; 21:222Baygi F, Mohammadian Khonsari N, Agoushi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931081 13. Assessment of depression, anxiety and stress levels in the Ecuadorian general population during social isolation due to the COVID-19 outbreak: a cross-sectional study. BMC Psychiatry 2021; 21:212Mautong H, Gallardo-Rumbea JA, Alvarado-Villa GE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910550 14. Perceived stress in the time of COVID-19: the association with brooding and COVID-related rumination in adults with and without migraine. BMC Psychol 2021; 9:68Kovács LN, Baksa D, Dobos D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931113 15. Occupational burnout and job satisfaction among physicians in times of COVID-19 crisis: a convergent parallel mixed-method study. BMC Public Health 2021; 21:811Alrawashdeh HM, Al-Tammemi AB, Alzawahreh MK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906619 16. The qualitative analysis of characteristic of callers to a psychological hotline at the early stage of COVID-19 in China. BMC Public Health 2021; 21:809Du N, Ouyang Y, He Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906613 17. Fear of COVID-19 and workplace phobia among Pakistani doctors: A survey study. BMC Public Health 2021; 21:833Malik S, Ullah I, Irfan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931040 18. Emotional exhaustion in front-line healthcare workers during the COVID-19 pandemic in Wuhan, China: the effects of time pressure, social sharing and cognitive appraisal. BMC Public Health 2021; 21:829Wang H, Zhou X, Jia X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931034 19. New-onset psychosis due to COVID-19. BMJ Case Rep. 2021; 14Kozato N, Mishra M, Firdosi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906867 20. Building resiliency in emergency room physicians: anticipating the next catastrophe. BMJ Health Care Inform 2021; 28Patel VL, Shidhaye R, Dev P, Shortliffe EH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926961 21. Psychological distress during COVID-19 pandemic in low-income and middle- income countries: a cross-sectional study of older persons in Thailand. BMJ Open 2021; 11:e047650Pothisiri W, Vicerra PMM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931412 22. Effects of COVID-19 Lockdown on the Emotional and Behavioral Profiles of Preschool Italian Children with and without Familial Risk for Neurodevelopmental Disorders. Brain Sci 2021; 11Cantiani C, Dondena C, Capelli E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918593 23. Predictors of Mental Health after the First Wave of the COVID-19 Pandemic in Poland. Brain Sci 2021; 11Długosz P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925292 24. The Impact of COVID-19 on Depressive Symptoms through the Lens of Sexual Orientation. Brain Sci 2021; 11Duarte M, Pereira H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924040 25. Mindfulness and Other Simple Neuroscience-Based Proposals to Promote the Learning Performance and Mental Health of Students during the COVID-19 Pandemic. Brain Sci 2021; 11Tortella GR, Seabra AB, Padrão J, Díaz-San Juan R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925627 26. Loneliness and symptom burden in oncology patients during the COVID-19 pandemic. Cancer 2021; Miaskowski C, Paul SM, Snowberg K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905528 27. Child maltreatment reports and Child Protection Service responses during COVID-19: Knowledge exchange among Australia, Brazil, Canada, Colombia, Germany, Israel, and South Africa. Child Abuse Negl. 2021:105078Katz I, Katz C, Andresen S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931238 28. Parenting stress among new parents before and during the COVID-19 pandemic. Child Abuse Negl. 2021; 117:105080Taubman-Ben-Ari O, Ben-Yaakov O, Chasson M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930664 29. COVID-19 pandemic and psychological wellbeing among health care workers and general population: A systematic-review and meta-analysis of the current evidence from India. Clin Epidemiol Glob Health 2021; 11:100737Singh RK, Bajpai R, Kaswan P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898866 30. Reply to "Impact of COVID-19 on the mental health of radiologists". Clin Imaging 2021; 79:102-103Demirjian NL, Fields BKK, Cen SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932871 31. Fear and Anxiety in COVID-19: Preexisting Anxiety Disorders. Cogn. Behav. Pract. 2021; Shafran R, Rachman S, Whittal M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897249 32. COVID-19 Inspired Relational Telemental Health Services for Incarcerated Individuals and Their Families. Contemp. Fam. Ther. 2021:1-12Tadros E, Aguirre N, Jensen S, Poehlmann-Tynan J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897102 33. Patients' Attitudes and Sources of Information on Coronavirus Disease 2019 in Rural Michigan. Cureus 2021; 13:e14036Kapila V, Baida I, Calderon A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898122 34. Guillain-Barre Syndrome in a Patient With Asymptomatic Coronavirus Disease 2019 Infection and Major Depressive Disorder. Cureus 2021; 13:e14161Mokhashi N, Narla G, Marchionni C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927956 35. The effects of COVID-19 continuous traumatic stressors on mental health and cognitive functioning: A case example from Turkey. Curr. Psychol. 2021:1- 12Kira IA, Alpay EH, Ayna YE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897228 36. Effects of restraining measures due to COVID-19: Pre- and post-lockdown cognitive status and mental health. Curr. Psychol. 2021:1-10Nogueira J, Gerardo B, Silva AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897227 37. The predictors of COVID-19 anxiety and helping behaviour during the pandemic: An investigation within the framework of individual and national level resources. Curr. Psychol. 2021:1-9Ünal Ö, Cesur-Atintaş M, Kiremitçi-Canıöz E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897225 38. Stress and anxiety among dental practitioners during the COVID-19 pandemic: A cross-sectional survey. Dent Med Probl 2021; Kamal AT, Sukhia RH, Ghandhi D, Sukhia HR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929792 39. A Cross-Sectional Survey to Assess Health Care Workers' Grief Counseling for Bereaved Families of COVID-19 Victims in Wuhan, China. Disaster Med Public Health Prep 2021:1-21Gao X, Wang Z, Kong C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926611 40. Burnout syndrome in medical oncologists during the COVID-19 pandemic: Argentinian national survey. Ecancermedicalscience 2021; 15:1213Guercovich A, Piazzioni G, Waisberg F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912238 41. Psychiatric disorders among hospitalized patients deceased with COVID-19 in Italy. EClinicalMedicine 2021:100854Lega I, Nisticò L, Palmieri L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907730 42. COVID-19 and women's health: Examining changes in mental health and fertility. Econ Lett 2021; 199:109729Silverio-Murillo A, Hoehn-Velasco L, Balmori de la Miyar JR, Rodríguez A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897073 43. COVID-19 in Brazil: The catastrophic results of an inappropriate and unequal health policy. Ethics Med Public Health 2021; 18:100673Silva RM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898691 44. Hospital workforce mental reaction to the pandemic in a low COVID-19 burden setting: a cross-sectional clinical study. Eur. Arch. Psychiatry Clin. Neurosci. 2021:1-11Alexopoulos P, Roukas D, Efkarpidis A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904979 45. The impact of COVID-19 on the lives and mental health of Australian adolescents. Eur. Child Adolesc. Psychiatry 2021:1-13Li SH, Beames JR, Newby JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913036 46. A qualitative investigation of LGBTQ+ young people's experiences and perceptions of self-managing their mental health. Eur. Child Adolesc. Psychiatry 2021:1-14Town R, Hayes D, Fonagy P, Stapley E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903961 47. Evaluations of Healthcare Providers' Perceived Support From Personal, Hospital, and System Resources: Implications for Well-Being and Management in Healthcare in Montreal, Quebec, During COVID-19. Eval. Health Prof. 2021:1632787211012742Lou NM, Montreuil T, Feldman LS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902348 48. Parents Are Stressed! Patterns of Parent Stress Across COVID-19. Front Psychiatry 2021; 12:626456Adams EL, Smith D, Caccavale LJ, Bean MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897489 49. Looking Back to Move Forward: Reflections on the Strengths and Challenges of the COVID-19 UK Mental Health Research Response. Front Psychiatry 2021; 12:622562Demkowicz O, Panayiotou M, Parsons S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897488 50. The Psychological Effect of COVID-19 on Home-Quarantined Nursing Students in China. Front Psychiatry 2021; 12:652296Li D, Zou L, Zhang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897502 51. Mental Symptoms and Stress of Hospitalized Schizophrenia Patients With 2019 Novel Coronavirus Disease: An Observation Study. Front Psychiatry 2021; 12:557611Ma J, Jiang T, Huang H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897476 52. Rapid Review on the Associations of Social and Geographical Isolation and Intimate Partner Violence: Implications for the Ongoing COVID-19 Pandemic. Front Psychiatry 2021; 12:578150Mojahed A, Brym S, Hense H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927649 53. Coping With the COVID-19 Pandemic: Examining Gender Differences in Stress and Mental Health Among University Students. Front Psychiatry 2021; 12:650759Prowse R, Sherratt F, Abizaid A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897499 54. The Psychodynamic Approach During COVID-19 Emotional Crisis. Front. Psychol. 2021; 12:670196Conversano C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897574 55. The Psychological Impact of COVID-19 on Healthcare Providers in Obstetrics: A Cross-Sectional Survey Study. Front. Psychol. 2021; 12:632999Del Piccolo L, Donisi V, Raffaelli R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897540 56. COVID-19 Protective Behaviors Are Forms of Prosocial and Unselfish Behaviors. Front. Psychol. 2021; 12:647710Dinić BM, Bodroža B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897553 57. Evaluation and Analysis of Mental Health Level of College Students With Financial Difficulties Under the Background of COVID-19. Front. Psychol. 2021; 12:649195Feng Y, Zhang Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897557 58. Preserving Cornerstones of Student's Assessment in Medical Education During COVID-19. Front. Psychol. 2021; 12:591152Hamamoto Filho PT, Bicudo AM, Cecilio-Fernandes D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897520 59. Professors' Expectations About Online Education and Its Relationship With Characteristics of University Entrance and Students' Academic Performance During the COVID-19 Pandemic. Front. Psychol. 2021; 12:642391Lobos Peña K, Bustos-Navarrete C, Cobo-Rendón R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897544 60. The Efficacy of Music for Emotional Wellbeing During the COVID-19 Lockdown in Spain: An Analysis of Personal and Context-Related Variables. Front. Psychol. 2021; 12:647837Martínez-Castilla P, Gutiérrez-Blasco IM, Spitz DH, Granot R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897554 61. Suffering and Salutogenesis: A Conceptual Analysis of Lessons for Psychiatry From Existential Positive Psychology (PP2.0) in the Setting of the COVID-19 Pandemic. Front. Psychol. 2021; 12:646334Rajkumar RP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897551 62. Educational and Social Exergaming: A Perspective on Physical, Social, and Educational Benefits and Pitfalls of Exergaming at Home During the COVID-19 Pandemic and Afterwards. Front. Psychol. 2021; 12:644036Rüth M, Kaspar K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897546 63. Facing COVID-19 Between Sensory and Psychoemotional Stress, and Instrumental Deprivation: A Qualitative Study of Unmanageable Critical Incidents With Doctors and Nurses in Two Hospitals in Northern Italy. Front. Psychol. 2021; 12:622894Testoni I, Franco C, Gallo Stampino E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912104 64. Promoting Graduate Student Mental Health During COVID-19: Acceptability, Feasibility, and Perceived Utility of an Online Single-Session Intervention. Front. Psychol. 2021; 12:569785Wasil AR, Taylor ME, Franzen RE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897511 65. The Psychological and Academic Effects of Studying From the Home and Host Country During the COVID-19 Pandemic. Front. Psychol. 2021; 12:644096Wilczewski M, Gorbaniuk O, Giuri P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897547 66. Quality of Life and Its Predictive Factors Among Healthcare Workers After the End of a Movement Lockdown: The Salient Roles of COVID-19 Stressors, Psychological Experience, and Social Support. Front. Psychol. 2021; 12:652326Woon LS, Mansor NS, Mohamad MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897561 67. A Follow-Up Investigation of Mental Health Among Discharged COVID-19 Patients in Wuhan, China. Front Public Health 2021; 9:640352Li L, Wu MS, Tao J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912531 68. Inclusive Finance, Environmental Regulation, and Public Health in China: Lessons for the COVID-19 Pandemic. Front Public Health 2021; 9:662166Liu X, Guo S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912533 69. Evaluation of a Short-Term Digital Group Intervention to Relieve Mental Distress and Promote Well-Being Among Community-Dwelling Older Individuals During the COVID-19 Outbreak: A Study Protocol. Front Public Health 2021; 9:577079Shapira S, Yeshua-Katz D, Goren G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898369 70. Feelings of loneliness and mental health needs and services utilization among Chinese residents during the COVID-19 epidemic. Global Health 2021; 17:51Bao L, Li WT, Zhong BL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902638 71. The first wave of the COVID-19 pandemic and its impact on socioeconomic inequality in psychological distress in the UK. Health Econ. 2021; Davillas A, Jones AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904203 72. Burnout Status of Italian Healthcare Workers during the First COVID-19 Pandemic Peak Period. Healthcare (Basel) 2021; 9Conti C, Fontanesi L, Lanzara R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925215 73. Sources of Care Stress of Nursing Staff for Patients with Infectious Diseases during the Prevalence of COVID-19: A Case Study of Some Regional Teaching Hospitals in Southern Taiwan. Healthcare (Basel) 2021; 9Huang Y, Yu L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919871 74. Evaluating the Practice of Preventive Behaviors and the Fear of COVID-19 among Dentists in Oradea Metropolitan Area after the First Wave of Pandemic; a Cross-Sectional Study. Healthcare (Basel) 2021; 9Iurcov R, Pop LM, Ciavoi G, Iorga M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918835 75. COVID-19 and Mental Health: A Study of Stress, Resilience, and Depression among the Older Population in Pakistan. Healthcare (Basel) 2021; 9Mumtaz A, Manzoor F, Jiang S, Anisur Rahaman M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33917346 76. COVID-19-Related Fear, Risk Perception, and Safety Behavior in Individuals with Diabetes. Healthcare (Basel) 2021; 9Musche V, Kohler H, Bäuerle A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919519 77. Assessing Knowledge, Preventive Practices, and Depression among Chinese University Students in Korea and China during the COVID-19 Pandemic: An Online Cross-Sectional Study. Healthcare (Basel) 2021; 9Zhao B, Kong F, Nam EW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917674 78. Economic stressors and mental health symptoms among Bangladeshi rehabilitation professionals: A cross-sectional study amid COVID-19 pandemic. Heliyon 2021; 7:e06715Ali M, Uddin Z, Hossain A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898834 79. Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis. Heliyon 2021; 7:e06677Hossain MM, Rahman M, Trisha NF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898819 80. Stress, Anxiety, and Depression Among Undergraduate Students during the COVID-19 Pandemic and their Use of Mental Health Services. Innov High Educ 2021:1-20Lee J, Jeong HJ, Kim S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907351 81. Should people with severe mental illness be prioritized for the COVID-19 vaccination? Int J Biol Sci 2021; 17:1443-1445Yang Y, Li W, Zhang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907507 82. Evaluating the Anxiety and Depression Status of Prostate Cancer Patients whose Operations were Postponed due to the COVID-19 Pandemic. Int J Clin Pract 2021:e14278Kizilkan Y, Senel S, Ozercan AY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914983 83. A Perfect Storm? Health Anxiety, Contamination Fears, and COVID-19: Lessons Learned from Past Pandemics and Current Challenges. Int. J. Cogn. Ther. 2021:1-17Dennis D, Radnitz C, Wheaton MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907592 84. Public Response, Anxiety and Behaviour during the First Wave of COVID-19 Pandemic in Saudi Arabia. Int J Environ Res Public Health 2021; 18Alqahtani AS, Alrasheed MM, Alqunaibet AM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925408 85. Impact of the 2019 Coronavirus Disease Pandemic on Health-Related Quality of Life and Psychological Status: The Role of Physical Activity. Int J Environ Res Public Health 2021; 18Alzahrani H, Alshehri F, Alsufiany M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920147 86. Quality of Life and Symptoms of PTSD during the COVID-19 Lockdown in Italy. Int J Environ Res Public Health 2021; 18Bonichini S, Tremolada M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924236 87. Patterns of Psychological Responses among the Public during the Early Phase of COVID-19: A Cross-Regional Analysis. Int J Environ Res Public Health 2021; 18Chong YY, Chien WT, Cheng HY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919888 88. The Impact of Intolerance of Uncertainty on Negative Emotions in COVID-19: Mediation by Pandemic-Focused Time and Moderation by Perceived Efficacy. Int J Environ Res Public Health 2021; 18Dai W, Meng G, Zheng Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920976 89. Mental Health during the COVID-19 Lockdown over the Christmas Period in Austria and the Effects of Sociodemographic and Lifestyle Factors. Int J Environ Res Public Health 2021; 18Dale R, Budimir S, Probst T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916019 90. Psychological Responses According to Gender during the Early Stage of COVID-19 in Spain. Int J Environ Res Public Health 2021; 18Del Río-Casanova L, Sánchez-Martín M, García-Dantas A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918378 91. Alcohol Use and Mental Health among Older American Adults during the Early Months of the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Eastman MR, Finlay JM, Kobayashi LC. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923483 92. Protocol for the Implementation and Assessment of "MoodUP": A Stepped Care Model Assisted by a Digital Platform to Accelerate Access to Mental Health Care for Cancer Patients Amid the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Frasquilho D, Matias R, Grácio J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925412 93. The Significance of Demographic Variables on Psychosocial Health from the Early Stage and Nine Months after the COVID-19 Pandemic Outbreak. A Cross- National Study. Int J Environ Res Public Health 2021; 18Geirdal A, Price D, Schoultz M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923936 94. Are Rurality, Area Deprivation, Access to Outside Space, and Green Space Associated with Mental Health during the COVID-19 Pandemic? A Cross Sectional Study (CHARIS-E). Int J Environ Res Public Health 2021; 18Hubbard G, Daas CD, Johnston M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917067 95. The Enabling Role of ICT to Mitigate the Negative Effects of Emotional and Social Loneliness of the Elderly during COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Llorente-Barroso C, Kolotouchkina O, Mañas-Viniegra L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917966 96. SARS/MERS/SARS-CoV-2 Outbreaks and Burnout Syndrome among Healthcare Workers. An Umbrella Systematic Review. Int J Environ Res Public Health 2021; 18Magnavita N, Chirico F, Garbarino S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924026 97. CORONAcrisis-An Observational Study on the Experience of Healthcare Professionals in a University Hospital during a Pandemic Emergency. Int J Environ Res Public Health 2021; 18Matarazzo T, Bravi F, Valpiani G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923784 98. The Influence of the Urban Environment on Mental Health during the COVID-19 Pandemic: Focus on Air Pollution and Migration-A Narrative Review. Int J Environ Res Public Health 2021; 18Menculini G, Bernardini F, Attademo L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917942 99. Stress and Mental Health among Children/Adolescents, Their Parents, and Young Adults during the First COVID-19 Lockdown in Switzerland. Int J Environ Res Public Health 2021; 18Mohler-Kuo M, Dzemaili S, Foster S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925743 100. The Role of Healthcare Professionals' Passion in Predicting Secondary Traumatic Stress and Posttraumatic Growth in the Face of COVID-19: A Longitudinal Approach. Int J Environ Res Public Health 2021; 18Moreno-Jiménez JE, Blanco-Donoso LM, Demerouti E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33922232 101. The Impact of the COVID-19 Pandemic on Mental Health: Evidence from Cyprus. Int J Environ Res Public Health 2021; 18Mousoulidou M, Siakalli M, Christodoulou A, Argyrides M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33917065 102. Effect of COVID-19 on Health-Related Quality of Life in Adolescents and Children: A Systematic Review. Int J Environ Res Public Health 2021; 18Nobari H, Fashi M, Eskandari A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923120 103. Tired, Worried and Burned Out, but Still Resilient: A Cross-Sectional Study of Mental Health Workers in the UK during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Pappa S, Barnett J, Berges I, Sakkas N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922281 104. Impact of the COVID-19 Pandemic on Estonian Elite Athletes: Survey on Mental Health Characteristics, Training Conditions, Competition Possibilities, and Perception of Supportiveness. Int J Environ Res Public Health 2021; 18Parm Ü, Aluoja A, Tomingas T, Tamm AL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921723 105. Quality of Life Changes during the COVID-19 Pandemic for Caregivers of Children with ADHD and/or ASD. Int J Environ Res Public Health 2021; 18Pecor KW, Barbyannis G, Yang M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915884 106. Psychological Impact of the Lockdown Due to the COVID-19 Pandemic in University Workers: Factors Related to Stress, Anxiety, and Depression. Int J Environ Res Public Health 2021; 18Salazar A, Palomo-Osuna J, de Sola H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924133 107. Social Support and Optimism as Protective Factors for Mental Health among 7765 Healthcare Workers in Germany during the COVID-19 Pandemic: Results of the VOICE Study. Int J Environ Res Public Health 2021; 18Schug C, Morawa E, Geiser F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917493 108. Validation of the Korean Version of the COVID-19 Phobia Scale (K-C19PS). Int J Environ Res Public Health 2021; 18Seong M, Lee M, Kim I, Kang M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916718 109. The Collateral Damage of the COVID-19 Outbreak on Mental Health and Psychiatry. Int J Environ Res Public Health 2021; 18Simon FAJ, Schenk M, Palm D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922054 110. Concerns Related to the COVID-19 in Adult Norwegians during the First Outbreak in 2020: A Qualitative Approach. Int J Environ Res Public Health 2021; 18Skogstad L, Schou-Bredal I, Bonsaksen T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921705 111. Public Health Workforce Burnout in the COVID-19 Response in the U.S. Int J Environ Res Public Health 2021; 18Stone KW, Kintziger KW, Jagger MA, Horney JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924084 112. Prevalence of Depression, Anxiety, and Perceived Stress in Postpartum Mexican Women during the COVID-19 Lockdown. Int J Environ Res Public Health 2021; 18Suárez-Rico BV, Estrada-Gutierrez G, Sánchez-Martínez M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925373 113. Effects of Interoceptive Sensibility on Mental Health during the Coronavirus Disease 2019 Pandemic. Int J Environ Res Public Health 2021; 18Suzuki N, Yamamoto T, Uchiumi C, Sugaya N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925328 114. Women's Depressive Symptoms during the COVID-19 Pandemic: The Role of Pregnancy. Int J Environ Res Public Health 2021; 18Yirmiya K, Yakirevich-Amir N, Preis H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919564 115. Peritraumatic Distress during the COVID-19 Pandemic in Seoul, South Korea. Int J Environ Res Public Health 2021; 18Yoon H, You M, Shon C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924879 116. Effect of Inquiry-Based Stress Reduction (IBSR) Intervention on Well-Being, Resilience and Burnout of Teachers during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Zadok-Gurman T, Jakobovich R, Dvash E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916258 117. The Impact of COVID-19 on Consumers' Psychological Behavior Based on Data Mining for Online User Comments in the Catering Industry in China. Int J Environ Res Public Health 2021; 18Zhang C, Jiang J, Jin H, Chen T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920875 118. Psychological Burden and Experiences Following Exposure to COVID-19: A Qualitative and Quantitative Study of Chinese Medical Student Volunteers. Int J Environ Res Public Health 2021; 18Zhang K, Peng Y, Zhang X, Li L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924448 119. Higher Depression of Patients with Alzheimer's Disease During than Before the Lockdown. J. Alzheimers Dis. 2021; El Haj M, Moustafa AA, Gallouj K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896844 120. Higher Depression of Patients with Alzheimer's Disease During than Before the Lockdown. J. Alzheimers Dis. 2021; Haj ME, Moustafa AA, Gallouj K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896844 121. Elevated Levels of COVID-19-Related Stress and Mental Health Problems Among Parents of Children with Developmental Disorders During the Pandemic. J. Autism Dev. Disord. 2021:1-12Chan RCH, Fung SC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913075 122. Psychological Distress, Fear of COVID-19, and Resilient Coping Abilities among Healthcare Workers in a Tertiary First-Line Hospital during the Coronavirus Pandemic. J Clin Med 2021; 10Collantoni E, Saieva AM, Meregalli V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918169 123. The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL). J Clin Med 2021; 10Kwiatkowska J, Meyer-Szary J, Mazurek-Kula A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921526 124. Can Psychological Empowerment Prevent Emotional Disorders in Presence of Fear of COVID-19 in Health Workers? A Cross-Sectional Validation Study. J Clin Med 2021; 10Llorente-Alonso M, García-Ael C, Topa G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920260 125. Telepsychotherapy During the COVID-19 Pandemic: The Experience of Lebanese Mental Health Professionals. J Contemp Psychother 2021:1-7Tohme P, De Witte NAJ, Van Daele T, Abi-Habib R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33903776 126. Psychological distress and associated factors of the primary caregivers of offspring with eating disorder during the coronavirus disease 2019 pandemic. J Eat Disord 2021; 9:58Zhang L, Wu MT, Guo L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926562 127. COVID-19, time to oneself, and loneliness: Creativity as a resource. J. Gerontol. B Psychol. Sci. Soc. Sci. 2021; Pauly T, Chu L, Zambrano E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930141 128. Daily Positive Support and Perceived Stress During COVID-19 Outbreak: The Role of Daily Gratitude Within Couples. J Happiness Stud 2021:1-15Jiang D, Chiu MM, Liu S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897277 129. Factors mediating the psychological well-being of healthcare workers responding to global pandemics: A systematic review. J Health Psychol 2021:13591053211012759Schneider J, Talamonti D, Gibson B, Forshaw M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913356 130. The relationship between psychological capital and mental health during the Covid-19 pandemic: A longitudinal mediation model. J Health Psychol 2021:13591053211012771Turliuc MN, Candel OS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913353 131. COVID-19 and fatigue: Where do we go from here? Response to Ortelli et al. J Neurol Sci 2021; 426:117470Conti I, Cross B, Rooney AG, Nicholson TR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930693 132. Assessment of Depression, Anxiety, and Sleep Disturbance in COVID-19 Patients at Tertiary Care Center of North India. J. Neurosci. Rural Pract. 2021; 12:316-322Yadav R, Yadav P, Kumar SS, Kumar R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927522 133. Humility and Acceptance: Working Within Our Limits With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Orthop. Sports Phys. Ther. 2021; 51:197-200Décary S, Gaboury I, Poirier S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930983 134. The Utility of the Pandemic Grief Scale in Identifying Functional Impairment from COVID-19 Bereavement. J. Palliat. Med. 2021; Lee SA, Neimeyer RA, Breen LJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926228 135. Responding to the Global Pandemic: A Pulse of the Well-Being of Clubhouse Communities Moving Virtual. J Psychosoc Rehabil Ment Health 2021:1-13Michon A, Hinchey L, Pernice F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903848 136. Stress, anxiety and depression in 1466 pregnant women during and before the COVID-19 pandemic: a Dutch cohort study. J. Psychosom. Obstet. Gynaecol. 2021:1-7Zilver SJM, Broekman BFP, Hendrix Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900872 137. COVID-19 Imperils Access to Health and Human Services in El Paso, Texas and New York City: Perspectives from Hispanic Parents. J Racial Ethn Health Disparities 2021:1-6Moya EM, Zamore C, Perez LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900584 138. Estimating the prevalence of stress among Indian students during the COVID- 19 pandemic: A cross-sectional study from India. J Taibah Univ Med Sci 2021; 16:260-267Chhetri B, Goyal LM, Mittal M, Battineni G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897332 139. Effects of Age, Gender, Health Status, and Political Party on COVID-19-Related Concerns and Prevention Behaviors: Results of a Large, Longitudinal Cross- sectional Survey. JMIR Public Health Surveill 2021; 7:e24277Naeim A, Baxter-King R, Wenger N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908887 140. Use of Mobile Applications by Pregnant Women and Levels of Pregnancy Distress During the COVID-19 (Coronavirus) Pandemic. Matern Child Health J 2021:1-12Özkan Şat S, Yaman Sözbir Ş. http://www.ncbi.nlm.nih.gov/pubmed/? term=33929653 141. Trajectories of depression and anxiety symptoms during the COVID-19 pandemic in a representative Australian adult cohort. Med. J. Aust. 2021; Batterham PJ, Calear AL, McCallum SM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33899939 142. Subjective cognitive failures and their psychological correlates in a large Italian sample during quarantine/self-isolation for COVID-19. Neurol Sci 2021:1- 11Santangelo G, Baldassarre I, Barbaro A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914195 143. Immediate reactions to the covid-19 pandemic in adults with obsessive- compulsive disorder: a self-report survey. Nord J Psychiatry 2021:1-8Højgaard D, Duholm C, Nissen JB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928838 144. Moral distress in nurses caring for patients with Covid-19. Nurs. Ethics 2021:9697330211003217Silverman HJ, Kheirbek RE, Moscou-Jackson G, Day J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910406 145. The mediating effect of academic engagement between psychological capital and academic burnout among nursing students during the COVID-19 pandemic: A cross-sectional study. Nurse Educ. Today 2021; 102:104938Wang J, Bu L, Li Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934039 146. COVID-19-Related Stress and Anxiety, Body Mass Index, Eating Disorder Symptomatology, and Body Image in Women from Poland: A Cluster Analysis Approach. Nutrients 2021; 13Czepczor-Bernat K, Swami V, Modrzejewska A, Modrzejewska J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924010 147. Psychological interventions during COVID pandemic: Telehealth for individuals with cystic fibrosis and caregivers. Pediatr Pulmonol 2021; Graziano S, Boldrini F, Righelli D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905614 148. Trait mindfulness is negatively associated with distress related to COVID-19. Pers. Individ. Dif. 2021; 179:110955Dillard AJ, Meier BP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907344 149. The association between personality traits and hoarding behavior during the COVID-19 pandemic in Japan. Pers. Individ. Dif. 2021; 179:110927Yoshino S, Shimotsukasa T, Hashimoto Y, Oshio A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897078 150. Structural distress: experiences of moral distress related to structural stigma during the COVID-19 pandemic. Perspect Med Educ 2021:1-8Sukhera J, Kulkarni C, Taylor T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914288 151. Mental wellbeing and perception of health in the era of COVID-19 pandemic: A cross-sectional study in the general population. Perspect. Psychiatr. Care 2021; Gül İ, Yeşiltaş A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931871 152. Evolving Employer-Sponsored Health Care Toward a Post-COVID-19 Marketplace. Popul Health Manag 2021; Sokol MC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902361 153. [Intensive Care Nurses, Psychological Disorders and COVID-19. The COVID IMPACT NATIONAL STUDY]. Prat Anesth Reanim 2021; Caillet A, Allaouchiche B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897261 154. [The COVID-19 implications: the role of stress and stigmatization]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 2021; 29:194-196Mironava K, Lipai TP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901353 155. Psychosocial Impact of COVID-19 Pandemic in Elderly Psychiatric Patients: a Longitudinal Study. Psychiatr. Q. 2021:1-19Seethaler M, Just S, Stötzner P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904123 156. The Role of Event-Related Rumination and Perceived Social Support on Psychological Distress during the COVID-19 Pandemic: Results from Greater Daegu Region in South Korea. Psychiatry Investig 2021; Kang HS, Kim BN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910327 157. The Prevalence of Post-Traumatic Stress Disorder in the General Population during the COVID-19 Pandemic: A Systematic Review and Single-Arm Meta- Analysis. Psychiatry Investig 2021; Zhang L, Pan R, Cai Y, Pan J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910325 158. COVID-19 as a traumatic stressor is an indicator of mental health symptomatology. Psychiatry Res 2021; 300:113936Sommer JL, Mota N, Reynolds K, El-Gabalawy R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901973 159. The emotional impact of the Covid-19 pandemic in women facing infertility. Psychol Health Med 2021:1-7Galhardo A, Carolino N, Monteiro B, Cunha M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913772 160. Posttraumatic stress symptoms among health care workers during the COVID- 19 epidemic: The roles of negative coping and fatigue. Psychol Health Med 2021:1-12Hou T, Yin Q, Cai W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906519 161. Investigation on sleep quality in Chinese medical staff during the COVID-19 pandemic. Psychol Health Med 2021:1-7Jin LR, Zhou S, Yuan H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906538 162. Going Virtual During a Pandemic: An Academic Psychiatry Department's Experience with Telepsychiatry. Psychopharmacol. Bull. 2021; 51:59-68Parikh SV, Taubman DS, Grambeau M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897063 163. A critical narrative of Ecuador's preparedness and response to the COVID-19 pandemic. Public Health Pract (Oxf) 2021; 2:100127Alava JJ, Guevara A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907741 164. Psychological impact during COVID-19 lockdown in children and adolescents with previous mental health disorders. Rev Psiquiatr Salud Ment 2021; Lopez- Serrano J, Díaz-Bóveda R, González-Vallespí L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901700 165. [Not Available]. Rev Psiquiatr Salud Ment 2021; Lopez-Serrano J, Díaz-Bóveda R, González-Vallespí L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901700 166. The immediate impact of lockdown measures on mental health and couples' relationships during the COVID-19 pandemic - results of a representative population survey in Germany. Soc. Sci. Med. 2021; 278:113954Sachser C, Olaru G, Pfeiffer E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932692 167. Overwhelmed by the news: A longitudinal study of prior trauma, posttraumatic stress disorder trajectories, and news watching during the COVID-19 pandemic. Soc. Sci. Med. 2021; 278:113956Solomon Z, Ginzburg K, Ohry A, Mikulincer M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930678 168. Detecting the Relationship between the Stress Levels and Perceived Burnout in Law-enforcement Officers during the COVID-19 Outbreak: A Cross-sectional Study. Soc Work Public Health 2021:1-10Sener H, Arikan I, Gündüz N, Gülekci Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896405 169. COVID-19 pandemic impacts physical activity levels and sedentary time but not sleep quality in young badminton athletes. Sport Sci Health 2021:1-9da Silva Santos AM, Rossi FE, Dos Santos Nunes de Moura HP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903803 170. Well-being and sleep in stressful times of the COVID-19 pandemic: Relations to worrying and different coping strategies. Stress Health 2021; Saalwirth C, Leipold B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913244 171. Association between indoor-outdoor green features and psychological health during the COVID-19 lockdown in Italy: A cross-sectional nationwide study. Urban For Urban Green 2021; 62:127156Spano G, D'Este M, Giannico V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911997 172. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis. Vaccine 2021; Hogan AB, Winskill P, Watson OJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933313 173. Assessing the mental health condition of home-confined university level students of Bangladesh due to the COVID-19 pandemic. Z Gesundh Wiss 2021:1-8Alam MK, Ali FB, Banik R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898164

Meta-analyses - systematic reviews (13 articles)

1. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta- Regression. Clin. Appl. Thromb. Hemost. 2021; 27:10760296211010976Zhan H, Chen H, Liu C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926262 2. COVID-19 pandemic and psychological wellbeing among health care workers and general population: A systematic-review and meta-analysis of the current evidence from India. Clin Epidemiol Glob Health 2021; 11:100737Singh RK, Bajpai R, Kaswan P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898866 3. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia 2021:1- 12Schlesinger S, Neuenschwander M, Lang A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907860 4. Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:624924Bansal V, Mahapure KS, Mehra I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898477 5. Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis. Heliyon 2021; 7:e06677Hossain MM, Rahman M, Trisha NF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898819 6. We're Not Gonna Fall: Depressive Complaints, Personal Resilience, Team Social Climate, and Worries about Infections among Hospital Workers during a Pandemic. Int J Environ Res Public Health 2021; 18Fleuren BPI, Poesen LT, Gifford RE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925036 7. Maternal death related to COVID-19: A systematic review and meta-analysis focused on maternal co-morbidities and clinical characteristics. Int J Gynaecol Obstet 2021; La Verde M, Riemma G, Torella M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930185 8. Mortality escalates in patients of proximal femoral fractures with COVID-19: A systematic review and meta-analysis of 35 studies on 4255 patients. J Clin Orthop Trauma 2021; 18:80-93Patralekh MK, Jain VK, Iyengar KP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897205 9. Clinical Determinants of Severe COVID-19 Disease - A Systematic Review and Meta-Analysis. J. Glob. Infect. Dis. 2021; 13:13-19Sahu AK, Mathew R, Aggarwal P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911447 10. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta- analysis. J Med Virol 2021; Lee J, Song JU. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913533 11. Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis. J Nepal Health Res Counc 2021; 19:1- 9Budhathoki P, Shrestha DB, Khadka S, Rawal E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934125 12. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta- analysis, and meta-regression. Parkinsonism Relat. Disord. 2021; Putri C, Hariyanto TI, Hananto JE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33931304 13. The Prevalence of Post-Traumatic Stress Disorder in the General Population during the COVID-19 Pandemic: A Systematic Review and Single-Arm Meta- Analysis. Psychiatry Investig 2021; Zhang L, Pan R, Cai Y, Pan J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910325

Mortality (32 articles)

1. Impact of COVID-19 on Care-Home Mortality and Life Expectancy in Scotland. Age Ageing 2021; Burton JK, Reid M, Gribben C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914870 2. More stringent measures against COVID-19 are associated with lower cases and deaths in Florida and Miami-Dade. Am J Emerg Med 2021; Piquero AR, Kurland J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931277 3. Can C-Reactive Protein to Albumin Ratio Predict In-Hospital Death Rate Due to COVID-19 in Patients With Hypertension? Angiology 2021:33197211012145Saylik F, Akbulut T, Kaya S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902353 4. Excess of all-cause mortality is only partially explained by COVID-19 in Veneto (Italy) during spring outbreak. BMC Public Health 2021; 21:797Gallo E, Prosepe I, Lorenzoni G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902527 5. An Early Warning Tool for Predicting Mortality Risk of COVID-19 Patients Using Machine Learning. Cognit. Comput. 2021:1-16Chowdhury MEH, Rahman T, Khandakar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897907 6. Mortality Rates of Coronavirus Disease 2019 (COVID-19) Caused by the Novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Cureus 2021; 13:e14081Kandi V, Thungaturthi S, Vadakedath S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903841 7. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico. Cytokine 2021:155543Avila-Nava A, Cortes-Telles A, Torres- Erazo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896708 8. Epidemiology of Confirmed COVID-19 Deaths in Adults, England, March- December 2020. Emerg Infect Dis 2021; 27:1468-1471Brown AE, Heinsbroek E, Kall MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900176 9. Visual lung damage CT score at hospital admission of COVID-19 patients and 30-day mortality. Eur Radiol 2021:1-10Charpentier E, Soulat G, Fayol A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914118 10. Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:624924Bansal V, Mahapure KS, Mehra I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898477 11. Exploring COVID-19 Daily Records of Diagnosed Cases and Fatalities Based on Simple Nonparametric Methods. Infect Dis Rep 2021; 13:302-328Diebner HH, Timmesfeld N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915940 12. Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study. Infect Dis Ther 2021:1-3Janapala RN, Patel J, Belfaqeeh O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914266 13. COVID-19: Asymptomatic Carrier: An Autopsy Case Report. Int J Appl Basic Med Res 2021; 11:120-124Malik Y, Singh K, Yadav S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912436 14. Impact of COVID-19 Pandemic on Total Mortality in Poland. Int J Environ Res Public Health 2021; 18Barański K, Brożek G, Kowalska M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924261 15. Estimation of Excess Mortality and Years of Life Lost to COVID-19 in Norway and Sweden between March and November 2020. Int J Environ Res Public Health 2021; 18Rypdal M, Rypdal K, Løvsletten O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917872 16. Social Distancing Associations with COVID-19 Infection and Mortality Are Modified by Crowding and Socioeconomic Status. Int J Environ Res Public Health 2021; 18VoPham T, Weaver MD, Adamkiewicz G, Hart JE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924821 17. Community Risk Factors in the COVID-19 Incidence and Mortality in Catalonia (Spain). A Population-Based Study. Int J Environ Res Public Health 2021; 18Zaldo-Aubanell Q, Campillo ILF, Bach A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916590 18. COVID-19 related mortality in post-operative cardiac surgical patients. J. Cardiothorac. Surg. 2021; 16:112Hussain A, Khalil A, Kolvekar P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902671 19. Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy. J Clin Med 2021; 10Posteraro B, De Angelis G, Menchinelli G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33920701 20. Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19. J Clin Med 2021; 10Wu CC, Lee AJ, Su CH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916281 21. Pharmacological Predictors of Morbidity and Mortality in COVID-19. J. Clin. Pharmacol. 2021; Oddy C, McCaul J, Keeling P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908637 22. Fragmented QRS on surface electrocardiography as a predictor of cardiac mortality in patients with SARS-CoV-2 infection. J. Electrocardiol. 2021; 66:108- 112Yildirim A, Karaca IO, Yilmaz FK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906057 23. COVID-19-related deaths in residential care homes for elderly: The situation in Italy. J. Forensic Leg. Med. 2021; 80:102179Ventura F, Molinelli A, Barranco R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934045 24. Hemophagocytic lymphohistiocytosis, a new cause of death during 'post- acute COVID-19 syndrome?' A case report. J. Hematop. 2021:1-5Naous E, Nassani BM, Yaghi C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897909 25. Decreased In-Hospital Mortality Associated with Aspirin Administration in Hospitalized Patients Due to Severe COVID-19. J Med Virol 2021; Aghajani MH, Moradi O, Amini H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913549 26. Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong. J. Neurol. Neurosurg. Psychiatry 2021; Fan FSY, Yip TCF, Yiu B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906935 27. Predicting in-Hospital Mortality of Patients with COVID-19 Using Machine Learning Techniques. J Pers Med 2021; 11Tezza F, Lorenzoni G, Azzolina D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923332 28. Actual Racial/Ethnic Disparities in COVID-19 Mortality for the Non-Hispanic Black Compared to Non-Hispanic White Population in 35 US States and Their Association with Structural Racism. J Racial Ethn Health Disparities 2021:1- 13Siegel M, Critchfield-Jain I, Boykin M, Owens A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905110 29. [The characteristics of population mortality of the Russian Federation, the Central Federal Okrug and City of Moscow in 2020]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 2021; 29:189-193Shchepin VO, Khabriev RU. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901352 30. The evolution of the association between community level social capital and COVID-19 deaths and hospitalizations in the United States. Soc. Sci. Med. 2021; 278:113948Borgonovi F, Andrieu E, Subramanian SV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930677 31. COVID-19 mortality analysis from soft-data multivariate curve regression and machine learning. Stoch. Environ. Res. Risk Assess. 2021:1-20Torres-Signes A, Frías MP, Ruiz-Medina MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897300 32. Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2. Viruses 2021; 13Zhao S, Lou J, Chong MKC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918060

Online – IT – Apps (90 articles)

1. Exploring the Relationships Between Resilience and News Monitoring with COVID Distress in Health Profession Students. Acad. Psychiatry 2021:1-9Yu A, Wilkes M, Iosif AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928535 2. An evaluation of social media utilization by general surgery programs in the COVID-19 era. Am. J. Surg. 2021; Fang HA, Boudreau HB, Khan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906728 3. Student perception and the effectiveness of Kahoot!: A scoping review in histology, anatomy and medical education. Anat Sci Educ 2021; Donkin R, Rasmussen R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900041 4. An adaptive blended learning model for the implementation of an integrated medical neuroscience course during the Covid-19 pandemic. Anat Sci Educ 2021; T IN, Goodwin RL, Fowler L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915035 5. Information Overload, Wellbeing and COVID-19: A Survey in China. Behav Sci (Basel) 2021; 11Fan J, Smith AP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925611 6. Recent Advances of Field-Effect Transistor Technology for Infectious Diseases. Biosensors (Basel) 2021; 11Panahi A, Sadighbayan D, Forouhi S, Ghafar-Zadeh E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918325 7. Trust in health information sources and its associations with COVID-19 disruptions to social relationships and health services among people living with HIV. BMC Public Health 2021; 21:817Kalichman SC, Shkembi B, Kalichman MO, Eaton LA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910548 8. Qualitative analysis of visual risk communication on twitter during the Covid- 19 pandemic. BMC Public Health 2021; 21:810Sleigh J, Amann J, Schneider M, Vayena E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906626 9. Improving the evidence base for digital health interventions to increase contraception use. BMJ Health Care Inform 2021; 28Smith C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910924 10. Telemedicine in oculoplastic and adnexal surgery: clinicians' perspectives in the UK. Br J Ophthalmol 2021; Kang S, Raja L, Sim DA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910884 11. An Early Warning Tool for Predicting Mortality Risk of COVID-19 Patients Using Machine Learning. Cognit. Comput. 2021:1-16Chowdhury MEH, Rahman T, Khandakar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897907 12. Social Media Data Analytics for Outbreak Risk Communication: Public Attention on the "New Normal" During the COVID-19 Pandemic in Indonesia. Comput. Methods Programs Biomed. 2021; 205:106083Rahmanti AR, Ningrum DNA, Lazuardi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906012 13. COVID-19 Inspired Relational Telemental Health Services for Incarcerated Individuals and Their Families. Contemp. Fam. Ther. 2021:1-12Tadros E, Aguirre N, Jensen S, Poehlmann-Tynan J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897102 14. Federal, State, and Institutional Barriers to the Expansion of Medication and Telemedicine Abortion Services in Ohio, Kentucky, and West Virginia during the COVID-19 Pandemic. Contraception 2021; Mello K, Smith MH, Hill BJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930382 15. Chronic Inflammatory Demyelinating Polyradiculoneuropathy During the COVID-19 Pandemic: Telemedicine Limitations and Strategies for Improvement. Cureus 2021; 13:e14146Zubair AS, Zubair AS, Desai K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927948 16. Impact of online classes on the satisfaction and performance of students during the pandemic period of COVID 19. Educ Inf Technol (Dordr) 2021:1- 25Gopal R, Singh V, Aggarwal A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33903795 17. COVID 19 response: An analysis of teachers' perception on pedagogical successes and challenges of digital teaching practice during new normal. Educ Inf Technol (Dordr) 2021:1-24Kundu A, Bej T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897267 18. Distance education in COVID-19 pandemic: An evaluation of parent's, child's and teacher's competences. Educ Inf Technol (Dordr) 2021:1-21Öçal T, Halmatov M, Ata S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897269 19. An innovative and authentic way of learning how to consult remotely in response to the COVID-19 pandemic. Educ. Prim. Care 2021:1-6Cannon P, Lumsden L, Wass V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913401 20. A first look at Android applications in Google Play related to COVID-19. Empir Softw Eng 2021; 26:57Samhi J, Allix K, Bissyandé TF, Klein J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903798 21. The COVID-19 Pandemic's Influence on Family Systems Therapists' Provision of Teletherapy. Fam. Process 2021; McKee GB, Pierce BS, Tyler CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913526 22. A Crisis-Responsive Framework for Medical Device Development Applied to the COVID-19 Pandemic. Front Digit Health 2021; 3Antonini MJ, Plana D, Srinivasan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899045 23. Neurologic Music Therapy via Telehealth: A Survey of Clinician Experiences, Trends, and Recommendations During the COVID-19 Pandemic. Front. Neurosci. 2021; 15:648489Cole LP, Henechowicz TL, Kang K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897362 24. Nutritional and Gastroenterological Monitoring of Patients With Celiac Disease During COVID-19 Pandemic: The Emerging Role of Telemedicine and Point-of- Care Gluten Detection Tests. Front Nutr 2021; 8:622514Costantino A, Roncoroni L, Noviello D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928109 25. Attitudes and Perceptions of Telemedicine in Response to the COVID-19 Pandemic: A Survey of Naïve Healthcare Providers. Front Pediatr 2021; 9:647937Schinasi DA, Foster CC, Bohling MK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898361 26. Pediatric Subspecialty Adoption of Telemedicine Amidst the COVID-19 Pandemic: An Early Descriptive Analysis. Front Pediatr 2021; 9:648631Xie J, Prahalad P, Lee TC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928058 27. Workload, Techno Overload, and Behavioral Stress During COVID-19 Emergency: The Role of Job Crafting in Remote Workers. Front. Psychol. 2021; 12:655148Ingusci E, Signore F, Giancaspro ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912116 28. Evaluation of a Short-Term Digital Group Intervention to Relieve Mental Distress and Promote Well-Being Among Community-Dwelling Older Individuals During the COVID-19 Outbreak: A Study Protocol. Front Public Health 2021; 9:577079Shapira S, Yeshua-Katz D, Goren G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898369 29. Speech Interaction to Control a Hands-Free Delivery Robot for High-Risk Health Care Scenarios. Front Robot AI 2021; 8:612750Grasse L, Boutros SJ, Tata MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898530 30. U.S. Political Partisanship and COVID-19: Risk Information Seeking and Prevention Behaviors. Health Commun 2021:1-11Moon WK, Atkinson L, Kahlor LA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906522 31. Student Health Implications of School Closures during the COVID-19 Pandemic: New Evidence on the Association of e-Learning, Outdoor Exercise, and Myopia. Healthcare (Basel) 2021; 9Liu J, Li B, Chen Q, Dang J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922486 32. A Comparative Study on Distancing, Mask and Vaccine Adoption Rates from Global Twitter Trends. Healthcare (Basel) 2021; 9Roy S, Ghosh P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919097 33. A novel approach to anterior segment imaging with smartphones in the COVID-19 era. Indian J Ophthalmol 2021; 69:1257-1262Dutt S, Vadivel SS, Nagarajan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913872 34. A Proposed Sentiment Analysis Deep Learning Algorithm for Analyzing COVID-19 Tweets. Inf Syst Front 2021:1-13Kaur H, Ahsaan SU, Alankar B, Chang V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897274 35. Sentimental Analysis of COVID-19 Tweets Using Deep Learning Models. Infect Dis Rep 2021; 13:329-339Chintalapudi N, Battineni G, Amenta F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916139 36. Implementation of a telemedicine service during COVID-19 pandemic in Pakistan. Int J Clin Pract 2021:e14310Nagra MH, Ehsan S, Ahmad U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932075 37. Associations between Google Search Trends for Symptoms and COVID-19 Confirmed and Death Cases in the United States. Int J Environ Res Public Health 2021; 18Abbas M, Morland TB, Hall ES, El-Manzalawy Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923094 38. Telemedicine Chronic Viral Hepatitis C Treatment during the Lockdown Period in Romania: A Pilot Study. Int J Environ Res Public Health 2021; 18Doica IP, Florescu DN, Oancea CN et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33916226 39. A Study of the Effects of the COVID-19 Pandemic on the Experience of Back Pain Reported on Twitter(®) in the United States: A Natural Language Processing Approach. Int J Environ Res Public Health 2021; 18Fiok K, Karwowski W, Gutierrez E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922924 40. Protocol for the Implementation and Assessment of "MoodUP": A Stepped Care Model Assisted by a Digital Platform to Accelerate Access to Mental Health Care for Cancer Patients Amid the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Frasquilho D, Matias R, Grácio J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925412 41. The Impact of Health Information Exposure and Source Credibility on COVID- 19 Vaccination Intention in Germany. Int J Environ Res Public Health 2021; 18Gehrau V, Fujarski S, Lorenz H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33924796 42. The Impact of COVID-19 on Sport in Twitter: A Quantitative and Qualitative Content Analysis. Int J Environ Res Public Health 2021; 18González LM, Devís- Devís J, Pellicer-Chenoll M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923042 43. The Role of Conspiracy Theories in the Spread of COVID-19 across the United States. Int J Environ Res Public Health 2021; 18Gu F, Wu Y, Hu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917575 44. Uptake of Tele-Rehabilitation in Finland amongst Rehabilitation Professionals during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Heiskanen T, Rinne H, Miettinen S, Salminen AL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924234 45. Translating Co-Design from Face-to-Face to Online: An Australian Primary Producer Project Conducted during COVID-19. Int J Environ Res Public Health 2021; 18Kennedy A, Cosgrave C, Macdonald J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919920 46. The Enabling Role of ICT to Mitigate the Negative Effects of Emotional and Social Loneliness of the Elderly during COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Llorente-Barroso C, Kolotouchkina O, Mañas-Viniegra L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917966 47. "At Least until the Second Wave Comes…": A Twitter Analysis of the NHS and COVID-19 between March and June 2020. Int J Environ Res Public Health 2021; 18McKay K, Wayland S, Ferguson D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918586 48. Application of Artificial Intelligence-Based Regression Methods in the Problem of COVID-19 Spread Prediction: A Systematic Review. Int J Environ Res Public Health 2021; 18Musulin J, Baressi Šegota S, Štifanić D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919496 49. Use of Digital Media for Home-Based Sports Activities during the COVID-19 Pandemic: Results from the German SPOVID Survey. Int J Environ Res Public Health 2021; 18Mutz M, Müller J, Reimers AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919180 50. The Effectiveness of the Blended Learning in Conservative Dentistry with Endodontics on the Basis of the Survey among 4th-Year Students during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Nijakowski K, Lehmann A, Zdrojewski J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923047 51. Recreational Screen Time Behaviors during the COVID-19 Pandemic in the U.S.: A Mixed-Methods Study among a Diverse Population-Based Sample of Emerging Adults. Int J Environ Res Public Health 2021; 18Wagner BE, Folk AL, Hahn SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925317 52. COVID-19 and Health Information Seeking Behavior: Digital Health Literacy Survey amongst University Students in Pakistan. Int J Environ Res Public Health 2021; 18Zakar R, Iqbal S, Zakar MZ, Fischer F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920404 53. Depressive symptoms in community-dwelling older adults in Japan before and during the COVID-19 pandemic. Int. J. Geriatr. Psychiatry 2021; Aihara Y, Kiyoshi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931892 54. The impact of increased outpatient telehealth during COVID-19: Retrospective analysis of patient survey and routine activity data from a major healthcare system in England. Int. J. Health Plann. Manage. 2021; Tyler JMB, Pratt AC, Wooster J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913190 55. Telemedicine use in Sub-Saharan Africa: Barriers and policy recommendations for Covid-19 and beyond. Int. J. Med. Inform. 2021; 151:104467Dodoo JE, Al-Samarraie H, Alzahrani AI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915421 56. IgM anti-SARS-CoV-2-specific determination: useful or confusing? Big Data analysis of a real-life scenario. Intern Emerg Med 2021; Trenti T, Pecoraro V, Pirotti T, Plebani M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934298 57. Patient satisfaction with hidradenitis suppurativa televisits correlates with less severe disease. J Am Acad Dermatol 2021; Andriano TM, Babbush KM, Nosrati A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901569 58. Proceedings From an International Virtual Townhall: Reflecting on the COVID- 19 Pandemic: Themes From Long-Term Care. J. Am. Med. Dir. Assoc. 2021; Heckman GA, Kay K, Morrison A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33932351 59. Rehabilitation guidance for hip fracture patients during the COVID-19 pandemic using chat software: A new model. J. Back Musculoskelet. Rehabil. 2021; Gao SS, Wang YJ, Zhang GX, Zhang WT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896813 60. Comparative study of machine learning methods for COVID-19 transmission forecasting. J. Biomed. Inform. 2021:103791Dairi A, Harrou F, Zeroual A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915272 61. Global digital social learning as a strategy to promote engagement in the era of COVID-19. J. Clin. Nurs. 2021; Davidson PM, Lin CJ, Beaman A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904196 62. An academic-practice partnership during COVID-19 pandemic: Transitioning from a clinical to virtual fellowship. J. Clin. Nurs. 2021; Gillett C, Mason S, Fleming L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913557 63. Telepsychotherapy During the COVID-19 Pandemic: The Experience of Lebanese Mental Health Professionals. J Contemp Psychother 2021:1-7Tohme P, De Witte NAJ, Van Daele T, Abi-Habib R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33903776 64. Simulation Centers and Simulation-Based Education during the Time of COVID 19: A Multi-Center Best Practice Position Paper by the World Academic Council of Emergency Medicine. J. Emerg. Trauma Shock 2021; 14:3-13Lateef F, Suppiah M, Chandra S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911429 65. Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape. J Pers Med 2021; 11Chatterjee A, Nardi C, Oberije C, Lambin P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919882 66. Predicting in-Hospital Mortality of Patients with COVID-19 Using Machine Learning Techniques. J Pers Med 2021; 11Tezza F, Lorenzoni G, Azzolina D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923332 67. Going virtual for EAPM 2021. J. Psychosom. Res. 2021:110499Fiedorowicz JG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896645 68. Mental Health and Endocrine Telemedicine Consultations in Transgender Subjects During the COVID-19 Outbreak in Italy: A Cross-Sectional Web-Based Survey. J. Sex. Med. 2021; Gava G, Fisher AD, Alvisi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903046 69. Evaluating the effectiveness of an online faculty development programme for nurse educators about remote teaching during COVID-19. J Taibah Univ Med Sci 2021; 16:268-273Swaminathan N, Govindharaj P, Jagadeesh NS, Ravichandran L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897333 70. Use of Mobile Applications by Pregnant Women and Levels of Pregnancy Distress During the COVID-19 (Coronavirus) Pandemic. Matern Child Health J 2021:1-12Özkan Şat S, Yaman Sözbir Ş. http://www.ncbi.nlm.nih.gov/pubmed/? term=33929653 71. Mathematical model optimized for prediction and health care planning for COVID-19. Med. Intensiva 2021; Garrido JM, Martínez-Rodríguez D, Rodríguez- Serrano F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926752 72. Comments on "Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations" by D'Amato et al. Multidiscip Respir Med 2021; 16:757Adiletta G, Baglioni S, Bettoncelli G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907625 73. Turning a New Chapter in Neurosurgery Outpatient Services: Telemedicine A "Savior" in this Pandemic. Neurol. India 2021; 69:344-351Raheja A, Manjunath N, Garg K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904449 74. Evaluation of E-Health Applications for Paediatric Patients with Refractory Epilepsy and Maintained on Ketogenic Diet. Nutrients 2021; 13Costa AM, Marchiò M, Bruni G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918854 75. Managing Obesity in Lockdown: Survey of Health Behaviors and Telemedicine. Nutrients 2021; 13Minsky NC, Pachter D, Zacay G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921602 76. Boosting positive mood in medical and emergency personnel during the COVID-19 pandemic: preliminary evidence of efficacy, feasibility and acceptability of a novel online ambulatory intervention. Occup. Environ. Med. 2021; Coifman KG, Disabato DD, Seah THS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903280 77. COVID-19 has changed the way we think about training future pediatric hematologists/oncologists. Pediatr Blood Cancer 2021:e29088Moerdler S, Gampel B, Levine JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913620 78. Psychological interventions during COVID pandemic: Telehealth for individuals with cystic fibrosis and caregivers. Pediatr Pulmonol 2021; Graziano S, Boldrini F, Righelli D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905614 79. Utilizing Artificial Intelligence to Manage COVID-19 Scientific Evidence Torrent with Risklick AI: A Critical Tool for Pharmacology and Therapy Development. Pharmacology 2021:1-10Haas Q, Alvarez DV, Borissov N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910199 80. Developing a blended learning postgraduate teaching programme in anaesthesia: pandemic and beyond. Postgrad. Med. J. 2021; Cooke PC, Hajamohideen N, Gooneratne H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33931560 81. The digital divide behind the news spread of novel coronavirus. Procedia Comput Sci 2021; 183:820-826Dong H, Cao X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897915 82. Going Virtual During a Pandemic: An Academic Psychiatry Department's Experience with Telepsychiatry. Psychopharmacol. Bull. 2021; 51:59-68Parikh SV, Taubman DS, Grambeau M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897063 83. Disputes over the production and dissemination of misinformation in the time of COVID-19. Respir. Med. 2021; 182:106380Cazzola M, de Novellis V, Bianco A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930690 84. Machine Learning and Deep Learning Approaches to Analyze and Detect COVID-19: A Review. SN Comput Sci 2021; 2:226Aishwarya T, Ravi Kumar V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899005 85. Smart Simon Bot with Public Sentiment Analysis for Novel Covid-19 Tweets Stratification. SN Comput Sci 2021; 2:227Ramya BN, Shetty SM, Amaresh AM, Rakshitha R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907735 86. Proactive Teleconsultation for Coronavirus Disease 2019 Cases Identified Through the Community-Testing Initiative in Karachi, Pakistan: A Low-Cost Value-Added Service to Support a Pandemic Response in a Resource-Limited Setting. Telemed J E Health 2021; Moosa S, Shah S, Mohiuddin AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913786 87. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis. Vaccine 2021; Hogan AB, Winskill P, Watson OJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933313 88. #Scamdemic, #Plandemic, or #Scaredemic: What Parler Social Media Platform Tells Us about COVID-19 Vaccine. Vaccines (Basel) 2021; 9Baines A, Ittefaq M, Abwao M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922343 89. Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing. Vaccines (Basel) 2021; 9Evans WD, French J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915695 90. Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands. Value Health 2021; 24:658-667Mouter N, Collewet M, de Wit GA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933234

Other – Miscellaneous (127 articles)

1. Metal-Free Multilayer Hybrid PENG Based on Soft Electrospun/-Sprayed Membranes with Cardanol Additive for Harvesting Energy from Surgical Face Masks. ACS Appl Mater Interfaces 2021; Mariello M, Qualtieri A, Mele G, De Vittorio M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896167 2. Adherence to subcutaneous immunotherapy with aeroallergens in real-life practice during the COVID-19 pandemic. Allergy 2021; Yeğit OO, Demir S, Ünal D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904166 3. Capturing Beneficial Changes to Racehorse Veterinary Care Implemented during the COVID-19 Pandemic. Animals (Basel) 2021; 11Butler D, Upton L, Mullan S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926093 4. Response of UK Horse, Pony and Donkey Owners to the Early Stages of the COVID-19 Pandemic. Animals (Basel) 2021; 11Hockenhull J, Bell C, White J, Rogers S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922408 5. Meat Demand Monitor during COVID-19. Animals (Basel) 2021; 11Tonsor GT, Lusk JL, Tonsor SL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917222 6. The National Institute of Health and the Italian Poison Centers Network: results of a collaborative study for the surveillance of exposures to chemicals. Ann. Ig. 2021; Giordano F, Pennisi L, Fidente RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908599 7. Knowledge, attitudes, and practices towards COVID-19 among residents of Bosnia and Herzegovina during the first stage of COVID-19 outbreak. Ann. Ig. 2021; 33:371-380Šljivo A, Kačamaković M, Siručić I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908602 8. The role of meat appetite in willfully disregarding factory farming as a pandemic catalyst risk. Appetite 2021:105279Dhont K, Piazza J, Hodson G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930493 9. "Watching the tsunami come": A case study of female healthcare provider experiences during the COVID-19 pandemic. Appl Psychol Health Well Being 2021; Austin EJ, Blacker A, Kalia I. http://www.ncbi.nlm.nih.gov/pubmed/? term=33929103 10. Assessing the Impact of COVID-19 on Work-Related Quality of Life through the Lens of Sexual Orientation. Behav Sci (Basel) 2021; 11Mendes C, Pereira H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922411 11. Testing of human equivalent dose of health food 5-aminolevulinic acid using the experimental pig. Biomed. Pharmacother. 2021; 139:111629Kobayashi E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906080 12. The impact of COVID-19 social distancing and isolation recommendations for Muslim communities in North West England. BMC Public Health 2021; 21:812Hassan SM, Ring A, Tahir N, Gabbay M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910534 13. Maintaining Essential Nutrition Services to Underfive Children in Yemen: A Programmatic Adaptation Amidst the COVID-19 Pandemic. Children (Basel) 2021; 8Coulibaly-Zerbo F, Al-Jawaldeh A, Prinzo ZCW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925020 14. Changes in Seasonal Respiratory Illnesses in the United States During the COVID-19 Pandemic. Clin Infect Dis 2021; Rodgers L, Sheppard M, Smith A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912902 15. Meal and Sleep Timing before and during the COVID-19 Pandemic: A Cross- Sectional Anonymous Survey Study from Sweden. Clocks Sleep 2021; 3:251- 258Benedict C, Brandão LEM, Merikanto I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921946 16. Greasing the wheels: The impact of COVID-19 on US physician attitudes and practices regarding medication abortion. Contraception 2021; Karlin J, Sarnaik S, Holt K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932400 17. Discourse of the Post-COVID 19 New Deal in South Korea. East Asia (Piscataway) 2021:1-16Yoon K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897253 18. Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands. Emerg Infect Dis 2021; 27:1362-1370Zhao S, Schuurman N, Li W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900184 19. Persistent high PM(2.5) pollution driven by unfavorable meteorological conditions during the COVID-19 lockdown period in the Beijing-Tianjin-Hebei Region, China. Environ. Res. 2021:111186Sulaymon ID, Zhang Y, Hopke PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930403 20. Investigating the roles of meteorological factors in COVID-19 transmission in Northern Italy. Environ. Sci. Pollut. Res. Int. 2021:1-12Khursheed A, Mustafa F, Akhtar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907953 21. Climate change during the COVID-19 outbreak: scoping future perspectives. Environ. Sci. Pollut. Res. Int. 2021; Usman M, Husnain M, Riaz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934308 22. Environmental implications of reduced electricity consumption in Wuhan during COVID-19 outbreak: A brief study. Environ Technol Innov 2021; 23:101578Xu X, Zhang W, Yin Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898658 23. No country or continent is on its own in the ongoing COVID-19 pandemic. Euro Surveill 2021; 26Johansen K, Nohynek H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33928901 24. Outbreaks and Outgroups: Three Tests of the Relationship Between Disease Avoidance Motives and Xenophobia During an Emerging Pandemic. Evol Psychol Sci 2021:1-11Moran JB, Goh JX, Kerry N, Murray DR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903849 25. Impacts of COVID-19 outbreak on the spillovers between US and Chinese stock sectors. Financ Res Lett 2021; 40:101922Hanif W, Mensi W, Vo XV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897307 26. The Past in the Present: What our Ancestors Taught us about Surviving Pandemics. Food Ethics 2021; 6:7Valle GR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33898736 27. Impact of COVID-19 Pandemic on Willingness to Consume Insect-Based Food Products in Catalonia. Foods 2021; 10Khalil R, Kallas Z, Haddarah A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917989 28. Exploring Dietary Behavior Changes Due to the COVID-19 Confinement in Colombia: A National and Regional Survey Study. Front Nutr 2021; 8:644800Pertuz-Cruz SL, Molina-Montes E, Rodríguez-Pérez C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912582 29. Adaptive Managers as Emerging Leaders During the COVID-19 Crisis. Front. Psychol. 2021; 12:661628Bajaba A, Bajaba S, Algarni M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927672 30. Training in Rhythmic Gymnastics During the Pandemic. Front. Psychol. 2021; 12:658872Bobo-Arce M, Sierra-Palmeiro E, Fernández-Villarino MA, Fink H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897567 31. Physical Activity Is Associated With Improved Eating Habits During the COVID-19 Pandemic. Front. Psychol. 2021; 12:664568Christofaro DGD, Werneck AO, Tebar WR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912120 32. Awareness of COVID-19 Before and After Quarantine Based on Crowdsourced Data From Rabigh City, Saudi Arabia: A Cross-Sectional and Comparative Study. Front Public Health 2021; 9:632024Aldhahri M, Alghamdi R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898375 33. Health, Transport and the Environment: The Impacts of the COVID-19 Lockdown on Air Pollution. Front Public Health 2021; 9:637540De Maria L, Caputi A, Tafuri S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928063 34. Inclusive Finance, Environmental Regulation, and Public Health in China: Lessons for the COVID-19 Pandemic. Front Public Health 2021; 9:662166Liu X, Guo S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912533 35. Determinants of Tourism Stocks During the COVID-19: Evidence From the Deep Learning Models. Front Public Health 2021; 9:675801Pan WT, Huang QY, Yang ZY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898386 36. Societal Impacts of Pandemics: Comparing COVID-19 With History to Focus Our Response. Front Public Health 2021; 9:630449Patterson GE, McIntyre KM, Clough HE, Rushton J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912529 37. Impact of COVID-19 Pandemic on Life-Space Mobility of Older Adults Living in Brazil: REMOBILIZE Study. Front Public Health 2021; 9:643640Perracini MR, de Amorim JSC, Lima CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898378 38. Frequency, Stressfulness and Type of Ethically Challenging Situations Encountered by Veterinary Team Members During the COVID-19 Pandemic. Front Vet Sci 2021; 8:647108Quain A, Mullan S, McGreevy PD, Ward MP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912607 39. Aislamiento comunitario como estrategia para la mitigación de un brote de COVID-19: el caso de Villa Azul. Glob Health Promot 2021:17579759211007120Esposito M, Bustos S, Cardonetti L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926337 40. The feminist political economy of Covid-19: Capitalism, women, and work. Glob Public Health 2021:1-15Cohen J, van der Meulen Rodgers Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905301 41. Pandemic momentum for health systems financialisation: Under the cloaks of Universal Health Coverage. Glob Public Health 2021:1-12López Cabello A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905312 42. The role of religion in mitigating the COVID-19 pandemic: the Malaysian multi- faith perspectives. Health Promot. Int. 2021; Tan MM, Musa AF, Su TT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928389 43. Anti-Immigrant Rhetoric, Deteriorating Health Access, and COVID-19 in the Rio Grande Valley, Texas. Health Secur 2021; Blackburn CC, Sierra LA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926220 44. Reducing Financial Barriers for Households Due to COVID-19: The Case in India. Health Syst Reform 2021; 7:e1897323Kabaniha GA, Gedam P, Bekedam H, Bhushan I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914672 45. Beyond COVID-19 Pandemic: An Integrative Review of Global Health Crisis Influencing the Evolution and Practice of Corporate Social Responsibility. Healthcare (Basel) 2021; 9Asante Antwi H, Zhou L, Xu X, Mustafa T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921512 46. Mapping Evidence of Impacts of COVID-19 Outbreak on Sexual and Reproductive Health: A Scoping Review. Healthcare (Basel) 2021; 9Bolarinwa OA, Ahinkorah BO, Seidu AA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33917784 47. Physical Activity during COVID-19 Lockdown: Data from An Italian Survey. Healthcare (Basel) 2021; 9Guidetti M, Averna A, Castellini G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925257 48. On shaping expectations of "new normals" for living in a post-COVID-19 world. Hist Philos Life Sci 2021; 43:65Leeming W. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929631 49. Counting the dead and making the dead count: configuring data and accountability. Hist Philos Life Sci 2021; 43:62Rappert B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900513 50. One Health, "Disease X" & the challenge of "Unknown" Unknowns. Indian J Med Res 2021; 153:264-271Chatterjee P, Nair P, Chersich M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906988 51. COVID-19 and Infection Disease and Health. Infect Dis Health 2021; Mitchell BG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931364 52. The impact of COVID-19 on development assistance. Int J 2021; 76:42-54Brown S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896998 53. The Impact of Reduced Training Activity of Elite Kickboxers on Physical Fitness, Body Build, and Performance during Competitions. Int J Environ Res Public Health 2021; 18Ambroży T, Rydzik Ł, Obmiński Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923913 54. Sink or Swim: Virtual Life Challenges among African American Families during COVID-19 Lockdown. Int J Environ Res Public Health 2021; 18Anakwe A, Majee W, Noel-London K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33919524 55. Feasibility of an Outpatient Training Program after COVID-19. Int J Environ Res Public Health 2021; 18Betschart M, Rezek S, Unger I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918887 56. Impact of COVID-19 on Healthcare Labor Market in the United States: Lower Paid Workers Experienced Higher Vulnerability and Slower Recovery. Int J Environ Res Public Health 2021; 18Bhandari N, Batra K, Upadhyay S, Cochran C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917682 57. Impact of Meteorological Conditions on the Dynamics of the COVID-19 Pandemic in Poland. Int J Environ Res Public Health 2021; 18Bochenek B, Jankowski M, Gruszczynska M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918658 58. Emission Variations of Primary Air Pollutants from Highway Vehicles and Implications during the COVID-19 Pandemic in Beijing, China. Int J Environ Res Public Health 2021; 18Cao X, Tian Y, Shen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921210 59. Post-Pandemic Patient Safety Culture: A Case from a Large Metropolitan Hospital Group in Taiwan. Int J Environ Res Public Health 2021; 18Chen HY, Lu L, Ko YM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923352 60. Does COVID-19 Affect the Behavior of Buying Fresh Food? Evidence from Wuhan, China. Int J Environ Res Public Health 2021; 18Chen J, Zhang Y, Zhu S, Liu L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922354 61. COVID-19 Pandemic and Quality of Life among Romanian Athletes. Int J Environ Res Public Health 2021; 18Cosma GA, Chiracu A, Stepan AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921546 62. Changes to Physical Activity during a Global Pandemic: A Mixed Methods Analysis among a Diverse Population-Based Sample of Emerging Adults in the U.S. Int J Environ Res Public Health 2021; 18Folk AL, Wagner BE, Hahn SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915944 63. COVID-19 and Recreational Skiing: Results of a Rapid Systematic Review and Possible Preventive Measures. Int J Environ Res Public Health 2021; 18Gianfredi V, Mauer NS, Gentile L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923960 64. Social Inequalities in Health Determinants in Spanish Children during the COVID-19 Lockdown. Int J Environ Res Public Health 2021; 18González-Rábago Y, Cabezas-Rodríguez A, Martín U. http://www.ncbi.nlm.nih.gov/pubmed/? term=33924441 65. Risk Assessment of the SME Sector Operations during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Grondys K, Ślusarczyk O, Hussain HI, Androniceanu A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920916 66. Effects of Home Confinement on the Intensity of Physical Activity during the COVID-19 Outbreak in Team Handball According to Country, Gender, Competition Level, and Playing Position: A Worldwide Study. Int J Environ Res Public Health 2021; 18Hermassi S, Bouhafs EG, Bragazzi NL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921377 67. Impact of the COVID-19 Lockdown Measures on Noise Levels in Urban Areas- A Pre/during Comparison of Long-Term Sound Pressure Measurements in the Ruhr Area, Germany. Int J Environ Res Public Health 2021; 18Hornberg J, Haselhoff T, Lawrence BT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925635 68. Perceiving Social-Emotional Volatility and Triggered Causes of COVID-19. Int J Environ Res Public Health 2021; 18Jiang S, Zhang H, Qi J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926072 69. Does International Travel Frequency Affect COVID-19 Biosecurity Behavior in the United States? Int J Environ Res Public Health 2021; 18Kim MJ, Hall CM, Bonn M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924641 70. Fluctuations in National Resilience during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Kimhi S, Eshel Y, Marciano H, Adini B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917101 71. Impact of the COVID-19 Pandemic on Teacher Quality of Life: A Longitudinal Study from before and during the Health Crisis. Int J Environ Res Public Health 2021; 18Lizana PA, Vega-Fernadez G, Gomez-Bruton A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916544 72. Evaluations of Muscular Strength, Ability to Balance and Health Status in Prisoners during COVID-19. Int J Environ Res Public Health 2021; 18Moffa S, Perna A, Cattolico A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921737 73. Job Demands, Resources and Strains of Outpatient Caregivers during the COVID-19 Pandemic in Germany: A Qualitative Study. Int J Environ Res Public Health 2021; 18Mojtahedzadeh N, Wirth T, Nienhaus A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916134 74. The Influence of Internal Marketing and Job Satisfaction on Task Performance and Counterproductive Work Behavior in an Emerging Market during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Nemteanu MS, Dabija DC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915926 75. Impact of the COVID-19 Pandemic on Physical Activity and Sedentary Behaviour: A Qualitative Study in a Canadian City. Int J Environ Res Public Health 2021; 18Petersen JA, Naish C, Ghoneim D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922094 76. Indoor Air Quality in Domestic Environments during Periods Close to Italian COVID-19 Lockdown. Int J Environ Res Public Health 2021; 18Pietrogrande MC, Casari L, Demaria G, Russo M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921463 77. The Economic Impact of the SARS-COV-2 (COVID-19) Pandemic in Spain. Int J Environ Res Public Health 2021; 18Pinilla J, Barber P, Vallejo-Torres L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925185 78. Changes in Alcohol Consumption during the COVID-19 Pandemic-Small Change in Total Consumption, but Increase in Proportion of Heavy Drinkers. Int J Environ Res Public Health 2021; 18Rossow I, Bye EK, Moan IS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923567 79. 'I'm Gonna Tell You about How Mrs Rona Has Affected Me'. Exploring Young People's Experiences of the COVID-19 Pandemic in North East England: A Qualitative Diary-Based Study. Int J Environ Res Public Health 2021; 18Scott S, McGowan VJ, Visram S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917557 80. Spatial and Social Behavior of Single and Coupled Individuals of Both Sexes during COVID-19 Lockdown Regime in Russia. Int J Environ Res Public Health 2021; 18Semenova O, Apalkova J, Butovskaya M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920747 81. The Impact of COVID-19 Lockdown on Health Behaviors among Students of a French University. Int J Environ Res Public Health 2021; 18Tavolacci MP, Wouters E, Van de Velde S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923943 82. Economic Role of Population Density during Pandemics-A Comparative Analysis of Saudi Arabia and China. Int J Environ Res Public Health 2021; 18Yusuf N, Shesha LS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921729 83. Individual-Level Determinants of Lifestyle Behavioral Changes during COVID- 19 Lockdown in the United States: Results of an Online Survey. Int J Environ Res Public Health 2021; 18Zhang X, Oluyomi A, Woodard L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924056 84. Does the End Justify the Means? The Role of Organizational Communication among Work-from-Home Employees during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Zito M, Ingusci E, Cortese CG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918095 85. Impact of the COVID-19 pandemic on the food rations of refugees in Rwanda. Int J Equity Health 2021; 20:107Manirambona E, Uwizeyimana T, Uwiringiyimana E, Reddy H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902619 86. Income-related health inequality among Chinese adults during the COVID-19 pandemic: evidence based on an online survey. Int J Equity Health 2021; 20:106Nie P, Ding L, Chen Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902603 87. "Apples and Oranges:" Examining Different Social Groups' Compliance With Government Health Instructions During the COVID-19 Pandemic. Int J Health Policy Manag 2021; Goren T, Vashdi DR, Beeri I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904702 88. COVID-19 Lockdown and Social Capital Changes Among Youths in China. Int J Health Policy Manag 2021; Luo M, Zhang D, Shen P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904698 89. Taking Care of Business: Privileging Private Sector Hospitals During the COVID Crisis. Int J Health Serv 2021:207314211012147Player SD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913354 90. Exposure to air pollution and COVID-19 severity: a review of current insights, management and challenges. Integr. Environ. Assess. Manag. 2021; Ali N, Fariha KA, Islam F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913626 91. Technical note: Understanding the effect of COVID-19 on particle pollution using a low-cost sensor network. J Aerosol Sci 2021; 155:105766Chadwick E, Le K, Pei Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897001 92. The Impact of Lockdown on Couples' Sex Lives. J Clin Med 2021; 10Costantini E, Trama F, Villari D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915856 93. Public Concerns during the COVID-19 Lockdown: A Multicultural Cross- Sectional Study among Internet Survey Respondents in Three Countries. J Clin Med 2021; 10Emodi-Perlman A, Eli I, Uziel N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918017 94. Health impacts of daily weather fluctuations: Empirical evidence from COVID- 19 in U.S. counties. J. Environ. Manage. 2021; 291:112662Emediegwu LE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930636 95. Rigorous quantification of statistical significance of the COVID-19 lockdown effect on air quality: The case from ground-based measurements in Ontario, Canada. J. Hazard. Mater. 2021; 413:125445Al-Abadleh HA, Lysy M, Neil L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930965 96. Does holding elections during a Covid-19 pandemic put the lives of politicians at risk? J. Health Econ. 2021; 78:102462Bach L, Guillouzouic A, Malgouyres C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915491 97. Change in eating habits and physical activities before and during the COVID- 19 pandemic in Hong Kong: a cross-sectional study via random telephone survey. J. Int. Soc. Sports Nutr. 2021; 18:33Wang J, Yeoh EK, Yung TKC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910582 98. A supply chain disruption recovery strategy considering product change under COVID-19. J Manuf Syst 2021; Chen J, Wang H, Zhong RY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911327 99. Additive manufacturing and the COVID-19 challenges: An in-depth study. J Manuf Syst 2021; Tareq MS, Rahman T, Hossain M, Dorrington P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897085 100. Road to recovery: Managing an epidemic. J Math Econ 2021; 93:102482Loertscher S, Muir EV. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897087 101. Unweighted lotteries and compounding injustice: reply to Schmidt et al. J. Med. Ethics 2021; Miller Tate AJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=33910973 102. Possible Effects of Air Temperature on COVID-19 Disease Severity and Transmission Rates. J Med Virol 2021; Kang D, Ellgen C, Kulstad E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913555 103. Dungaw: Re-imagined Religious Expression in Response to the COVID-19 Pandemic. J Relig Health 2021:1-21F ADC, Del Castillo CD, Corpuz JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905005 104. COVID-19 and prejudice against migrants: the mediating roles of need for cognitive closure and binding moral foundations. A comparative study. J. Soc. Psychol. 2021:1-15Bianco F, Kosic A, Pierro A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906584 105. Estimating marine plastic pollution from COVID-19 face masks in coastal regions. Mar. Pollut. Bull. 2021; 168:112419Chowdhury H, Chowdhury T, Sait SM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930644 106. Current Status of Putative Animal Sources of SARS-CoV-2 Infection in Humans: Wildlife, Domestic Animals and Pets. Microorganisms 2021; 9Maurin M, Fenollar F, Mediannikov O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33920724 107. Moments in autophagy and disease: Past and present. Mol. Aspects Med. 2021:100966Wen X, Yang Y, Klionsky DJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=33931245 108. The effect of Covid-19 on ethical sensitivity. Nurs. Ethics 2021:9697330211003231Mert S, Sayilan AA, Karatoprak AP, Baydemir C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910398 109. Effect of COVID-19 Lockdown on Dietary Habits and Lifestyle of Food Science Students and Professionals from Spain. Nutrients 2021; 13Celorio-Sardà R, Comas-Basté O, Latorre-Moratalla ML et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33924965 110. Composition and Nutritional Quality of the Diet in Spanish Households during the First Wave of the COVID-19 Pandemic. Nutrients 2021; 13Del Pozo de la Calle S, Alonso Ledesma I, Nuñez O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923258 111. Social Distancing in Chronic Migraine during the COVID-19 Outbreak: Results from a Multicenter Observational Study. Nutrients 2021; 13Di Stefano V, Ornello R, Gagliardo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921674 112. An Italian Survey on Dietary Habits and Changes during the COVID-19 Lockdown. Nutrients 2021; 13Izzo L, Santonastaso A, Cotticelli G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916384 113. Physical Activity, Sedentariness, Eating Behaviour and Well-Being during a COVID-19 Lockdown Period in Greek Adolescents. Nutrients 2021; 13Morres ID, Galanis E, Hatzigeorgiadis A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923341 114. Consequences of the COVID-19 Syndemic for Nutritional Health: A Systematic Review. Nutrients 2021; 13Neira C, Godinho R, Rincón F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916087 115. Coronavirus Disease 19 from the Perspective of Ageing with Focus on Nutritional Status and Nutrition Management-A Narrative Review. Nutrients 2021; 13Rothenberg E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919840 116. The impact of Covid-19 pandemic: A review on maritime sectors in Malaysia. Ocean Coast Manag 2021; 209:105638Menhat M, Mohd Zaideen IM, Yusuf Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897122 117. Coronavirus Disease 19 and Future Ecological Crises: Hopes from Epigenomics and Unraveling Genome Regulation in Humans and Infectious Agents. OMICS 2021; Dzobo K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33904782 118. Impact of COVID-19 on peoples' willingness to consume wild animals: Empirical insights from China. One Health 2021; 12:100240Si R, Lu Q, Aziz N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898724 119. World Health Organization High Priority Pathogens: Ophthalmic Disease Findings and Vision Health Perspectives. Pathogens 2021; 10Kuthyar S, Anthony CL, Fashina T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917710 120. Learnings from Health Behavioural Survey Practices in France and Belgium During the First COVID-19 Stay-at-Home Order. Patient Prefer Adherence 2021; 15:807-809Pétré B, Kirkove D, de Andrade V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897257 121. Stigmatization spreads faster than the virus. Viruses do not discriminate, and neither should we." Combatting the stigmatization surrounding coronavirus disease (COVID-19) pandemic. Perspect. Psychiatr. Care 2021; Ozturk A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931855 122. [The impact of COVID-19 pandemic on medical tourism development]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 2021; 29:203-205Ananchenkova PI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901355 123. [The trends and perspectives of development of medical tourism]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 2021; 29:206-212Zakharova EN, Gisina OG, Kalnitskaya OV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901356 124. COVID-19 lockdowns show reduced pollution on snow and ice in the Indus River Basin. Proc Natl Acad Sci U S A 2021; 118Bair E, Stillinger T, Rittger K, Skiles M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903254 125. "It's so tough for us now" - COVID-19 has negatively impacted religious practices relating to death among minority ethnic groups. Public Health 2021; 194:146-148Routen A, Darko N, Willis A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906088 126. Regional differences in the impact of the COVID-19 pandemic on food sufficiency in California, April-July, 2020: Implications for food programs and policies. Public Health Nutr. 2021:1-23Blumenberg E, Pinski M, Nhan LA, Wang MC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928894 127. Urban greenery cushions the decrease in leisure-time physical activity during the COVID-19 pandemic: A natural experimental study. Urban For Urban Green 2021; 62:127136Yang Y, Lu Y, Yang L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897317

Pathology (5 articles)

1. COVID-19: Asymptomatic Carrier: An Autopsy Case Report. Int J Appl Basic Med Res 2021; 11:120-124Malik Y, Singh K, Yadav S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912436 2. Development of Sacral/Buttock Retiform Purpura as an Ominous Presenting Sign of COVID-19 and Clinical and Histopathologic Evolution during Severe Disease Course. J. Cutan. Pathol. 2021; McBride JD, Narang J, Simonds R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931901 3. Moments in autophagy and disease: Past and present. Mol. Aspects Med. 2021:100966Wen X, Yang Y, Klionsky DJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=33931245 4. Minimally Invasive Autopsy Practice in COVID-19 Cases: Biosafety and Findings. Pathogens 2021; 10Rakislova N, Marimon L, Ismail MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915771 5. Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts. Virchows Arch. 2021; Bertero L, Borella F, Botta G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934229

Protection (41 articles)

1. Face Mask Use During the COVID-19 Outbreak: How Did Educated Brazilians Behave? Am. J. Health Promot. 2021:8901171211011352Fernandes DE, Riguetti MTP, Mastroianni Kirsztajn G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902343 2. Has the COVID 19 Virus Changed Adherence to Hand Washing among Healthcare Workers? Behav Sci (Basel) 2021; 11Ragusa R, Marranzano M, Lombardo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920791 3. Effectiveness of personal protective health behaviour against COVID-19. BMC Public Health 2021; 21:827Lio CF, Cheong HH, Lei CI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926406 4. Fit Testing Retrofitted Full-Face Snorkel Masks as a Form of Novel Personal Protective Equipment During the COVID-19 Pandemic. Disaster Med Public Health Prep 2021:1-16Toigo S, Jacques M, Razek T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926606 5. Mitigation effect of face shield to reduce SARS-CoV-2 airborne transmission risk: Preliminary simulations based on computed tomography. Environ. Res. 2021; 198:111229Tretiakow D, Tesch K, Skorek A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932477 6. Development of a Novel Design and Subsequent Fabrication of an Automated Touchless Hand Sanitizer Dispenser to Reduce the Spread of Contagious Diseases. Healthcare (Basel) 2021; 9Das A, Barua A, Mohimin MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920290 7. Eyeglasses Reduce Risk of COVID-19 Infection. In Vivo 2021; 35:1581- 1582Lehrer S, Rheinstein P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910839 8. Dissemination of Aerosol and Splatter in Clinical Environment during Cavity Preparation: An In Vitro Study. Int J Environ Res Public Health 2021; 18Ahmed MA, Jouhar R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916609 9. Effectiveness of Face Coverings in Mitigating the COVID-19 Pandemic in the United States. Int J Environ Res Public Health 2021; 18Ayodeji OJ, Ramkumar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915868 10. Preliminary Evaluation of Filtration Efficiency and Differential Pressure ASTM F3502 Testing Methods of Non-Medical Masks Using a Face Filtration Mount. Int J Environ Res Public Health 2021; 18Freeman C, Burch R, Strawderman L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924707 11. SARS-CoV-2 Infection among the Dental Staff from Lombardy Region, Italy. Int J Environ Res Public Health 2021; 18Gallus S, Paroni L, Re D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918153 12. Assessing Public Willingness to Wear Face Masks during the COVID-19 Pandemic: Fresh Insights from the Theory of Planned Behavior. Int J Environ Res Public Health 2021; 18Irfan M, Akhtar N, Ahmad M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925929 13. Disposal Behavior of Used Masks during the COVID-19 Pandemic in the Moroccan Community: Potential Environmental Impact. Int J Environ Res Public Health 2021; 18Mejjad N, Cherif EK, Rodero A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924217 14. Analyses of Commercially Available Alcohol-Based Hand Rubs Formulated with Compliant and Non-Compliant Ethanol. Int J Environ Res Public Health 2021; 18Tse TJ, Nelson FB, Reaney MJT. http://www.ncbi.nlm.nih.gov/pubmed/? term=33916568 15. Environmental Detection of SARS-CoV-2 Virus RNA in Health Facilities in Brazil and a Systematic Review on Contamination Sources. Int J Environ Res Public Health 2021; 18Vicente VA, Lustosa BPR, Grisolia ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917465 16. SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan. Int J Environ Res Public Health 2021; 18Yoshihara T, Ito K, Zaitsu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916399 17. Tackling Airborne Virus Threats in the Food Industry: A Proactive Approach. Int J Environ Res Public Health 2021; 18Zimmerman T, Siddiqui SA, Bischoff W, Ibrahim SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921880 18. Use numbers not words! Communicating hotels' cleaning programs for COVID-19 from the brand perspective. Int J Hosp Manag 2021; 94:102872Jiménez-Barreto J, Loureiro S, Braun E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897084 19. The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: a multicenter seroprevalence study. Int J Infect Dis 2021; Al-Maani A, Al Wahaibi A, Al-Sooti J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33930541 20. The effect of wearing an FFP3 mask (3M(TM) Aura(TM)) with an exhalation valve on gas exchange in medical staff. Int. J. Occup. Med. Environ. Health 2021; Fantin R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908412 21. Views on COVID-19 and Use of Face Coverings Among U.S. Youth. J. Adolesc. Health 2021; 68:873-881DeJonckheere M, Waselewski M, Amaro X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896552 22. Decreased CRRT Filter Lifespan in COVID-19 ICU Patients. J Clin Med 2021; 10Legouis D, Montalbano MF, Siegenthaler N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925999 23. Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19 Pandemic-A Simulation, Randomised Crossover Trial. J Clin Med 2021; 10Rauch S, van Veelen MJ, Oberhammer R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923620 24. Dental biofilm of symptomatic COVID-19 patients harbors SARS-CoV-2. J. Clin. Periodontol. 2021; Gomes SC, Fachin S, da Fonseca JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899251 25. Dental biofilm of symptomatic COVID-19 patients harbours SARS-CoV-2. J. Clin. Periodontol. 2021; Gomes SC, Fachin S, da Fonseca JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899251 26. Hand hygiene during the COVID-19 pandemic among people experiencing homelessness-Atlanta, Georgia, 2020. J. Community Psychol. 2021; Montgomery MP, Carry MG, Garcia-Williams AG et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33899228 27. Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes. J. Gen. Virol. 2021; 102Davies K, Buczkowski H, Welch SR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913803 28. Evidence of presence of SARS-CoV-2 virus in atmospheric air and surfaces of dedicated COVID hospital. J Med Virol 2021; Dubey A, Kotnala G, Mandal TK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913527 29. Evidence of the presence of SARS-CoV-2 virus in atmospheric air and surfaces of a dedicated COVID hospital. J Med Virol 2021; Dubey A, Kotnala G, Mandal TK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913527 30. Seroprevalence of SARS-CoV-2 Antibody in Echocardiography and Stress Laboratory. J Patient Cent Res Rev 2021; 8:146-150Jain R, Kroboth S, Ignatowski D, Khandheria BK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898648 31. Preprocedure COVID-19 Testing in Early Phase of Pandemic. J Patient Cent Res Rev 2021; 8:151-153Jain R, Kruger B, Citronberg R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898649 32. Size-Dependent Filtration Efficiency of Alternative Facemask Filter Materials. Materials (Basel) 2021; 14Dhanraj DIA, Choudhary S, Jammalamadaka U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918714 33. A Review of Impact of Textile Research on Protective Face Masks. Materials (Basel) 2021; 14Militky J, Novak O, Kremenakova D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924470 34. Saliva: What Dental Practitioners Should Know about the Role of This Biofluid in the Transmission and Diagnostic of SARS-CoV-2. Medicina (Kaunas) 2021; 57Casillas Santana MA, Dipp Velázquez FA, Sámano Valencia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917276 35. Photopolymerizable, Universal Antimicrobial Coating to Produce High- Performing, Multifunctional Face Masks. Nano Lett 2021; Kumaran S, Oh E, Han S, Choi HJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900775 36. Assessment of Alcohol-Based Hand Sanitizers for Long-Term Use, Formulated with Addition of Natural Ingredients in Comparison to WHO Formulation 1. Pharmaceutics 2021; 13Fallica F, Leonardi C, Toscano V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920509 37. Five approaches to the suppression of SARS-CoV-2 without intensive social distancing. Proc. Biol. Sci. 2021; 288:20203074Drake JM, Dahlin K, Rohani P, Handel A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906405 38. Public Compliance With Social Distancing Measures and SARS-CoV-2 Spread : A Quantitative Analysis of 5 States. Public Health Rep. 2021:333549211011254Liu H, Chen C, Cruz-Cano R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909541 39. Adaptive Floor Cleaning Strategy by Human Density Surveillance Mapping with a Reconfigurable Multi-Purpose Service Robot. Sensors (Basel) 2021; 21Sivanantham V, Le AV, Shi Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33922638 40. Social distancing in public transport: mobilising new technologies for demand management under the Covid-19 crisis. Transportation (Amst) 2021:1-30Hörcher D, Singh R, Graham DJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907339 41. SARS-CoV-2 aerosol and droplets: an overview. Virusdisease 2021:1-8Ranga U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907703

Pulmonary disease (15 articles)

1. Journal Club: The Intersection of Racial/Ethnic Disparities in Coronavirus Disease 2019 and COPD. Chronic Obstr Pulm Dis 2021; 8:292-302Balkissoon R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909967 2. Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-chip model. EMBO Rep 2021:e52744Thacker VV, Sharma K, Dhar N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908688 3. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy. Expert Rev. Respir. Med. 2021:1-4Caruso C, Colantuono S, Urbani S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896350 4. Caring for Respiratory disease in India in the COVID era. Expert Rev. Respir. Med. 2021; Jindal SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929927 5. Pulmonary fibrosis secondary to COVID-19: a narrative review. Expert Rev. Respir. Med. 2021:1-13Tanni SE, Fabro AT, de Albuquerque A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902377 6. Short-Term Consequences of SARS-CoV-2-Related Pneumonia: A Follow Up Study. High Blood Press Cardiovasc Prev 2021:1-9Boari GEM, Bonetti S, Braglia- Orlandini F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909284 7. Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomes. Hum. Pathol. 2021; Gelarden I, Nguyen J, Gao J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905777 8. Bronchopleural Fistula as a Complication in a COVID-19 Patient Managed With Endobronchial Valves. J Investig Med High Impact Case Rep 2021; 9:23247096211013215Talon A, Arif MZ, Mohamed H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928804 9. Persistent interstitial lung abnormalities in post-COVID-19 patients: a case series. J. Venom. Anim. Toxins Incl. Trop. Dis. 2021; 27:e20200157Lago VC, Prudente RA, Luzia DA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907556 10. Recommendations for pulmonary function laboratories in the COVID-19 era. Medicina (B. Aires) 2021; 81:229-240Rodríguez Moncalvo JJ, Brea Folco JC, Arce SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906142 11. New perspectives on natural flavonoids on COVID-19-induced lung injuries. Phytother. Res. 2021; Santana FPR, Thevenard F, Gomes KS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928690 12. Plasma LDH: A specific biomarker for lung affectation in COVID-19? Pract Lab Med 2021; 25:e00226Serrano-Lorenzo P, Coya ON, López-Jimenez A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898686 13. Towards Detecting Pneumonia Progression in COVID-19 Patients by Monitoring Sleep Disturbance Using Data Streams of Non-Invasive Sensor Networks. Sensors (Basel) 2021; 21Dimitrievski A, Zdravevski E, Lameski P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925869 14. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax 2021; McGroder CF, Zhang D, Choudhury MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927016 15. Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic. Virol J 2021; 18:93Marshall NC, Kariyawasam RM, Zelyas N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933115

Renal disease (17 articles)

1. Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital. BMC Infect. Dis. 2021; 21:397Zhang NH, Cheng YC, Luo R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926392 2. Fatigue, anxiety, depression and sleep quality in patients undergoing haemodialysis. BMC Nephrol. 2021; 22:157Al Naamani Z, Gormley K, Noble H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910523 3. Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom. BMC Nephrol. 2021; 22:154Wickens O, Chinnadurai R, Mannan F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902482 4. The effect of refined nursing intervention on patients undergoing maintenance hemodialysis in the hemodialysis center during the COVID-19 epidemic. BMC Nurs. 2021; 20:66Zhang QL, Wang S, Zhang Y, Meng F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902563 5. COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates. Hum. Immunol. 2021; Roll GR, Lunow-Luke T, Braun HJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910707 6. Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury. Int J Biol Sci 2021; 17:1497-1506Chen J, Wang W, Tang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907513 7. Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19. J Clin Med 2021; 10Bodro M, Cofan F, Ríos J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917093 8. Use of Peritoneal Dialysis for Acute Kidney Injury during the COVID-19 Pandemic in New York City: A multicenter observational study. Kidney Int 2021; Chen W, Caplin N, El Shamy O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33930411 9. Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney- transplant patient. Kidney Int 2021; Del Bello A, Marion O, Delas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932459 10. Post-vaccine anti-SARS-CoV-2 spike protein antibody development in kidney transplants recipients. Kidney Int Rep 2021; Husain SA, Tsapepas D, Paget KF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907723 11. COVID-19-Importance for Patients on the Waiting List and after Kidney Transplantation-A Single Center Evaluation in 2020-2021. Pathogens 2021; 10Boedecker SC, Klimpke P, Kraus D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33916836 12. Critical analysis of acute kidney injury in pediatric COVID-19 patients in the intensive care unit. Pediatr. Nephrol. 2021:1-12Raina R, Chakraborty R, Mawby I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928439 13. Opioids and Acute Kidney Injury. Semin. Nephrol. 2021; 41:11-18Mallappallil M, Bajracharya S, Salifu M, Yap E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33896468 14. An update on Sars-CoV-2: a review. Theor. Biol. Forum. 2020; 113:47-54Nishwa DE, Riaz HA, Fatima A, Wahid B. http://www.ncbi.nlm.nih.gov/pubmed/? term=33929003 15. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients. Transpl Infect Dis 2021:e13628Basic-Jukic N, Jelicic I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915005 16. Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer- BioNTech) in Patients on Hemodialysis. Vaccines (Basel) 2021; 9Jahn M, Korth J, Dorsch O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918085 17. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech). Viruses 2021; 13Korth J, Jahn M, Dorsch O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923063

Reviews (23 articles)

1. Myasthenia gravis and COVID-19: A case series and comparison with literature. Acta Neurol. Scand. 2021; Saied Z, Rachdi A, Thamlaoui S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914898 2. The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models. Acta Neuropathol. 2021:1-14Butowt R, Meunier N, Bryche B, von Bartheld CS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903954 3. Liver Function Tests Profile in COVID-19 Patients at the Admission Time: A Systematic Review of Literature and Conducted Researches. Adv Biomed Res 2020; 9:74Laali A, Tabibzadeh A, Esghaei M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912490 4. EULAR COVID-19 registry: lessons learnt and future considerations. Ann. Rheum. Dis. 2021; Lawson-Tovey S, Strangfeld A, Hyrich KL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906854 5. Prevalence of thrombotic complications in children with SARS-CoV-2. Arch. Dis. Child. 2021; Aguilera-Alonso D, Murias S, Martínez-de-Azagra Garde A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931403 6. Psychopathological Impact and Resilient Scenarios in Inpatient with Schizophrenia Spectrum Disorders Related to Covid Physical Distancing Policies: A Systematic Review. Behav Sci (Basel) 2021; 11Caponnetto P, Benenati A, Maglia MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924365 7. [Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]. Bull Cancer 2021; Tougeron D, Seitz-Polski B, Hentzien M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902918 8. Rapid recovery achieved by intensive therapy after preterm cesarean section for worsening COVID-19-induced acute respiratory failure: A case report and literature review. Case Rep Womens Health 2021; 30:e00315Ito A, Hayata E, Nakata M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898274 9. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review. Cells 2021; 10Demeulemeester F, de Punder K, van Heijningen M, van Doesburg F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920604 10. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis. Comput Struct Biotechnol J 2021; 19:2347-2355Abdelrahman Z, Chen Z, Lyu H, Wang X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907612 11. Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER). Eur. J. Cancer 2021; 150:232-239Tougeron D, Hentzien M, Seitz-Polski B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934060 12. Heart Failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings. Eur J Heart Fail 2021; Hadzibegovic S, Lena A, Churchill TW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932255 13. Pulmonary fibrosis secondary to COVID-19: a narrative review. Expert Rev. Respir. Med. 2021:1-13Tanni SE, Fabro AT, de Albuquerque A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902377 14. Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature. Front. Oncol. 2021; 11:662211Woźniak K, Sachs W, Boguradzki P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912468 15. Intra-Household and Close-Contact SARS-CoV-2 Transmission Among Children - a Systematic Review. Front Pediatr 2021; 9:613292Spielberger BD, Goerne T, Geweniger A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898355 16. Rapid Review on the Associations of Social and Geographical Isolation and Intimate Partner Violence: Implications for the Ongoing COVID-19 Pandemic. Front Psychiatry 2021; 12:578150Mojahed A, Brym S, Hense H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927649 17. Gastroenterology 2021: from the heart of the COVID-19 pandemic. Frontline Gastroenterol. 2021; 12:249-251Tavabie OD, Clough J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907619 18. [Epidemiologic evidence on the role of hospitality venues in the transmission of COVID-19: A rapid review of the literature]. Gac. Sanit. 2021; Bilal U, Gullón P, Padilla-Bernáldez J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933322 19. Management and Prevention of COVID-19 in Pregnancy and Pandemic Obstetric Care: A Review of Current Practices. Healthcare (Basel) 2021; 9Pountoukidou A, Potamiti-Komi M, Sarri V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920781 20. Respiratory supports of COVID-19 patients in intensive care unit: A systematic review. Heliyon 2021; 7:e06813Ouyang L, Yu M, Zhu Y, Gong J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898856 21. Impact of the Covid-19 Pandemic on Orthopaedic and Trauma Surgery - A Systematic Review of the Current Literature. In Vivo 2021; 35:1337-1343Blum P, Putzer D, Liebensteiner MC, Dammerer D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33910811 22. Coronavirus Disease 2019 and Nasal Conditions: A Review of Current Evidence. In Vivo 2021; 35:1409-1417Suzaki I, Kobayashi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910818 23. Brief review of the mRNA vaccines COVID-19. Inflammopharmacology 2021:1- 5Vitiello A, Ferrara F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932192 24. Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. Int Immunopharmacol 2021; 97:107679Bayat M, Asemani Y, Najafi S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33930707 25. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities. Int Immunopharmacol 2021; 97:107694Moradinasab S, Pourbagheri-Sigaroodi A, Zafari P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932694 26. The role of vitamin D in reducing SARS-CoV-2 infection: An update. Int Immunopharmacol 2021; 97:107686Shah Alam M, Czajkowsky DM, Aminul Islam M, Ataur Rahman M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930705 27. Construction and applications of SARS-CoV-2 pseudoviruses: a mini review. Int J Biol Sci 2021; 17:1574-1580Chen M, Zhang XE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907521 28. COVID-19 and Recreational Skiing: Results of a Rapid Systematic Review and Possible Preventive Measures. Int J Environ Res Public Health 2021; 18Gianfredi V, Mauer NS, Gentile L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923960 29. Effect of COVID-19 on Health-Related Quality of Life in Adolescents and Children: A Systematic Review. Int J Environ Res Public Health 2021; 18Nobari H, Fashi M, Eskandari A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923120 30. Prediction Models for Public Health Containment Measures on COVID-19 Using Artificial Intelligence and Machine Learning: A Systematic Review. Int J Environ Res Public Health 2021; 18Payedimarri AB, Concina D, Portinale L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922693 31. Factors Associated with the Implementation of Non-Pharmaceutical Interventions for Reducing Coronavirus Disease 2019 (COVID-19): A Systematic Review. Int J Environ Res Public Health 2021; 18Regmi K, Lwin CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920613 32. Environmental Detection of SARS-CoV-2 Virus RNA in Health Facilities in Brazil and a Systematic Review on Contamination Sources. Int J Environ Res Public Health 2021; 18Vicente VA, Lustosa BPR, Grisolia ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917465 33. COVID-2019 fundamentals. J. Am. Dent. Assoc. 2021; 152:354-363Lamberghini F, Testai FD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926623 34. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. J Clin Med 2021; 10Bareille M, Hardy M, Douxfils J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923851 35. A Perspective on COVID-19 Management. J Clin Med 2021; 10Pavelić K, Kraljević Pavelić S, Brix B, Goswami N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918624 36. Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host- pathogen interaction and immunomodulation. J. Funct. Foods 2021; 82:104503Dhar S, Bhattacharjee P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33897833 37. Factors mediating the psychological well-being of healthcare workers responding to global pandemics: A systematic review. J Health Psychol 2021:13591053211012759Schneider J, Talamonti D, Gibson B, Forshaw M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913356 38. Neurological update: COVID-19. J. Neurol. 2021:1-9Ren AL, Digby RJ, Needham EJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929617 39. Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape. J Pers Med 2021; 11Chatterjee A, Nardi C, Oberije C, Lambin P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919882 40. The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19. J. Pharm. Pract. 2021:897190021997399Aljadeed R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906514 41. Review of COVID-19 Treatment. J Res Pharm Pract 2020; 9:169-174Sadeghi S, Momenzadeh M, Nasri P, Nickpour M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33912498 42. Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn J Radiol 2021:1-12Cozzi D, Cavigli E, Moroni C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900542 43. The Three Pillars of COVID-19 Convalescent Plasma Therapy. Life (Basel) 2021; 11Franchini M, Liumbruno GM, Piacentini G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919577 44. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021; 11Palazzuoli A, Giustozzi M, Ruocco G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925334 45. [Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital]. Medwave 2021; 21:e8142Luna-Muñoz C, Reyes-Florian G, Seminario-Aliaga M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905406 46. Internal medicine: Thinking outside the box. MMW-Fortschritte der Medizin 2021; 163:5Parhofer KG. 47. Relation between Vitamin D and COVID-19 in Aged People: A Systematic Review. Nutrients 2021; 13Dramé M, Cofais C, Hentzien M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920639 48. Managing Obesity in Lockdown: Survey of Health Behaviors and Telemedicine. Nutrients 2021; 13Minsky NC, Pachter D, Zacay G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921602 49. Consequences of the COVID-19 Syndemic for Nutritional Health: A Systematic Review. Nutrients 2021; 13Neira C, Godinho R, Rincón F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916087 50. Could Antigen Presenting Cells Represent a Protective Element during SARS- CoV-2 Infection in Children? Pathogens 2021; 10Lauro R, Irrera N, Eid AH, Bitto A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920011 51. Thrombosis in coronavirus disease. We must become active!! Phlebologie 2021; 50:158-159Mendoza E. 52. Sex hormones, autoimmunity and gender disparity in COVID-19. Rheumatol. Int. 2021:1-12Raza HA, Sen P, Bhatti OA, Gupta L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903964 53. E-Triage Systems for COVID-19 Outbreak: Review and Recommendations. Sensors (Basel) 2021; 21Alhaidari F, Almuhaideb A, Alsunaidi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920744 54. Machine Learning and Deep Learning Approaches to Analyze and Detect COVID-19: A Review. SN Comput Sci 2021; 2:226Aishwarya T, Ravi Kumar V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899005 55. Ivermectin & COVID-19: Let's keep a One Health perspective. Sustain Chem Pharm 2021; 21:100438Domingo-Echaburu S, Orive G, Lertxundi U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898692 56. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines (Basel) 2021; 9García- Montero C, Fraile-Martínez O, Bravo C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925526 57. The COVID-19 Vaccines: Recent Development, Challenges and Prospects. Vaccines (Basel) 2021; 9Yan Y, Pang Y, Lyu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916489 58. Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2. Viruses 2021; 13Zhao S, Lou J, Chong MKC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918060 59. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection? World J. Gastroenterol. 2021; 27:1406-1418Troisi J, Venutolo G, Pujolassos Tanyà M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911464

Risk factors (59 articles)

1. Predictors of readmission requiring hospitalization after discharge from emergency departments in patients with COVID-19. Am J Emerg Med 2021; 46:146-149Menditto VG, Fulgenzi F, Bonifazi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932638 2. Modified PRIEST score for identification of very low-risk COVID patients. Am J Emerg Med 2021; 47:213-216Suh EH, Lang KJ, Zerihun LM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906127 3. Can C-Reactive Protein to Albumin Ratio Predict In-Hospital Death Rate Due to COVID-19 in Patients With Hypertension? Angiology 2021:33197211012145Saylik F, Akbulut T, Kaya S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902353 4. A hybrid data envelopment analysis-artificial neural network prediction model for COVID-19 severity in transplant recipients. Artif Intell Rev 2021:1-32Revuelta I, Santos-Arteaga FJ, Montagud-Marrahi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907345 5. The prognostic role of cardiac troponin in hospitalized COVID-19 patients. Atherosclerosis 2021; 325:83-88Tanboğa IH, Canpolat U, Özcan Çetin EH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910152 6. Increased Hospitalization and Mortality from COVID-19 in Prostate Cancer Patients. Cancers (Basel) 2021; 13Chakravarty D, Ratnani P, Sobotka S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915795 7. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review. Cells 2021; 10Demeulemeester F, de Punder K, van Heijningen M, van Doesburg F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920604 8. Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019. Clin Infect Dis 2020; Xiang F, Sun J, Chen PH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33909004 9. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study. Clin. Interv. Aging 2021; 16:675-685Xu W, Huang C, Fei L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911856 10. Clinical characteristics and factors associated with hospital admission or death in 43,103 adult outpatients with COVID-19 managed with the Covidom telesurveillance solution: a prospective cohort study. Clin Microbiol Infect 2021; Yordanov Y, Dinh A, Bleibtreu A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915287 11. Region-specific COVID-19 risk scores and nutritional status of a high-risk population based on individual vulnerability assessment in the national survey data. Clin. Nutr. 2021; Baik I. http://www.ncbi.nlm.nih.gov/pubmed/? term=33933298 12. Nutritional risk at hospital admission is associated with prolonged length of hospital stay in old patients with COVID-19. Clin. Nutr. 2021; Mendes A, Serratrice C, Herrmann FR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33933295 13. An Early Warning Tool for Predicting Mortality Risk of COVID-19 Patients Using Machine Learning. Cognit. Comput. 2021:1-16Chowdhury MEH, Rahman T, Khandakar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897907 14. Implications of cardiac markers in risk-stratification and management for COVID-19 patients. Crit Care 2021; 25:158Li P, Wu W, Zhang T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902676 15. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico. Cytokine 2021:155543Avila-Nava A, Cortes-Telles A, Torres- Erazo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896708 16. Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study. Eur. J. Cancer 2021; 150:190-202Pinato DJ, Scotti L, Gennari A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932726 17. The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19. Expert Rev. Respir. Med. 2021; Kuluöztürk M, Deveci F, Turgut T, Öner Ö. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905286 18. Advancing Risk Analysis of COVID-19 Clinical Predictors: The Case of Fasting Blood Glucose. Front Med (Lausanne) 2021; 8:636065Ali H, Al-Shammari AA, Alahmad B, Al-Mulla F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898480 19. Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women. Genes (Basel) 2021; 12Monticelli M, Hay Mele B, Benetti E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921689 20. Identification of PBMC-based Molecular Signature Associational with COVID- 19 Disease Severity. Heliyon 2021:e06866Shaath H, Alajez NM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898797 21. Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomes. Hum. Pathol. 2021; Gelarden I, Nguyen J, Gao J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33905777 22. HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk. Immunol. Lett. 2021; Bonaccorsi I, Carrega P, Rullo EV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905752 23. Dyslipidemia in breast cancer patients increases the risk of SAR-CoV-2 infection. Infect Genet Evol 2021; 92:104883Shakartalla SB, Alhumaidi RB, Shammout ODA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905884 24. Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants. Infect Genet Evol 2021:104888Shoily SS, Ahsan T, Fatema K, Sajib AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933634 25. Evaluation of hepatic enzymes activities in COVID-19 patients. Int Immunopharmacol 2021; 97:107701Hwaiz R, Merza M, Hamad B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930704 26. Cigarette and E-Cigarettes Dual Users, Exclusive Users and COVID-19: Findings from Four UK Birth Cohort Studies. Int J Environ Res Public Health 2021; 18Chen DT, Kyriakos CN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918098 27. SARS-CoV-2 and the Risk Assessment Document in Italian Work; Specific or Generic Risk Even If Aggravated? Int J Environ Res Public Health 2021; 18Cirrincione L, Rapisarda V, Mazzucco W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918369 28. Identification of Vulnerable Populations and Areas at Higher Risk of COVID-19- Related Mortality during the Early Stage of the Epidemic in the United States. Int J Environ Res Public Health 2021; 18Correa-Agudelo E, Mersha TB, Branscum AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921217 29. Geographic Factors Associated with Poorer Outcomes in Patients Diagnosed with COVID-19 in Primary Health Care. Int J Environ Res Public Health 2021; 18Magallón-Botaya R, Oliván-Blázquez B, Ramírez-Cervantes KL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917578 30. Risk of Exposure to COVID-19: Visit Duration Data Can Inform Our Daily Activities Choices: An Epidemiological Investigation Using Community Mobility Data from the Metropolitan Area of Genoa, Italy. Int J Environ Res Public Health 2021; 18Oliva C, Favato G. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925428 31. Community Risk Factors in the COVID-19 Incidence and Mortality in Catalonia (Spain). A Population-Based Study. Int J Environ Res Public Health 2021; 18Zaldo-Aubanell Q, Campillo ILF, Bach A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916590 32. Development and Validation of CoV19-OM Intensive Care Unit Score: An Early ICU Identification for Laboratory-Confirmed SARS-CoV-2 Patients from a Retrospective Cohort Study in Oman. Int J Infect Dis 2021; Lacap EM, Jr., Varghese A, Khamis F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901655 33. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem. Intern Emerg Med 2021:1-10Lalueza A, Lora-Tamayo J, Maestro-de la Calle G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914228 34. Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI- COVID-19 Registry. J Clin Med 2021; 10Ayala Gutiérrez MDM, Rubio-Rivas M, Romero Gómez C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922777 35. Comorbidities and Susceptibility to COVID-19: A Generalized Gene Set Data Mining Approach. J Clin Med 2021; 10Beckman MF, Mougeot FB, Mougeot JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924631 36. Physical Activity and the Risk of COVID-19 Infection and Mortality: A Nationwide Population-Based Case-Control Study. J Clin Med 2021; 10Cho DH, Lee SJ, Jae SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917558 37. Admission High-Sensitive Cardiac Troponin T Level Increase Is Independently Associated with Higher Mortality in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med 2021; 10Larcher R, Besnard N, Akouz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924475 38. Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy. J Clin Med 2021; 10Posteraro B, De Angelis G, Menchinelli G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33920701 39. Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study. J Clin Med 2021; 10Simon TP, Stoppe C, Breuer T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33924637 40. Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19. J Clin Med 2021; 10Ylescupidez A, Rips A, Bahnson HT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917702 41. Pharmacological Predictors of Morbidity and Mortality in COVID-19. J. Clin. Pharmacol. 2021; Oddy C, McCaul J, Keeling P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908637 42. Fragmented QRS on surface electrocardiography as a predictor of cardiac mortality in patients with SARS-CoV-2 infection. J. Electrocardiol. 2021; 66:108- 112Yildirim A, Karaca IO, Yilmaz FK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906057 43. Clinical Determinants of Severe COVID-19 Disease - A Systematic Review and Meta-Analysis. J. Glob. Infect. Dis. 2021; 13:13-19Sahu AK, Mathew R, Aggarwal P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33911447 44. Sex differences in the induction of angiotensin converting enzyme 2 (ACE-2) in mouse lungs after e-cigarette vapor exposure and its relevance to COVID- 19. J. Investig. Med. 2021; Naidu V, Zeki AA, Sharma P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926967 45. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. J Med Virol 2021; Zervou FN, Louie P, Stachel A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932299 46. Diabesity Associated with Poor COVID-19 Outcomes among Hospitalized Patients. J Obes Metab Syndr 2021; Nikniaz Z, Somi MH, Dinevari MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927066 47. Predicting in-Hospital Mortality of Patients with COVID-19 Using Machine Learning Techniques. J Pers Med 2021; 11Tezza F, Lorenzoni G, Azzolina D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923332 48. Vitamin D status of Arab Gulf residents screened for SARS-CoV-2 and its association with COVID-19 infection: a multi-centre case-control study. J Transl Med 2021; 19:166Al-Daghri NM, Amer OE, Alotaibi NH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902635 49. Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19. Lab Med 2021; Lo Sasso B, Gambino CM, Scichilone N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928380 50. Rapid clinical evolution for COVID-19 translates into early hospital admission and unfavourable outcome: a preliminary report. Multidiscip Respir Med 2021; 16:744Heim M, Lahmer T, Rasch S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907624 51. COVID-19: In- or Outpatient Care? - Risk Score to Differentiate Expected Mild and Severe Cases. Notarzt 2021; Peters L, Burkert S, Dinse-Lambracht A et al. 52. Relation between Vitamin D and COVID-19 in Aged People: A Systematic Review. Nutrients 2021; 13Dramé M, Cofais C, Hentzien M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920639 53. Impact of COVID-19 Pandemic on Serum Vitamin D Level among Infants and Toddlers: An Interrupted Time Series Analysis and before-and-after Comparison. Nutrients 2021; 13Wong RS, Tung KTS, So HK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924387 54. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta- analysis, and meta-regression. Parkinsonism Relat. Disord. 2021; Putri C, Hariyanto TI, Hananto JE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33931304 55. Smoking and risk of COVID-19 hospitalization. Respir. Med. 2021; 182:106414Puebla Neira D, Watts A, Seashore J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915414 56. Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population. Sensors (Basel) 2021; 21Saha A, Bajpai A, Krishna V, Bhattacharya S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918646 57. The association between high risk of sleep apnea, comorbidities, and risk of COVID-19: a population-based international harmonized study. Sleep Breath 2021:1-12Chung F, Waseem R, Pham C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907966 58. Shift work is associated with positive COVID-19 status in hospitalised patients. Thorax 2021; Maidstone R, Anderson SG, Ray DW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903187 59. D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients. Viruses 2021; 13Thoreau B, Galland J, Delrue M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33926038 Safety (29 articles)

1. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation. Clin Immunol 2021; 227:108748Turk VE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932618 2. COVID-19 Vaccine and Hyperosmolar Hyperglycemic State. Cureus 2021; 13:e14125Abu-Rumaileh MA, Gharaibeh AM, Gharaibeh NE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927933 3. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG. Eur. Ann. Allergy Clin. Immunol. 2021; Radice A, Fassio F, Meucci E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913314 4. COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations. Front. Immunol. 2021; 12:669339He Q, Mao Q, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912196 5. Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting. Healthcare (Basel) 2021; 9Simonetti O, Rizzetto G, Molinelli E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33916122 6. Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines. Immunol. Invest. 2021:1-37Hofman K, Shenoy GN, Chak V, Balu-Iyer SV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929280 7. Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers. Int J Biol Sci 2021; 17:1530-1537Yang R, Yu Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907516 8. Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study. Int. J. Gen. Med. 2021; 14:1389-1401El-Shitany NA, Harakeh S, Badr-Eldin SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907443 9. Lung Cancer and Heart Disease Risks Associated with Low-Dose Pulmonary Radiotherapy to COVID-19 Patients with Different Background Risks. Int. J. Radiat. Oncol. Biol. Phys. 2021; Shuryak I, Kachnic LA, Brenner DJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930480 10. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. J Clin Med 2021; 10Riad A, Pokorná A, Attia S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916020 11. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure. J Clin Med 2021; 10Wolf ME, Luz B, Niehaus L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918932 12. Evaluation of the frequency and intensity of favipiravir-associated yellow- green fluorescence in lunulae, hair, and face. J Cosmet Dermatol 2021; Turan Ç, Metin N, Utlu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915020 13. Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report. J Eur Acad Dermatol Venereol 2021; Akdaş E, İlter N, Öğüt B, Erdem Ö. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914958 14. BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2. J Eur Acad Dermatol Venereol 2021; Piccolo V, Bassi A, Argenziano G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914966 15. Herpes Zoster emergence following mRNA COVID-19 Vaccine. J Med Virol 2021; Eid E, Abdullah L, Kurban M, Abbas O. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913545 16. Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis. J Nepal Health Res Counc 2021; 19:1- 9Budhathoki P, Shrestha DB, Khadka S, Rawal E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934125 17. A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration. J Pers Med 2021; 11D'Agostino V, Caranci F, Negro A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917902 18. Post adenoviral-based COVID-19 vaccines thrombosis: A proposed mechanism. J Thromb Haemost 2021; Kadkhoda K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904251 19. New-onset chilblains in close temporal association to mRNA-1273 vaccination. JAAD Case Rep 2021; 12:12-14Kha C, Itkin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898675 20. Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney- transplant patient. Kidney Int 2021; Del Bello A, Marion O, Delas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932459 21. Review the safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg 2021; 15:20Anand P, Stahel VP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933145 22. Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV- 2 Identified by Hierarchical In Silico/In Vitro Screening Methods. Pharmaceuticals (Basel) 2021; 14Ginex T, Garaigorta U, Ramírez D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917313 23. COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials. Pharmaceuticals (Basel) 2021; 14Yan ZP, Yang M, Lai CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923054 24. Assessing vaccine durability in randomized trials following placebo crossover. Stat. Med. 2021; Fintzi J, Follmann D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928660 25. Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia. Stroke 2021; American Heart Association/American Stroke Association Stroke Council L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914590 26. Safety of COVID-19 vaccines administered in the EU: Should we be concerned? Toxicol Rep 2021; 8:871-879Hernández AF, Calina D, Poulas K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898273 27. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients. Transpl Infect Dis 2021:e13628Basic-Jukic N, Jelicic I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915005 28. Feasibility and safety of Remdesivir in SARS-CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation. Transpl Infect Dis 2021:e13629Meshram HS, Kute VB, Patel H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915006 29. Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database. Vaccines (Basel) 2021; 9Tobaiqy M, Elkout H, MacLure K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923530

Treatment options (94 articles) 1. Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule. Acta Pharmacol. Sin. 2021:1-18Lan XF, Olaleye OE, Lu JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931765 2. Supramolecular cylinders target bulge structures in the 5' UTR of the RNA genome of SARS-CoV-2 and inhibit viral replication. Angew. Chem. Int. Ed. Engl. 2021; Melidis L, Hill H, Coltman N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915014 3. Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'. Ann. Rheum. Dis. 2021; Kaklamanos A, Karamichalos P, Vlachoyiannopoulos PG, Tzioufas AG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903096 4. Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Kaklamanos et al. Ann. Rheum. Dis. 2021; Ramiro S, Mostard RLM, Landewé RBM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903095 5. Innate immune-mediated antiviral response to SARS-CoV-2 and convalescent sera a potential prophylactic and therapeutic agent to tackle COVID-19. Antib Ther 2020; 3:212-220Abdullah, Faisal S, Aman K, Rahman AU. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912794 6. Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective. Antib Ther 2020; 3:285-299Huang Y, Sun H, Yu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912797 7. Human neutralizing antibodies to SARS-CoV-2: views and perspectives from Professor Linqi Zhang at Tsinghua University. Antib Ther 2020; 3:155-156Li Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912792 8. Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates. Antib Ther 2020; 3:115-125Verma HK, Farran B, Bhaskar L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912791 9. Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro. Biomedicines 2021; 9Gilham D, Smith AL, Fu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919584 10. SARS-CoV-2 M(pro): A Potential Target for Peptidomimetics and Small- Molecule Inhibitors. Biomolecules 2021; 11Citarella A, Scala A, Piperno A, Micale N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921886 11. Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach. Biomolecules 2021; 11Hopp MT, Domingo-Fernández D, Gadiya Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925394 12. Podophyllotoxin: History, Recent Advances and Future Prospects. Biomolecules 2021; 11Shah Z, Gohar UF, Jamshed I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921719 13. Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals. Bioorg. Chem. 2021; 112:104889Sun LY, Chen C, Su J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915460 14. Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients. Clin Infect Dis 2021; Papayanni PG, Chasiotis D, Koukoulias K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905481 15. Dual targeting of cytokine storm and viral replication in COVID-19 by plant- derived steroidal pregnanes: An in silico perspective. Comput. Biol. Med. 2021; 134:104406Gyebi GA, Ogunyemi OM, Ibrahim IM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915479 16. Promising phytochemicals of traditional Himalayan medicinal plants against putative replication and transmission targets of SARS-CoV-2 by computational investigation. Comput. Biol. Med. 2021; 133:104383Natesh J, Mondal P, Kaur B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915361 17. Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients? Curr Pharmacol Rep 2021:1-5Alkotaji M, Al-Zidan RN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907665 18. Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19. Cytokine 2021:155544Geng J, Wang F, Huang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926774 19. Potential Effects of Melatonin and Micronutrients on Mitochondrial Dysfunction during a Cytokine Storm Typical of Oxidative/Inflammatory Diseases. Diseases 2021; 9Martín Giménez VM, de Las Heras N, Ferder L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919780 20. Drug delivery of amoxicillin molecule as a suggested treatment for covid-19 implementing functionalized mesoporous SBA-15 with aminopropyl groups. Drug Deliv 2021; 28:856-864Alazzawi HF, Salih IK, Albayati TM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928831 21. In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes. Environ. Sci. Pollut. Res. Int. 2021; Shaldam MA, Yahya G, Mohamed NH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33934306 22. JAK inhibitors: Ten years after. Eur. J. Immunol. 2021; Spinelli FR, Meylan F, O'Shea JJ, Gadina M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930196 23. Case Report: Interferon-γ Restores Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) in Severe COVID-19 With Acquired Immunosuppression Syndrome. Front. Immunol. 2021; 12:645124Dickel S, Grimm C, Amschler K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897692 24. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment. Front. Immunol. 2021; 12:666693Vallée A, Lecarpentier Y, Vallée JN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927728 25. Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV- 2 infections. Front Med 2021:1-5Lai R, Zhou T, Xiang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33909259 26. Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial. Front Med 2021:1-14Ni L, Wen Z, Hu X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33909260 27. Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:624924Bansal V, Mahapure KS, Mehra I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898477 28. Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS- CoV-2. Front Mol Biosci 2021; 8:645216Kumar DT, Shaikh N, Kumar SU et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898520 29. Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019. Front. Pharmacol. 2021; 12:631646Bifulco M, Fiore D, Piscopo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912048 30. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection. Front. Pharmacol. 2021; 12:634176Chen RH, Yang LJ, Hamdoun S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897423 31. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut 2021; Kennedy NA, Lin S, Goodhand JR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33903149 32. Convalescent plasma therapy - a silver lining for COVID-19 management? Hematol Transfus Cell Ther 2021; Saha S, Kadam S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903854 33. COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic? Infect Dis Rep 2021; 13:259-284Jirjees F, Saad AK, Al Hano Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915690 34. Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study. Infect Dis Ther 2021:1-3Janapala RN, Patel J, Belfaqeeh O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914266 35. A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort. Infect Dis Ther 2021:1-3Ruiz-Antorán B, Sancho- López A, Torres F, Fernández-Cruz A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33928532 36. The role of vitamin D in reducing SARS-CoV-2 infection: An update. Int Immunopharmacol 2021; 97:107686Shah Alam M, Czajkowsky DM, Aminul Islam M, Ataur Rahman M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930705 37. Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial. Int Immunopharmacol 2021; 97:107702Zhao H, Zhang C, Zhu Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930706 38. Chitin and chitosan as tools to combat COVID-19: A triple approach. Int. J. Biol. Macromol. 2021; 183:235-244Safarzadeh M, Sadeghi S, Azizi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930442 39. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery. Int J Biol Sci 2021; 17:1538-1546Chen Y, Li MX, Lu GD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907517 40. Development and application of therapeutic antibodies against COVID-19. Int J Biol Sci 2021; 17:1486-1496Ning L, Abagna HB, Jiang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907512 41. Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers. Int J Biol Sci 2021; 17:1530-1537Yang R, Yu Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907516 42. Aptamers for Anti-Viral Therapeutics and Diagnostics. Int J Mol Sci 2021; 22Kim TH, Lee SW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920628 43. Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19. Int J Mol Sci 2021; 22Pereira G, Leão A, Erustes AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920748 44. SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment. Int J Mol Sci 2021; 22Stasiulewicz A, Maksymiuk AW, Nguyen ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921228 45. Comments on: "Low dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study". Int. J. Radiat. Oncol. Biol. Phys. 2021; Bevelacqua JJ, Welsh JS, Mortazavi S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33933482 46. Lung Cancer and Heart Disease Risks Associated with Low-Dose Pulmonary Radiotherapy to COVID-19 Patients with Different Background Risks. Int. J. Radiat. Oncol. Biol. Phys. 2021; Shuryak I, Kachnic LA, Brenner DJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930480 47. Antibody therapy in patients with COVID-19. Internist 2021; Augustin M, Hallek M, Nitschmann S. 48. Monoclonal antibody therapy in COVID-19 induced by SARS-CoV-2. J Biol Regul Homeost Agents 2021; 35Conti P, Pregliasco FE, Calvisi V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904269 49. Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study. J Biomol Struct Dyn 2021:1-15Miroshnychenko KV, Shestopalova AV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896392 50. Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom. J Clin Med 2021; 10Calzetta L, Aiello M, Frizzelli A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920093 51. Sex-Related Differences in Drugs with Anti-Inflammatory Properties. J Clin Med 2021; 10Farkouh A, Baumgärtel C, Gottardi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916167 52. Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6. J Clin Med 2021; 10Flisiak R, Jaroszewicz J, Rogalska M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918563 53. Evaluation of the frequency and intensity of favipiravir-associated yellow- green fluorescence in lunulae, hair, and face. J Cosmet Dermatol 2021; Turan Ç, Metin N, Utlu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915020 54. Early favipiravir treatment was associated with early defervescence in non- severe COVID-19 patients. J Infect Chemother 2021; Fujii S, Ibe Y, Ishigo T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902990 55. Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2. J. Mol. Graph. Model. 2021; 106:107920Prabhu D, Rajamanikandan S, Sureshan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933885 56. Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part III: A green protocol for facile synthesis of complexes with TCNQ, DDQ, and TFQ acceptors. J. Mol. Liq. 2021; 335:116250Adam AMA, Saad HA, Alsuhaibani AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903781 57. Charge-transfer chemistry of azithromycin, the antibiotic used worldwide to treat the coronavirus disease (COVID-19). Part III: A green protocol for facile synthesis of complexes with TCNQ, DDQ, and TFQ acceptors. J. Mol. Liq. 2021; 335:116250Majid AAA, Saad HA, Alsuhaibani AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903781 58. In Search of RdRp and Mpro Inhibitors against SARS CoV-2: Molecular Docking, Molecular Dynamic Simulations and ADMET Analysis. J. Mol. Struct. 2021; 1239:130488Gajjar ND, Dhameliya TM, Shah GB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903778 59. Synthesis, X-ray crystal structure, IR and Raman spectroscopic analysis, quantum chemical computational and molecular docking studies on hydrazone-pyridine compound: as an insight into the inhibitor capacity of Main Protease of SARS-CoV2. J. Mol. Struct. 2021; 1239:130514Topal T, Zorlu Y, Karapınar N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903779 60. Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis. J Nepal Health Res Counc 2021; 19:1- 9Budhathoki P, Shrestha DB, Khadka S, Rawal E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934125 61. The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19. J. Pharm. Pract. 2021:897190021997399Aljadeed R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906514 62. Review of COVID-19 Treatment. J Res Pharm Pract 2020; 9:169-174Sadeghi S, Momenzadeh M, Nasri P, Nickpour M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33912498 63. The Three Pillars of COVID-19 Convalescent Plasma Therapy. Life (Basel) 2021; 11Franchini M, Liumbruno GM, Piacentini G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919577 64. Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study. Mar. Drugs 2021; 19Aatif M, Muteeb G, Alsultan A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33922914 65. Inhibition of SARS-CoV-2 Virus Entry by the Crude Polysaccharides of Seaweeds and Abalone Viscera In Vitro. Mar. Drugs 2021; 19Yim SK, Kim K, Kim IH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921174 66. A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms 2021; 9Pappa V, Bouchla A, Terpos E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920489 67. Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase. Microorganisms 2021; 9Zandi K, Musall K, Oo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921971 68. Targeting SARS-CoV-2 Spike Protein/ACE2 Protein-Protein Interactions: a Computational Study. Mol Inform 2021; Pirolli D, Righino B, De Rosa MC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904240 69. Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2. Molecules 2021; 26Alam MA, Parra-Saldivar R, Bilal M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917694 70. L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV- 2 Infection. Nutrients 2021; 13Bellamine A, Pham TNQ, Jain J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919991 71. Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc. Nutrients 2021; 13Corrao S, Mallaci Bocchio R, Lo Monaco M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33921297 72. Medicines against COVID-19 (as of the end of March 2020). Pharma-Kritik 2020; 41Gysling E. 73. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients. Pharmaceuticals (Basel) 2021; 14Noce A, Albanese M, Marrone G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917573 74. Transgene Delivery to Human Induced Pluripotent Stem Cells Using Nanoparticles. Pharmaceuticals (Basel) 2021; 14Yamoah MA, Thai PN, Zhang XD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917388 75. Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis. Pharmaceuticals (Basel) 2021; 14Zaki MEA, Al-Hussain SA, Masand VH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924395 76. Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics. Pharmaceutics 2021; 13Liu DY, Liu JC, Liang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919660 77. A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework. Pharmaceutics 2021; 13Pérez-Moraga R, Forés-Martos J, Suay-García B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918313 78. Utilizing Artificial Intelligence to Manage COVID-19 Scientific Evidence Torrent with Risklick AI: A Critical Tool for Pharmacology and Therapy Development. Pharmacology 2021:1-10Haas Q, Alvarez DV, Borissov N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910199 79. Endothelin Antagonism and Sodium Glucose Co-transporter 2 Inhibition A Potential Combination Therapeutic Strategy for COVID-19. Pulm. Pharmacol. Ther. 2021:102035Fisk M, Althage M, Moosmang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933611 80. NRF2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ards): novel mechanistic considerations. Radiother Oncol 2021; Calabrese EJ, Kozumbo WJ, Kapoor R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932453 81. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021:1-18Chan C, Foster ST, Chan KG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898925 82. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro. Structure 2021; Cheng MH, Porritt RA, Rivas MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930306 83. Ivermectin & COVID-19: Let's keep a One Health perspective. Sustain Chem Pharm 2021; 21:100438Domingo-Echaburu S, Orive G, Lertxundi U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898692 84. Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients. Transfus. Apher. Sci. 2021:103141Roshandel E, Sankanian G, Salimi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896671 85. COVID-19 convalescent plasma as long-term therapy in immunodeficient patients? Transfus. Clin. Biol. 2021; Rnjak D, Ravlić S, Šola AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901641 86. COVID-19 convalescent plasma as long-term therapy in immunodeficient patients? Transfus. Clin. Biol. 2021; Rnjak D, Ravlic S, Sola AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901641 87. Characteristics of COVID-19 Convalescent Plasma Donors and Donations in the New York Metropolitan Area. Transfusion 2021; Jain S, Garg K, Tran SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904609 88. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial. Trials 2021; 22:309Hosogaya N, Miyazaki T, Fukushige Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910617 89. Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2. Viruses 2021; 13Große M, Ruetalo N, Layer M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918670 90. Neutralizing Antibody Therapeutics for COVID-19. Viruses 2021; 13Hurt AC, Wheatley AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916927 91. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19. Viruses 2021; 13Ko M, Chang SY, Byun SY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33918958 92. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single- Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro. Viruses 2021; 13Lee G, Budhathoki S, Lee GY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918914 93. Roles of Type I and III Interferons in COVID-19. Yonsei Med. J. 2021; 62:381- 390Choi H, Shin EC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908208 94. Synthesis, antioxidant, antimicrobial and antiviral docking studies of ethyl 2- (2-(arylidene)hydrazinyl)thiazole-4-carboxylates. Z Naturforsch C J Biosci 2021; Haroon M, Akhtar T, Khalid M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=3390138

Trials (12 articles)

1. Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'. Ann. Rheum. Dis. 2021; Kaklamanos A, Karamichalos P, Vlachoyiannopoulos PG, Tzioufas AG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903096 2. Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Kaklamanos et al. Ann. Rheum. Dis. 2021; Ramiro S, Mostard RLM, Landewé RBM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903095 3. Clinical characteristics and factors associated with hospital admission or death in 43,103 adult outpatients with COVID-19 managed with the Covidom telesurveillance solution: a prospective cohort study. Clin Microbiol Infect 2021; Yordanov Y, Dinh A, Bleibtreu A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915287 4. Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2. Int J Environ Res Public Health 2021; 18McConnell D, Hickey C, Bargary N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925518 5. COVID-19 Vaccine Acceptance among College Students: A Theory-Based Analysis. Int J Environ Res Public Health 2021; 18Sharma M, Davis RE, Wilkerson AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925327 6. Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19 Pandemic-A Simulation, Randomised Crossover Trial. J Clin Med 2021; 10Rauch S, van Veelen MJ, Oberhammer R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923620 7. A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms 2021; 9Pappa V, Bouchla A, Terpos E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920489 8. A Hybrid Clinical Trial Delivery Model in the COVID-19 Era. Phys Ther 2021; Bhat A, Su WC, Cleffi C, Srinivasan S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33909902 9. Replicability of studies following a dual-criterion design. Stat. Med. 2021; Rosenkranz GK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928668 10. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial. Trials 2021; 22:309Hosogaya N, Miyazaki T, Fukushige Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910617 11. Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:310Molino S, Pisarevsky A, Mingorance FL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910614 12. The impact of theory-based messages on COVID-19 vaccination intentions: a structured summary of a study protocol for a randomised controlled trial. Trials 2021; 22:311Young B, Kotzur M, Gatting L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926540

Vaccines (128 articles)

1. Covid-19 Vaccine Acceptance, Hesitancy and Refusal among Canadian Healthcare Workers: a Multicenter Survey. Am. J. Infect. Control 2021; Dzieciolowska S, Hamel D, Gadio S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33930516 2. Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients. Ann Oncol 2021; Palich R, Veyri M, Marot S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932501 3. Response to: 'Correspondence on 'EULAR December 2020 View points on SARS-CoV-2 vaccination in patients with RMDs'' by Bugatti et al. Ann. Rheum. Dis. 2021; Bijlsma JWJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906856 4. Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs'. Ann. Rheum. Dis. 2021; Bugatti S, Balduzzi S, De Stefano L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906858 5. Behavioral and Attitudinal Correlates of Trusted Sources of COVID-19 Vaccine Information in the US. Behav Sci (Basel) 2021; 11Latkin CA, Dayton L, Miller JR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924118 6. Influenza vaccination during the coronavirus pandemic: intention to vaccinate among the at-risk population in the Central Catalonia Health Region (VAGCOVID). BMC Fam. Pract. 2021; 22:84Bonet-Esteve A, Muñoz-Miralles R, Gonzalez-Claramunt C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931039 7. Individual and social determinants of COVID-19 vaccine uptake. BMC Public Health 2021; 21:818Viswanath K, Bekalu M, Dhawan D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910558 8. Childhood immunisations in India during the COVID-19 pandemic. BMJ Paediatr Open 2021; 5:e001061Shet A, Dhaliwal B, Banerjee P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928197 9. [Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]. Bull Cancer 2021; Tougeron D, Seitz-Polski B, Hentzien M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902918 10. BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in high risk populations in Israel. Cell Rep Med 2021:100264Munitz A, Yechezkel M, Dickstein Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899031 11. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation. Clin Immunol 2021; 227:108748Turk VE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932618 12. Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel. Clin Infect Dis 2021; Swift MD, Breeher LE, Tande AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900384 13. The incremental burden of invasive pneumococcal disease associated with a decline in childhood vaccination using a dynamic transmission model in Japan: A secondary impact of COVID-19. Comput. Biol. Med. 2021; 133:104429Kitano T, Aoki H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930765 14. COVID-19 Vaccine and Hyperosmolar Hyperglycemic State. Cureus 2021; 13:e14125Abu-Rumaileh MA, Gharaibeh AM, Gharaibeh NE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927933 15. Green light after Easter: General practitioners should be able to vaccinate against COVID-19 in a few weeks. Deutsche Apotheker Zeitung 2021; 161Blasius H. 16. Why actually 6.58 euros? Fee for handling corona vaccine raises many questions - A commentary. Deutsche Apotheker Zeitung 2021; 161Müller-Bohn T. 17. Development and validation of a questionnaire to assess knowledge, attitude, practices, and concerns regarding COVID-19 vaccination among the general population. Diabetes Metab Syndr 2021; 15:919-925Kumari A, Ranjan P, Chopra S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930855 18. COVID-19 vaccination in pregnancy. Drug Ther. Bull. 2021; Girling J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931565 19. Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG. Eur. Ann. Allergy Clin. Immunol. 2021; Radice A, Fassio F, Meucci E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913314 20. Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER). Eur. J. Cancer 2021; 150:232-239Tougeron D, Hentzien M, Seitz-Polski B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934060 21. Immunogenicity of the BNT162b2 mRNA Vaccine in Heart Transplanted Patients-A Prospective Cohort Study. Eur J Heart Fail 2021; Itzhaki Ben Zadok O, Shaul AA, Ben-Avraham B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33915002 22. Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021. Euro Surveill 2021; 26Fabiani M, Ramigni M, Gobbetto V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928898 23. National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines. Euro Surveill 2021; 26Williams SR, Driscoll AJ, LeBuhn HM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928899 24. False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives. Expert Rev. Respir. Med. 2021:1-10Mouliou DS, Gourgoulianis KI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896332 25. Surveying willingness towards SARS-CoV-2 vaccination of healthcare workers in Italy. Expert Rev Vaccines 2021; Di Giuseppe G, Pelullo CP, Della Polla G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900148 26. The emergence of new strains of SARS-CoV-2. What does it mean for COVID- 19 vaccines? Expert Rev Vaccines 2021:1-4Hossain MK, Hassanzadeganroudsari M, Apostolopoulos V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33896316 27. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China. Expert Rev Vaccines 2021; Zhang MX, Zhang TT, Shi GF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929930 28. Potential 3-chymotrypsin-like cysteine protease cleavage sites in the coronavirus polyproteins pp1a and pp1ab and their possible relevance to COVID-19 vaccine and drug development. Faseb j 2021; 35:e21573Yan S, Wu G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913206 29. SARS-CoV-2 inactivated vaccine (Vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley rats. Food Chem. Toxicol. 2021; 152:112239Huang Z, Jiang Q, Wang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33901607 30. COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations. Front. Immunol. 2021; 12:669339He Q, Mao Q, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912196 31. Inhibition of SARS-CoV-2 3CL M(pro) by Natural and Synthetic Inhibitors: Potential Implication for Vaccine Production Against COVID-19. Front Mol Biosci 2021; 8:640819Ullah A, Ullah K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33912587 32. Position paper dated January 27, 2021 - COVID-19 vaccination for patients with active cancer. Geburtshilfe Frauenheilkd. 2021; 81:373-377. 33. Berlin, im Februar 2021 - COVID-19-Schutzimpfung von Schwangeren und Frauen mit Kinderwunsch. Geburtshilfe Frauenheilkd. 2021; 81:379-382Janine Z. 34. Berlin, im Januar 2021 - Hinweise zur Impfung von stillenden Frauen gegen SARS-CoV-2. Geburtshilfe Frauenheilkd. 2021; 81:377-378Zolkau J. 35. COVID-19 pandemic effect on female sexual function. Ginekol. Pol. 2021; Ilgen O, Kurt S, Aydin C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914325 36. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut 2021; Kennedy NA, Lin S, Goodhand JR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33903149 37. Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting. Healthcare (Basel) 2021; 9Simonetti O, Rizzetto G, Molinelli E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33916122 38. Parents' willingness to pay for a COVID-19 vaccine for themselves and their children in the United States. Hum Vaccin Immunother 2021:1-7Catma S, Reindl D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929290 39. Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines. Immunol. Invest. 2021:1-37Hofman K, Shenoy GN, Chak V, Balu-Iyer SV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929280 40. Determinants of intention to get vaccinated against COVID-19 among healthcare personnel in hospitals in Greece. Infect Dis Health 2021; Maltezou HC, Pavli A, Dedoukou X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906828 41. Brief review of the mRNA vaccines COVID-19. Inflammopharmacology 2021:1- 5Vitiello A, Ferrara F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932192 42. Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. Int Immunopharmacol 2021; 97:107679Bayat M, Asemani Y, Najafi S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33930707 43. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci 2021; 17:1446- 1460Park JW, Lagniton PNP, Liu Y, Xu RH. http://www.ncbi.nlm.nih.gov/pubmed/? term=33907508 44. Developing effective siRNAs to reduce the expression of key viral genes of COVID-19. Int J Biol Sci 2021; 17:1521-1529Wu R, Luo KQ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907515 45. Vaccination Prioritization Strategies for COVID-19 in Korea: A Mathematical Modeling Approach. Int J Environ Res Public Health 2021; 18Choi Y, Kim JS, Kim JE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923600 46. The Impact of Health Information Exposure and Source Credibility on COVID- 19 Vaccination Intention in Germany. Int J Environ Res Public Health 2021; 18Gehrau V, Fujarski S, Lorenz H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33924796 47. Factors Associated with COVID-19 Vaccine Hesitancy among People with Epilepsy in Lithuania. Int J Environ Res Public Health 2021; 18Puteikis K, Mameniškienė R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924140 48. Increased COVID-19 Vaccination Hesitancy and Health Awareness amid COVID-19 Vaccinations Programs in Israel. Int J Environ Res Public Health 2021; 18Shacham M, Greenblatt-Kimron L, Hamama-Raz Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917327 49. COVID-19 Severity and Neonatal BCG Vaccination among Young Population in Taiwan. Int J Environ Res Public Health 2021; 18Su WJ, Chang CH, Wang JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919644 50. Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study. Int. J. Gen. Med. 2021; 14:1389-1401El-Shitany NA, Harakeh S, Badr-Eldin SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907443 51. Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics. Int. J. Pept. Res. Ther. 2021:1-12Jain R, Jain A, Verma SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897313 52. SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey. J Am Soc Nephrol 2021; Garcia P, Montez-Rath ME, Moore H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927004 53. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. J Clin Med 2021; 10Riad A, Pokorná A, Attia S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916020 54. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure. J Clin Med 2021; 10Wolf ME, Luz B, Niehaus L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918932 55. COVID-19 Vaccination and Intention to Vaccinate Among a Sample of College Students in New Jersey. J. Community Health 2021:1-10Kecojevic A, Basch CH, Sullivan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905034 56. Dental students' attitudes and hesitancy toward COVID-19 vaccine. J. Dent. Educ. 2021; Mascarenhas AK, Lucia VC, Kelekar A, Afonso NM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913152 57. Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report. J Eur Acad Dermatol Venereol 2021; Akdaş E, İlter N, Öğüt B, Erdem Ö. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914958 58. "Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance". J Eur Acad Dermatol Venereol 2021; Busto-Leis JM, Servera-Negre G, Mayor-Ibarguren A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33899974 59. BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2. J Eur Acad Dermatol Venereol 2021; Piccolo V, Bassi A, Argenziano G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914966 60. Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations. J Immunother Cancer 2021; 9Abid MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931473 61. Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre. J Infect 2021; Garvey MI, Wilkinson MAC, Holden E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933530 62. Should healthcare workers be prioritised during the COVID-19 pandemic? A view from Madrid and New York. J. Med. Ethics 2021; Real de Asua D, Fins JJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33910974 63. Herpes Zoster emergence following mRNA COVID-19 Vaccine. J Med Virol 2021; Eid E, Abdullah L, Kurban M, Abbas O. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913545 64. COVID-19 vaccine hesitancy in perinatal women: a cross sectional survey. J. Perinat. Med. 2021; Mohan S, Reagu S, Lindow S, Alabdulla M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905622 65. A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration. J Pers Med 2021; 11D'Agostino V, Caranci F, Negro A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917902 66. COVID-19 Vaccination Perception and Attitude among Healthcare Workers in Egypt. J. Prim. Care Community Health 2021; 12:21501327211013303Fares S, Elmnyer MM, Mohamed SS, Elsayed R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913365 67. Post adenoviral-based COVID-19 vaccines thrombosis: A proposed mechanism. J Thromb Haemost 2021; Kadkhoda K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33904251 68. New-onset chilblains in close temporal association to mRNA-1273 vaccination. JAAD Case Rep 2021; 12:12-14Kha C, Itkin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898675 69. Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques. JCI Insight 2021; Sui Y, Li J, Zhang R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33908897 70. Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney- transplant patient. Kidney Int 2021; Del Bello A, Marion O, Delas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33932459 71. Post-vaccine anti-SARS-CoV-2 spike protein antibody development in kidney transplants recipients. Kidney Int Rep 2021; Husain SA, Tsapepas D, Paget KF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907723 72. Impact of COVID-19 on routine immunisation in South-East Asia and Western Pacific: Disruptions and solutions. Lancet Reg Health West Pac 2021:100140Harris RC, Chen Y, Côte P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33899040 73. Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions. Math. Biosci. 2021:108621Rao IJ, Brandeau ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915160 74. Corona vaccination in a family practice: a first experience report. MMW- Fortschritte der Medizin 2021; 163:12-17Jentzsch A, Bleckwenn M. 75. How the corona vaccination works in your practice: Remuneration for family physicians. MMW-Fortschritte der Medizin 2021; 163:34Zimmermann GW. 76. Vaccinating People with Obesity for COVID-19: EASO Call for Action. Obes Facts 2021:1-2Dicker D, Golan R, Baker JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915546 77. [Effects of the COVID-19 Pandemic on childhood immunization in Morocco: electronic survey of 103 pediatricians]. Pan Afr. Med. J. 2021; 38:134Chekhlabi N, Arrab R, Ettair S, Dini N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912304 78. Review the safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg 2021; 15:20Anand P, Stahel VP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933145 79. COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials. Pharmaceuticals (Basel) 2021; 14Yan ZP, Yang M, Lai CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923054 80. [The comparative analysis of population attitude to vaccination against COVID-19 infection in foreign countries and in Russia]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med 2021; 29:220-226Vosheva NA, Kamynina NN, Korotkova EO, Voshev DV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33901358 81. A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment. Proc Natl Acad Sci U S A 2021; 118Milkman KL, Patel MS, Gandhi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926993 82. A new fractional mathematical modelling of COVID-19 with the availability of vaccine. Results Phys 2021; 24:104213Kumar P, Erturk VS, Murillo-Arcila M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898210 83. [COVID-19 vaccination: the reality after clinical trials]. Rev. Esp. Quimioter. 2021; Ruiz-Galiana J, Cantón R, De Lucas Ramos P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33906339 84. [Effectiveness of the first dose of BNT162b2 vaccine to preventing covid-19 in healthcare personnel.]. Rev. Esp. Salud Publica 2021; 95Gras-Valentí P, Chico- Sánchez P, Algado-Sellés N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33913444 85. Assessing vaccine durability in randomized trials following placebo crossover. Stat. Med. 2021; Fintzi J, Follmann D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928660 86. Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia. Stroke 2021; American Heart Association/American Stroke Association Stroke Council L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914590 87. Safety of COVID-19 vaccines administered in the EU: Should we be concerned? Toxicol Rep 2021; 8:871-879Hernández AF, Calina D, Poulas K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898273 88. SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients. Transpl Infect Dis 2021:e13628Basic-Jukic N, Jelicic I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915005 89. The impact of theory-based messages on COVID-19 vaccination intentions: a structured summary of a study protocol for a randomised controlled trial. Trials 2021; 22:311Young B, Kotzur M, Gatting L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33926540 90. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis. Vaccine 2021; Hogan AB, Winskill P, Watson OJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933313 91. Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study. Vaccine 2021; Wang C, Han B, Zhao T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33896661 92. Strategies for Immunomonitoring after Vaccination and during Infection. Vaccines (Basel) 2021; 9Adam L, Rosenbaum P, Bonduelle O, Combadière B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918841 93. COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross- Sectional Web-Based Study. Vaccines (Basel) 2021; 9Almaghaslah D, Alsayari A, Kandasamy G, Vasudevan R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915890 94. Attitudes of Patients with Cancer towards Vaccinations-Results of Online Survey with Special Focus on the Vaccination against COVID-19. Vaccines (Basel) 2021; 9Brodziak A, Sigorski D, Osmola M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919048 95. Factors Influencing the Efficacy of COVID-19 Vaccines: A Quantitative Synthesis of Phase III Trials. Vaccines (Basel) 2021; 9Calzetta L, Ritondo BL, Coppola A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916222 96. Nursing Home and Vaccination Consent: The Italian Perspective. Vaccines (Basel) 2021; 9Cannovo N, Scendoni R, Fede MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923367 97. Willingness to Pay for a Hypothetical COVID-19 Vaccine in the United States: A Contingent Valuation Approach. Vaccines (Basel) 2021; 9Catma S, Varol S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915680 98. On a Discrete SEIR Epidemic Model with Two-Doses Delayed Feedback Vaccination Control on the Susceptible. Vaccines (Basel) 2021; 9De la Sen M, Alonso-Quesada S, Ibeas A, Nistal R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33919501 99. A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay. Vaccines (Basel) 2021; 9Donofrio G, Franceschi V, Macchi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920999 100. Demand Creation for COVID-19 Vaccination: Overcoming Vaccine Hesitancy through Social Marketing. Vaccines (Basel) 2021; 9Evans WD, French J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915695 101. Off-Label Use of COVID-19 Vaccines from Ethical Issues to Medico-Legal Aspects: An Italian Perspective. Vaccines (Basel) 2021; 9Ferorelli D, Spagnolo L, Marrone M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922415 102. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. Vaccines (Basel) 2021; 9García- Montero C, Fraile-Martínez O, Bravo C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925526 103. Analysis of the Feasibility of a Vaccination Campaign against Influenza Epidemic and COVID-19 Pandemic in French Emergency Departments: A National Survey. Vaccines (Basel) 2021; 9Ghazali DA, Choquet C, Bouzid D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921563 104. COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey. Vaccines (Basel) 2021; 9Hagens A, İnkaya A, Yildirak K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919586 105. Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation. Vaccines (Basel) 2021; 9Jahn B, Sroczynski G, Bicher M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33925650 106. Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer- BioNTech) in Patients on Hemodialysis. Vaccines (Basel) 2021; 9Jahn M, Korth J, Dorsch O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918085 107. BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19. Vaccines (Basel) 2021; 9Ji RR, Qu Y, Zhu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915773 108. COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns. Vaccines (Basel) 2021; 9Joma M, Fovet CM, Seddiki N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921113 109. COVID-19 Vaccination Intent and Willingness to Pay in Bangladesh: A Cross- Sectional Study. Vaccines (Basel) 2021; 9Kabir R, Mahmud I, Chowdhury MTH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919254 110. Effect of Information about COVID-19 Vaccine Effectiveness and Side Effects on Behavioural Intentions: Two Online Experiments. Vaccines (Basel) 2021; 9Kerr JR, Freeman ALJ, Marteau TM, van der Linden S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924542 111. The COVID-19 Vaccine Is Here-Now Who Is Willing to Get It? Vaccines (Basel) 2021; 9Killgore WDS, Cloonan SA, Taylor EC, Dailey NS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916161 112. Intention to Get COVID-19 Vaccinations among Ophthalmology Residents in Poland: A Cross-Sectional Survey. Vaccines (Basel) 2021; 9Konopińska J, Obuchowska I, Lisowski Ł et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33920462 113. Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland. Vaccines (Basel) 2021; 9Kowalska M, Niewiadomska E, Barański K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919206 114. Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy. Vaccines (Basel) 2021; 9Montalti M, Rallo F, Guaraldi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920109 115. Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST). Vaccines (Basel) 2021; 9Narasimhan M, Mahimainathan L, Araj E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924340 116. Acceptance of COVID-19 Vaccination among Front-Line Health Care Workers: A Nationwide Survey of Emergency Medical Services Personnel from Germany. Vaccines (Basel) 2021; 9Nohl A, Afflerbach C, Lurz C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33922812 117. Influenza Vaccination and Health Outcomes in COVID-19 Patients: A Retrospective Cohort Study. Vaccines (Basel) 2021; 9Pedote PD, Termite S, Gigliobianco A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917898 118. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups. Vaccines (Basel) 2021; 9Rammensee HG, Gouttefangeas C, Heidu S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923363 119. Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy. Vaccines (Basel) 2021; 9Reno C, Maietti E, Fantini MP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924534 120. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland. Vaccines (Basel) 2021; 9Rzymski P, Zeyland J, Poniedziałek B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919672 121. Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines (Basel) 2021; 9Thi TTH, Suys EJA, Lee JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918072 122. Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database. Vaccines (Basel) 2021; 9Tobaiqy M, Elkout H, MacLure K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923530 123. Motivation to Have COVID-19 Vaccination Explained Using an Extended Protection Motivation Theory among University Students in China: The Role of Information Sources. Vaccines (Basel) 2021; 9Wang PW, Ahorsu DK, Lin CY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33924604 124. Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China-A Cross-Sectional Study. Vaccines (Basel) 2021; 9Wang Q, Xiu S, Zhao S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916277 125. The COVID-19 Vaccines: Recent Development, Challenges and Prospects. Vaccines (Basel) 2021; 9Yan Y, Pang Y, Lyu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916489 126. Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study. Vaccines (Basel) 2021; 9Zanettini C, Omar M, Dinalankara W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923159 127. Development of a Vaccine against SARS-CoV-2 Based on the Receptor- Binding Domain Displayed on Virus-Like Particles. Vaccines (Basel) 2021; 9Zha L, Chang X, Zhao H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923573 128. How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Value Health 2021; 24:625-631Towse A, Chalkidou K, Firth I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33933230

Women – pregnancy (44 articles)

1. COVID-19 in Women's health: Epidemiology. Best Pract. Res. Clin. Obstet. Gynaecol. 2021; Jardine J, Morris E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33906791 2. SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave. BMC Pregnancy Childbirth 2021; 21:326Carrasco I, Muñoz-Chapuli M, Vigil-Vázquez S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33902483 3. Supporting breastfeeding in rural Newfoundland and Labrador communities during COVID-19. Can. J. Public Health. 2021; St Croix KA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929698 4. Rapid recovery achieved by intensive therapy after preterm cesarean section for worsening COVID-19-induced acute respiratory failure: A case report and literature review. Case Rep Womens Health 2021; 30:e00315Ito A, Hayata E, Nakata M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898274 5. Impact of COVID-19 Mitigation Policy in South Korea on the Reduction of Preterm or Low Birth Weight Birth Rate: A Single Center Experience. Children (Basel) 2021; 8Kim SY, Kim SY, Kil K, Lee Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=33922899 6. Bretton Woods' Pandemic Policies: A Gender Equality Analysis-Perspectives from Latin America. Development (Rome) 2021:1-10Bohoslavsky JP, Rulli M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33903788 7. COVID-19 vaccination in pregnancy. Drug Ther. Bull. 2021; Girling J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931565 8. COVID-19 and women's health: Examining changes in mental health and fertility. Econ Lett 2021; 199:109729Silverio-Murillo A, Hoehn-Velasco L, Balmori de la Miyar JR, Rodríguez A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897073 9. COVID-19 During Development: A Matter of Concern. Front Cell Dev Biol 2021; 9:659032Saavedra LPJ, Prates KV, Gonçalves GD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898461 10. Breastfeeding and COVID-19: From Nutrition to Immunity. Front. Immunol. 2021; 12:661806Vassilopoulou E, Feketea G, Koumbi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897707 11. Access to Maternal Health Services During the COVID-19 Pandemic: Experiences of Indigent Mothers and Health Care Providers in Kilifi County, Kenya. Front Sociol 2021; 6:613042Ombere SO. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898553 12. Managing a Department of Obstetrics and Gynecology in Times of COVID-19 Outbreak: The Foch Hospital Experience. Front Surg 2021; 8:564145Murtada R, Carbonnel M, Revaux A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33928113 13. Berlin, im Februar 2021 - COVID-19-Schutzimpfung von Schwangeren und Frauen mit Kinderwunsch. Geburtshilfe Frauenheilkd. 2021; 81:379-382Janine Z. 14. Vertical transmission in pregnant COVID-19 patients. Geburtshilfe Frauenheilkd. 2021; 81:361-362Lichert F. 15. Berlin, im Januar 2021 - Hinweise zur Impfung von stillenden Frauen gegen SARS-CoV-2. Geburtshilfe Frauenheilkd. 2021; 81:377-378Zolkau J. 16. Survey in hospitals - Breastfeeding management during the SARS-CoV-2 pandemic: High compliance with the recommendations of the professional societies in German gynecological hospitals. Geburtshilfe Frauenheilkd. 2021; 81:371-372Zöllkau J, Heimann Y, Kertscher C et al. 17. COVID-19 pandemic effect on female sexual function. Ginekol. Pol. 2021; Ilgen O, Kurt S, Aydin C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914325 18. COVID-19 during pregnancy one year on - what lessons did we learn? Ginekol. Pol. 2021; Nowakowski F, Krajewska K, Klimek K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914310 19. Management and Prevention of COVID-19 in Pregnancy and Pandemic Obstetric Care: A Review of Current Practices. Healthcare (Basel) 2021; 9Pountoukidou A, Potamiti-Komi M, Sarri V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920781 20. Childbirth Care among SARS-CoV-2 Positive Women in Italy. Int J Environ Res Public Health 2021; 18Donati S, Corsi E, Salvatore MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923642 21. Pregnancy Outcome during the First COVID 19 Lockdown in Vienna, Austria. Int J Environ Res Public Health 2021; 18Kirchengast S, Hartmann B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916365 22. First Surveillance of Violence against Women during COVID-19 Lockdown: Experience from "Niguarda" Hospital in Milan, Italy. Int J Environ Res Public Health 2021; 18Nittari G, Sagaro GG, Feola A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917305 23. Gender Differences in the COVID-19 Pandemic Risk Perception, Psychology, and Behaviors of Spanish University Students. Int J Environ Res Public Health 2021; 18Rodriguez-Besteiro S, Tornero-Aguilera JF, Fernández-Lucas J, Clemente- Suárez VJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33917827 24. Prevalence of Depression, Anxiety, and Perceived Stress in Postpartum Mexican Women during the COVID-19 Lockdown. Int J Environ Res Public Health 2021; 18Suárez-Rico BV, Estrada-Gutierrez G, Sánchez-Martínez M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33925373 25. Women's Depressive Symptoms during the COVID-19 Pandemic: The Role of Pregnancy. Int J Environ Res Public Health 2021; 18Yirmiya K, Yakirevich-Amir N, Preis H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33919564 26. Maternal death related to COVID-19: A systematic review and meta-analysis focused on maternal co-morbidities and clinical characteristics. Int J Gynaecol Obstet 2021; La Verde M, Riemma G, Torella M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33930185 27. Expression map of entry receptors and infectivity factors for pan- coronaviruses in preimplantation and implantation stage human embryos. J. Assist. Reprod. Genet. 2021:1-12Colaco S, Chhabria K, Singh D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913101 28. Sex-Related Differences in Drugs with Anti-Inflammatory Properties. J Clin Med 2021; 10Farkouh A, Baumgärtel C, Gottardi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916167 29. Molecular diagnosis of SARS-CoV-2 in seminal fluid. J. Endocrinol. Invest. 2021:1-10Paoli D, Pallotti F, Nigro G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33929709 30. Contested or complementary healing paradigms? Women's narratives of COVID-19 remedies in Mwanza, Tanzania. J Ethnobiol Ethnomed 2021; 17:30Mshana G, McHome Z, Aloyce D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33902620 31. COVID-19 vaccine hesitancy in perinatal women: a cross sectional survey. J. Perinat. Med. 2021; Mohan S, Reagu S, Lindow S, Alabdulla M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33905622 32. Stress, anxiety and depression in 1466 pregnant women during and before the COVID-19 pandemic: a Dutch cohort study. J. Psychosom. Obstet. Gynaecol. 2021:1-7Zilver SJM, Broekman BFP, Hendrix Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900872 33. Factors Affecting Delivery Health Service Satisfaction of Women and Fear of COVID- 19: Implications for Maternal and Child Health in Pakistan. Matern Child Health J 2021:1-11Jafree SR, Momina A, Muazzam A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33900516 34. Pandemic Birthing: Childbirth Satisfaction, Perceived Health Care Bias, and Postpartum Health During the COVID-19 Pandemic. Matern Child Health J 2021:1-10Janevic T, Maru S, Nowlin S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33909205 35. Use of Mobile Applications by Pregnant Women and Levels of Pregnancy Distress During the COVID-19 (Coronavirus) Pandemic. Matern Child Health J 2021:1-12Özkan Şat S, Yaman Sözbir Ş. http://www.ncbi.nlm.nih.gov/pubmed/? term=33929653 36. How the SARS-CoV-2 Pandemic Period Influenced the Health Status and Determined Changes in Professional Practice among Obstetrics and Gynecology Doctors in Romania. Medicina (Kaunas) 2021; 57Iorga M, Soponaru C, Socolov RV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33915713 37. Screening for Gestational Diabetes during the COVID-19 Pandemic-Current Recommendations and Their Consequences. Medicina (Kaunas) 2021; 57Panaitescu AM, Ciobanu AM, Popa M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920937 38. Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19. Pathogens 2021; 10Morotti D, Cadamuro M, Rigoli E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920814 39. The emotional impact of the Covid-19 pandemic in women facing infertility. Psychol Health Med 2021:1-7Galhardo A, Carolino N, Monteiro B, Cunha M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33913772 40. [COVID-19 and gender: certainties and uncertainties in monitoring the pandemic.]. Rev. Esp. Salud Publica 2021; 95Martín U, Bacigalupe A, Jiménez Carrillo M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33927179 41. COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment. SN Compr Clin Med 2021:1-7Hapshy V, Aziz D, Kahar P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898924 42. COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns. Vaccines (Basel) 2021; 9Joma M, Fovet CM, Seddiki N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33921113 43. Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts. Virchows Arch. 2021; Bertero L, Borella F, Botta G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33934229 44. SARS-CoV-2 and Placenta: New Insights and Perspectives. Viruses 2021; 13Resta L, Vimercati A, Cazzato G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33919284

to subscribe click here

mailing address is: [email protected]

© P.J. Lansberg